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Haem, a cyclic tetrapyrrole, is found in organisms from all three domains of life. Haem is a 
prosthetic group for many proteins involved in essential biological processes such as 
respiration and oxygen transport. Synthesis of haem in eukaryotes and most bacteria follows 
a well defined route with highly conserved intermediates. However, an alternative haem 
biosynthesis pathway in Archaea and some bacteria was recently elucidated. This newly 
discovered pathway utilises sirohaem as a metabolic intermediate rather than a prosthetic 
group.  
The alternative haem biosynthesis pathway is catalysed by the Ahb enzymes A, B, C and D. 
Initial decarboxylation of sirohaem occurs at the two acetic acid side-chains attached to 
carbons C12 and C18 to give didecarboxysirohaem, a process catalysed by AhbA and AhbB. 
Subsequently, the radical SAM enzyme AhbC converts didecarboxysirohaem to Fe-
coproporphyrin III. Finally, AhbD catalyses the conversion of Fe-coproporphyrin III into 
haem in another SAM dependent reaction. 
This study focused on the AhbA and AhbB proteins from three sources, Desulfovibrio 
desulfuricans, Desulfovibrio vulgaris and Methanosarcina barkeri. Purifications of 
individual recombinantly produced proteins revealed that both AhbA and AhbB are highly 
unstable. However, low concentrations of D. desulfuricans and D. vulgaris AhbA and AhbB 
proteins were isolated and were discovered to have decarboxylase activity. Simultaneous 
overproduction of AhbA and AhbB proteins facilitated the co-purification of stable 
heteromeric AhbA/B complexes from all three organisms. However, despite their sequence 
similarities, distinctly different properties were observed between the homologues including 
differences in oliogmeric state and haem/product binding capabilities. The D. desulfuricans 
enzyme has been crystallised and its structure has been elucidated in both apo- and product-
bound forms. Mutagenesis of the D. desulfuricans complex has provided further information 
about active site residues and a mechanism of action has been proposed. Finally, novel 
functional chimeric complexes were produced using the Desulfovibrio proteins. 
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1.1 Tetrapyrroles - The pigments of life 
Tetrapyrroles are a class of molecules which, as the name suggests, consist of four 
polymerised pyrrole rings arranged either in a linear fashion or as a macrocycle, usually 
connected via 4 methine bridges. The rings are labelled A-D in a clockwise direction (Fig. 
1.1). Linear tetrapyrroles are formed by the cleavage of cyclic tetrapyrroles and therefore 
contain 3 methine bridges, as do the cyclic corrinoids where the carbon 20 has been 
extruded. Modified tetrapyrroles are found in almost all organisms across the three domains 
of life (Bacteria, Eukaryota and Archaea) and participate in a diverse array of indispensable 
biological reactions. These reactions include electron and oxygen transport, and probably the 
most fundamental reaction required for life on Earth, photosynthesis. Naturally occurring 
tetrapyrroles include chlorophylls, haems, cobalamins, sirohaem, coenzyme F430 and haem d1 
















Figure 1.1. The structure of uroporphyrinogen III (uro’gen III). Carbon atoms that are 
frequently referred to in this thesis are labelled, as are the four pyrrole rings A-D. 
 
Modified cyclic tetrapyrroles are able to chelate a metal ion in the centre of the ring system, 
including Fe, Ni, Co, and Mg. The centrally chelated metal ion varies among the members of 
the family along with the oxidation state of the macrocycle and ring substituents all of which 
allow for the unique functional variation found within this class of molecules (Frankenberg 
et al., 2003). The combination of the conjugated ring system and bound metal ion gives 
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modified tetrapyrroles their distinctive colourations, from the green of chlorophyll to the 
deep purple of sirohaem. Due to their essential role in nature and characteristic colours they 
have been referred to as the pigments of life (Battersby, 2000). The similarities between 
cyclic tetrapyrroles are a consequence of their synthesis. All cyclic tetrapyrroles are derived 
from a central ‘blueprint’ molecule uroporphyrinogen (uro’gen III). From this molecule, 
following an array of modifications including metal insertion, side chain modification and 
ring oxidation an assortment of modified tetrapyrroles can be formed (Fig. 1.2). 
 
 
Figure 1.2. Important members of the cyclic tetrapyrrole family stemming from the 
common precursor uro’gen III. 
 




Haems, iron containing porphyrins with variants a, b, c and o,  have a plethora of 
functionalities, from oxygen and carbon dioxide transport in the cardiovascular system, to 
being cofactors to enzymes such as catalases, peroxidases and cytochrome P450s 
(Matsunaga & Shiro, 2004). As haem b is the subject of this thesis, more details of the 
structure and function of haems are given in a later section. 
 
1.1.2 Chlorophylls 
Perhaps the best known tetrapyrroles are the chlorophylls, which is reflected in the fact that 
they are the most abundant of all tetrapyrroles in nature with an estimated 10
9
 tons being 
produced each year in the changing seasons (Rudiger, 1997). Chlorophylls and 
bacteriochlorophylls are magnesium chelating tetrapyrroles and are indispensable 
components of the photosynthetic apparatus utilised by plants and bacteria to harness energy 
from sunlight and convert it to chemical energy for the organism (Bollivar, 2006). The 
production of oxygen as a by-product of photosynthesis is responsible for the formation of 
an aerobic atmosphere and the development of advanced eukaryotic life on Earth 
(Blankenship & Hartman, 1998). Bacteriochlorophyll is the bacterial equivalent of 
chlorophyll and may represent the evolutionary ancestor of chlorophyll (Lockhart et al., 
1996, Blankenship & Hartman, 1998). 
 
1.1.3 Cobalamin 
Cobalamins and other cobalt containing corrinoids are unique in the sense that they lack the 
methine bridge between rings A and D (Friedmann & Thauer, 1992). Cobalamin is the most 
complex of all the tetrapyrroles. It contains a lower nucleotide loop formed of 
dimethylbenzimidazole, as well as an upper axial ligand, which can be water 
(aquacobalamin), a methyl group (methylcobalamin), adenosine (adenosylcobalamin), or 
cyanide (vitamin B12 or cyanocobalamin). Methyl- and adenosyl-cobalamin represent the 
two active forms of cobalamin, utilising the properties of the cobalt carbon bond to augment 
a range of enzymatic processes including, rearrangement, methylation and reductive 
dehalogenation reactions (Banerjee & Ragsdale, 2003). 
 




Sirohaem is an iron containing isobacteriochlorin involved in assimilatory nitrite and 
sulphite reduction (Fritz et al., 2005, Richardson & Watmough, 1999). Sirohaem is 
considered to be one of the ‘simpler’ tetrapyrroles, requiring relatively few modifications for 
its synthesis beyond uro’gen III. Synthesis of sirohaem is discussed in greater detail later in 
this chapter. 
1.1.5 Coenzyme F430 & haem d1 
Coenzyme F430 and haem d1 remain some of the more elusive tetrapyrroles with relatively 
little known about their syntheses. Coenzyme F430 is  a yellow nickel-containing tetrapyrrole 
and is involved in methanogenesis as the cofactor of methyl-coenzyme M reductase (Thauer 
& Bonacker, 1994). Despite its name, haem d1 is not actually a member of the haem family 
as it is not a true porphyrin. In fact haem d1 is an iron containing isobacteriochlorin. Haem d1 
is a cofactor to a single enzyme, cytochrome cd1 nitrate reductase, involved in the conversion 
of nitrite to nitric oxide in denitrifying bacteria (Zajicek et al., 2009). The current 
understanding of the synthesis of haem d1 is discussed in more detail later in this chapter. 
 
1.2 Structure and function of haems 
Haems are categorised according to their side chain modifications and belong to one of the 
four types: a, b, c and o (Fig. 1.3). All haems are derived from haem b which is often 
referred to as protohaem (Kranz et al., 2009). Haems a and o have a farnesyl group in place 
of the vinyl side chain at carbon C3. Haem a also has a formyl group replacing the methyl at 
carbon C18. 
 
Haem a is the prosthetic group of cytochrome a, which forms part of the terminal enzyme 
complex of the respiratory chain responsible for reduction of dioxygen to water, causing 
release of energy in the form of a transmembrane electrochemical gradient (Hederstedt, 
2012). Haem a is found in bacteria, archaea, plants and animals. Haem o was first discovered 
as the prosthetic group of cytochrome o from Escherichia coli (Puustinen & Wikstrom, 
1991), but it was subsequently found that some archaea contain novel haem o variants as 
cofactors of cytochrome oxidases (Lubben & Morand, 1994). 
 
 





Figure 1.3. Structures of biologically important variants of haem with the dioxo-
isobacteriochlorin haem d1 for comparison. Ligands at different residues on the haem 
macrocycle are donated R1, R2, and R3 and are listed on the left. In archaea, the side chains at 
R1 of haem a and o can have longer groups (Lubben & Morand, 1994). 
 
Haem b has a diverse array of functions and is found in almost all forms of life. Haem b is 
responsible for binding and transport of oxygen and carbon dioxide as a prosthetic group of 
haemoglobin and myoglobin (O'Brian & Thony-Meyer, 2002). Cytochrome b utilises haem b 
molecules for electron transfer in the protonmotive Q cycle mechanism in the electron 
transport chain; it is therefore an indispensable component for energy generation in many 
organisms (Trumpower, 2002). Some enzymes, including peroxidases and catalases, employ 
a haem b cofactor to produce a highly reactive radical, compound I (oxo-ferryl porphyrin π-
cation radical), to catalyse a variety of reactions including oxidation, peroxidation, 
oxygenation and peroxygenation (Matsunaga & Shiro, 2004). The cytochrome P450 
enzymes are another class of proteins which utilise haem b as a cofactor, allowing them to 
catalyse complex reactions involved with the detoxification of endogenous biochemicals and 
xenobiotics (Munro et al., 2007). As well as having an extensive role as an enzyme cofactor, 
haem b has numerous other applications including being a source of iron, a transcriptional 
regulator, a component in diatomic gas sensing and having a role in pathogenicity control 
(Wilks & Burkhard, 2007, Rodgers, 1999). 
 
In contrast to the other haems, haem c is covalently attached to proteins via thioether bonds 
between two cysteine residues and the Cα of the vinyl groups at carbons C3 and C8 (Kranz 
et al., 2009). The so-called cytochrome c proteins contain a conserved CXXCH binding 
motif which provides the cysteines required for covalent modification and axial histidine 
ligand for the haem iron (Barker & Ferguson, 1999). Multiple copies of this motif can be 
present in a single polypeptide chain leading to a single protein with several covalently 
bound haem groups. Cytochrome c proteins are involved in the aerobic respiratory chain as 
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well as photosynthesis and reduction of terminal electron acceptors such as nitrates, dimethyl 
sulfoxide and metals (Richardson, 2000). As this thesis is restricted to the discussion of the 
synthesis of b-type haem further references to ‘haem’ should be considered to be referring to 
haem b. 
 
1.3 Haem biosynthesis 
1.3.1 An overview of the pathway 
Haem biosynthesis can be separated into three sections: (1) synthesis of 5-aminolevulinic 
acid (ALA), (2) formation of uro’gen III, (3) decoration of the ring system. The first two 
steps are common in the biosynthesis pathways of all cyclic tetrapyrroles. ALA, a small 5 
carbon aminoketone, is the progenitor of all cyclic tetrapyrroles and can be synthesised by 
one of two routes. The C-4 or ‘Shemin’ pathway is established in animals, fungi and the α-
proteobacteria (Shemin & Rittenberg, 1946, Kikuchi et al., 1958) and uses succinyl 
coenzyme A (succinyl-CoA) and glycine as substrates in a single step reaction to form ALA. 
The C-5 pathway, found in plants, archaea and most bacteria, uses glutamic acid to form 
ALA via glutamyl tRNA and glutamate-1-semialdehyde (Beale & Castelfranco, 1973, Jahn, 
2009). In general organisms employ one of the two pathways, although it has been shown 
that the photosynthetic organism Euglena gracilis contains functional enzymes from both 
pathways (Weinstein & Beale, 1983, Iida et al., 2002). A summary of ALA synthesis is 









Figure 1.4. A summary of ALA synthesis via the Shemin and C-5 pathways. ALA can be 
synthesised by two distinct routes. The C-4 or Shemin pathway (top) uses succinyl-CoA and 
glycine in a single step reaction. The C-5 pathway (bottom) proceeds from glutamyl-tRNA 
and glutamic acid to ALA in a three step process. 
 
After the formation of ALA, all organisms use a highly conserved pathway for the formation 
of the common cyclic tetrapyrrole intermediate uro’gen III. Porphobilinogen (PBG) is 
formed by the condensation of two molecules of ALA. Four molecules of PBG are then 
oligomerised to form pre-uroporphyrinogen (often referred to as hydroxymethylbilane). 
Subsequent ring closure and inversion of ring D produces the type III isomer of uro’gen (Fig. 
1.5). Therefore a total of eight molecules of ALA make up a single molecule of uro’gen III. 
The fact that uro’gen III is asymmetric may allow recognition of the molecule by enzymes 
facilitating selective modifications to the ring system. From the scaffold of uro’gen III a 
diverse array of chemical modifications can occur to form one of the many naturally 
occurring cyclic tetrapyrroles. The transformation of uro’gen III to haem requires 
decaboxylation of acetate side chains at carbons C2, C7, C12 and C18, conversion of 









Figure 1.5. Synthesis of uro’gen III from ALA. Synthesis of uro’gen III occurs via a 
highly conserved route in all organisms that synthesise cyclic tetrapyrroles. Chemical 
modifications are labelled in red. 
 
Enzymes involved in the biosynthesis of haem in eukaryotes are highly conserved and have 
been well characterised (Panek & O'Brian, 2002). Equally many prokaryotes follow the same 
conserved pathway with homologous enzymes, some of which are adapted for anaerobic 
haem synthesis (Panek & O'Brian, 2002). However, it has been noted that some bacteria and 
archaea lack the genes necessary for completion of haem synthesis via this route (Cavallaro 
et al., 2008). Indeed it has been demonstrated that they follow a distinctly different route 
from uro’gen III, via the formation of sirohaem and novel intermediates (Bali et al., 2011). 
Therefore, to distinguish between the two pathways they have been termed the ‘classical’ 
and ‘alternative’ pathways and will be referred to as such throughout. A summary of the two 
haem biosynthesis pathways is shown in Fig. 1.6. 
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Figure 1.6. Classic and alternative haem biosynthesis pathways. Classical haem synthesis 
route (bottom) proceeds from uro’gen III to haem in 4 steps with the final stage being iron 
insertion. For alternative haem biosynthesis (top) uro’gen III must first be converted to 
sirohaem. Modifications are labelled in blue for classical and red for sirohaem/alternative 
haem biosynthesis pathways.  
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1.3.1.1 The classical haem biosynthesis pathway 
The classical biosynthesis pathway proceeds from uro’gen III by the decarboxylation of all 
four acetate side chains yielding coproporphyrinogen. This is followed by the oxidative 
decarboxylation of the northern propionate side chains (rings A and B) forming 
protoporphyrinogen IX. Subsequent removal of six protons and six electrons and finally 
chelation of iron into the macrocycle yields the completed haem b molecule. 
 
1.3.1.2 The alternative haem biosynthesis pathway 
To start the alternative haem biosynthesis pathway uro’gen III must first be converted to 
sirohaem. This is initiated by the S-adenosyl-L-methionine (SAM) dependent methylation of 
carbons C2 and C7 to form precorrin-2. The ring system is then oxidised to produce 
sirohydrochlorin and subsequent iron chelation converts it to sirohaem. From sirohaem a 
double decarboxylation of acetate side chains occurs to form 12,18-didecarboxysirohaem. 
Removal of the northern acetate side chains (rings A and B) produces iron coproporphyrin 
III. Finally, oxidative decarboxylation of the northern propionate side chains (rings A and B) 
to vinyl groups concludes haem b synthesis. 
 
1.3.2 Synthesis of 5-aminolevulinic acid 
1.3.2.1 The C-4 or Shemin pathway 
The C-4 pathway is the simpler of the two routes to ALA formation as it is a single step 
process through the condensation of glycine and succinyl-CoA. To demonstrate the 
incorporation of glycine into tetrapyrroles Shemin ingested 
15
N labelled glycine resulting in 
the isotopic labelling of his own haem (Shemin & Rittenberg, 1946). The requirement for 
succinyl-CoA was later demonstrated using radioactively labelled acetate (Radin et al., 1950, 
Shemin & Kumin, 1952, Muir & Neuberger, 1950).  
 
ALA synthase (ALAS or HemA
C4
) catalyses the condensation of glycine and succinyl-CoA 
in a pyridoxal-5’-phostphate (PLP) dependent manner (Nandi, 1978, Alexander et al., 1994). 
ALAS has been purified from many bacterial and eukaryotic sources and has been 
biochemically characterised (Ferreira & Gong, 1995). Interestingly, bacterial sources usually 
contain a single isoform of ALAS, whereas mammals have two, the ‘housekeeping’ isoform 
(ALAS1) and the secondary isoform (ALAS2) which maintains high levels of haem 
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synthesis in erythrocytes (Bishop et al., 1990). The full length ALAS structure from 
Rhodobacter capsulatus is the only one to have been solved to date, allowing further insight 
to the mechanism of action of the enzyme (Astner et al., 2005). ALAS acts as a homodimer 
with two active sites, each binding a PLP molecule via a conserved lysine residue when in 
the substrate-free state. Addition of glycine causes transaldimination allowing the PLP to 
bind directly to glycine instead of the lysine. PLP-glycine then nucleophilically attacks 
succinyl-CoA, initiating addition of succinic acid to glycine and the loss of CoA. Finally, 
decarboxylation of the glycine moiety of this intermediate yields ALA bound to PLP ready 
for release. 
 
1.3.2.2 The C-5 pathway 
Surprisingly, the ALA synthesis pathway in plants was not discovered for a further 25 years, 
long after the C-4 pathway had been established and characterised. It was clear that using 
labelled glycine in plant tissues did not produced the same incorporation pattern in ALA that 
had been observed in organisms using the C-4 pathway. The use of 
14C labelled glutamate, α-
ketoglutarate and glutamine was employed and it was discovered that these yielded 
14
C 
labelled ALA (Beale & Castelfranco, 1973). Later it was revealed that the entire carbon 
skeleton from glutamate was incorporated into ALA (Beale et al., 1975). This work lead to 
the unearthing of the C-5 pathway; highly distinct from the C-4 pathway it is a multi-enzyme 
process that converts glutamic acid to ALA. 
 
The enzyme GluRS catalyses the addition of glutamic acid to tRNA, producing glutamyl-
tRNA (tRNA
Glu), which is often considered the ‘initial’ substrate of the C-5 pathway (Jahn et 
al., 1992). Both tetrapyrrole and protein biosyntheses utilise tRNA
Glu
. Subsequently, the 
NADPH-dependent reduction of tRNA
Glu
 by the enzyme glutamyl-tRNA reductase (GluTR 
or HemA
C5
) occurs, converting it to glutamate-1-semialdehyde [GSA; (Moser et al., 1999, 
Chen et al., 1990)]. Finally GSA is converted to ALA in a PLP-dependent manner by 
glutamate-1-semialdehyde-2,1-aminomutase [GSAM or HemL; (Hoober et al., 1988)]. 
 
GluTR functions as a homodimer and recognises the tRNA substrate by its size and shape 
(Randau et al., 2004). Use of NADPH analogues also showed that GluTR is highly specific 
for NADPH (Moser et al., 1999). The structure of Methanopyrus kandleri GluTR has been 
solved which revealed it to be an unusual extended V-shaped dimer linked at the C-terminal 
domain of each monomer. During the reaction a conserved cysteine acts as a nucleophile 
attacking the α-carbonyl group of tRNA-bound glutamate resulting in an enzyme-bound 
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thioester intermediate. Hydride transfer from NADPH to the thioester-bound glutamate 
produces GSA. Without NADPH the reactive thioester intermediate is hydrolysed releasing 
free glutamate (Schauer et al., 2002). 
 
There are two possible reaction mechanisms for the transamination of GSA to ALA and all 
GSAM proteins characterised to date have been shown to be able to catalyse both reactions 
(Smith et al., 1991, Ilag & Jahn, 1992). The first mechanism involves GSAM-bound 
pyridoxamine 5’-phosphate (PMP). In this instance the PMP reacts with the aldehyde of 
GSA creating the intermediates 4,5-diaminovalerate (DAVA) and PLP. The C4 amino group 
of DAVA is then abstracted, regenerating PMP and yielding ALA. The second mechanism 
starts with PLP as a cofactor and the reaction proceeds via the intermediates 4,5-
dioxovalerate (DOVA) and PMP, with the final step regenerating PLP and producing ALA.  
 
Crystal structures have been determined for two GSAM proteins, one from Synechococcus 
(Hennig et al., 1997) the other from Thermosynechococcus elongates (Schulze et al., 2006).  
Interestingly, both demonstrated differing dimer conformations and bound cofactors. 
Synechococcus revealed an asymmetric dimer containing a covalently bound PLP in one 
monomer and a non-covalent PMP in the other. The T. elongates enzyme was crystallised as 
a symmetric homodimer containing one PLP in each monomer. These results leave the true 
mechanism of action for GSAM still to be determined. 
 
Given the unstable nature of GSA it was proposed that the intermediate could be protected 
from the surrounding environment by the formation of a GluTR-GSAM complex (Layer et 
al., 2010). Based on surface complementarity between the two proteins it was suggested that 
direct substrate channelling occurred preventing exposure of GSA to the cellular 
environment. Indeed it has been shown that GluTR and GSAM form a complex in both 
Chlamydomonas reinhardtii and E. coli (Nogaj & Beale, 2005, Luer et al., 2005).  
 
1.3.3 Synthesis of uroporphyrinogen III 
From ALA, uro’gen III synthesis is completed in 3 further steps that are highly conserved in 
all organisms. The first step is the asymmetric condensation of two molecules of ALA to 
form the pyrrole PBG. This reaction is catalysed by the enzyme porphobilinogen synthase 
(PBGS) also known as ALA dehydratase (ALAD) or HemB (Gibson et al., 1954). Despite a 
high level of sequence similarity between PBGS proteins metal dependency of these 
enzymes varies between organisms (Jaffe, 2000). For example, PBGS enzymes from yeast 
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and mammals contain two zinc ions (Senior et al., 1996), whereas the enzyme from 
Psuedomonas aeruginosa contains magnesium instead (Shoolingin-Jordan et al., 2002). Dual 
zinc and magnesium proteins also exist, in E. coli for example (Jaffe, 2000). However, there 
is also evidence of PBGS enzymes that are functional independent of metals (Bollivar et al., 
2004). 
 
Structural studies showed that the fundamental subunit of PBGS is formed from an 
asymmetric homodimer that arranges into a final octameric structure. Substrate binding is 
achieved by two conserved lysine residues with the initial ALA molecule binding the ‘P-site’ 
that will form the propionate group on PBG, and the secondary ALA binding the ‘A-site’, to 
form the acetate side chain (Jordan & Gibbs, 1985).  After formation of a Schiff base 
between the lysine residues and ALA molecules the reaction continues with C-C bond 
formation between carbon C3 of the A-site ALA and carbon C4 of the P-site ALA. 
Consequently, the C-N bond forms between the ALA molecules and final deprotonation of 
the P-site ALA yields the completed PBG molecule (Frere et al., 2002, Jaffe et al., 2002, 
Kervinen et al., 2001). 
 
The subsequent stage in uro’gen synthesis is the oligomerisation of four molecules of PBG 
to form the linear tetrapyrrole pre-uroporphyrinogen [hydroxymethylbilane (Warren & 
Jordan, 1988)]. This reaction is catalysed by the enzyme porphobilinogen deaminase 
(PBGD) also known as hydroxymethylbilane synthase or HemC. PBGD contains a novel 
dipyrromethane cofactor that is in fact produced from two molecules of PBG (Hart et al., 
1987, Jordan & Warren, 1987). Dipyrromethane is covalently linked to the enzyme and is 
utilised as a primer for the ligation of the PBG molecules. This occurs sequentially starting 
with ring A and continuing with rings B, C and D in order releasing four molecules of 
ammonia and resulting in a linear protein-bound hexapyrrole (Warren & Scott, 1990, 
Battersby et al., 1979, Jordan & Seehra, 1979). Finally, the tetrapyrrole is released by the 
cleavage of the product-cofactor bond, regenerating the enzyme. Catalysis is achieved using 
a conserved aspartate residue that carries out the deamination of PBG (Woodcock & Jordan, 
1994). Structural studies revealed that this monomeric enzyme utilises a conserved cysteine 
residue in the active site to retain the cofactor through a thioether bond (Louie et al., 1992). 
 
In the final step of uro’gen III synthesis ring D is inverted, before closure of the ring system 
by linkage of rings A and D. Uro’gen III synthase (UROS or HemD) carries out these 
reactions via the formation of a spirocyclic pyrrolenine intermediate (Layer et al., 2004). Use 
of inhibitory spirocyclic intermediates and 
13
C NMR as well as discovery of an azafulvene 
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reaction intermediate has contributed to the current mechanistic understanding of these 
reactions (Shoolingin-Jordan, 1995, Silva & Ramos, 2008, Spivey et al., 1996). 
 
Completion of uro’gen III synthesis is initiated with the rearrangement of ring A producing a 
positive charge on the pyrrole nitrogen and removal of the ring A hydroxyl group as water. 
This represents the formation of the first azafulvene intermediate. After bond rearrangement 
of ring D, the ring A azafulvene then attacks the substituted α position of ring D to form the 
spirocyclic pyrrolenine intermediate. Bond breakage between rings C and D produces 
another azafulvene intermediate on ring C. After the orientation of ring D moves the free α 
position in the vicinity of the ring C azafulvene they react forming a closed ring system. 
Subsequent deprotonation and bond rearrangements yield the final reaction product uro’gen 
III. Formation of uro’gen III represents the final branch point in the biosynthesis of all cyclic 
tetrapyrroles. 
 
1.3.4 Completion of haem synthesis via the classical pathway 
The classical pathway of haem synthesis has been well characterised for many years and 
proceeds in a four step process from uro’gen III to haem through the modification of side 
chains, oxidation of the ring system and finally iron insertion. Crystal structures of enzymes 
involved in each stage of this process have been solved from various sources. Interestingly, 
the first two steps in this pathway are shared with the chlorophyll biosynthesis pathway 
which then diverges at the point of metal insertion. 
 
Uro’gen III is fated down the haem/chlorophyll pathway by the sequential decarboxylation 
of the four acetate side chains at carbons C2, C7, C12 and C18 (Dailey, 2002). These 
reactions are catalysed by the enzyme uro’gen III decarboxylase (UROD or HemE) which 
acts in a clockwise direction starting at ring D and successively decarboxylating to form the 
final product coproporphyrinogen III (copro’gen III) with the concomitant release of four 
molecules of CO2 (Luo & Lim, 1993). The decarboxylations occur in a random order at high 
concentrations of uro’gen III. UROD is capable of using uro’gen I and uro’gen III as 
substrates as well as all of the semi-decarboxylated intermediates between uro’gen III and 
copro’gen III (Smith & Francis, 1979). Interestingly, unlike many other decarboxylases 
UROD does not require any cofactor or metal ion to catalyse these reactions. 
 
The crystal structure of human HemE showed that it forms a homodimer with active sites 
from each monomer facing each other. Use of a single chain HemE along with the crystal 
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structure of HemE containing copro’gen III lead to the current understanding of the 
mechanism where-by after each decarboxylation the tetrapyrrole re-orientates 90° in the 
active site ready for the next decarboxylation, as opposed to the use of two active sites or the 
release and flipping of the tetrapyrrole by 180° (Phillips et al., 2009, Phillips et al., 2003). 
The exact reaction mechanism of HemE has not been determined; however, a reaction 
mechanism has been proposed involving two conserved residues, Arg37 and Asp86 (Lewis 
& Wolfenden, 2008). Initially, Arg37 is expected to form an ion pair with the scissile acetate 
carboxyl group, allowing that portion of the substrate to enter the nonpolar cavity within the 
active site where the decarboxylation occurs. Subsequently, Asp86 protonates the pyrrole 
ring at the α-position adjacent to the position of the acetate side chain as CO2 is removed, 
producing a carbanionic intermediate. The product is then formed by proton abstraction from 
Arg37. Each decarboxylation reaction is suspected to proceed using an identical reaction 
mechanism after reorientation of the decarboxylated intermediates by 90º. It has been 
estimated that if the decarboxylation of uro’gen III was to occur spontaneously the half-life 
would be in excess of two billion years, which has led to HemE being referred to as a 
‘benchmark for the catalytic proficiency of enzymes’ (Lewis & Wolfenden, 2008). 
 
Conversion of copro’gen III to protoporphyrinogen IX (proto’gen IX) requires the oxidative 
decarboxylation of the two propionate side chains on rings A and B to vinyl groups. These 
reactions are catalysed by one of two structurally and mechanistically distinct enzymes, the 
oxygen-dependent copro’gen oxidase (CPO) HemF and oxygen-independent CPO HemN, 
which is often called copro’gen dehydrogenase (CPDH) to avoid confusion (Layer et al., 
2010). HemF is found in eukaryotes and only a few bacteria, which normally contain HemN 
(Cavallaro et al., 2008). 
 
HemF is a dimeric metal-independent membrane associated enzyme which utilises molecular 
oxygen as a terminal electron acceptor during catalysis (Macieira et al., 2003, Medlock & 
Dailey, 1996, Breckau et al., 2003). The exact mechanism of action is yet to be determined 
but it has been demonstrated that the propionate group on ring A is decarboxylated before 
that of ring B forming a monovinyl intermediate harderoporphyrinogen (Elder et al., 1978). 
Mutagenesis of the human CPOs has suggested the involvement of two conserved arginine 
residues and a conserved aspartate residue in substrate binding and catalysis (Stephenson et 
al., 2007). Structures of Saccharomyces cerevisiae and human HemF proteins have been 
solved and confirmed the presence of the dimeric structure (Phillips et al., 2004, Lee et al., 
2005), but the lack of a substrate bound complex has restricted the understanding of the 
reaction mechanism of HemF. However, putative mechanisms have been proposed (Silva & 
Ramos, 2008, Lash, 2005). 




Unlike HemF, HemN belongs to the radical SAM family of enzymes (Sofia et al., 2001). 
Radical SAM enzymes are known to catalyse a wide range of reactions using SAM and a 
reductant to activate and functionalise typically unreactive C-H bonds (Atta et al., 2010, 
Booker, 2009). This is achieved through the use of a [4Fe-4S] centre which is coordinated by 
three cysteines usually found in the conserved motif CX3CX2C (Layer et al., 2004). Each 
cysteine coordinates one iron, with the final iron coordinated to the methionine moiety of 
SAM. The reaction cycle is initiated by the reduction of the iron sulphur cluster from the 
resting [4Fe-4S]
2+
 to the active [4Fe-4S]
+
 state. An electron is transferred onto SAM causing 
homolytic cleavage and the formation of a [4Fe-4S]
2+
-methionine intermediate and a 5’-
deoxyadenosyl radical which is capable of abstracting a hydrogen atom from the substrate or 
a glycine on a partner protein forming a substrate or protein localised radical. After this the 
following steps are unique to each radical SAM enzyme but generally result in the 
irreversible consumption of SAM which therefore acts as a co-substrate. 
 
The initial electron donor and final electron acceptor for the oxidative decarboxylation 
reactions of the northern propionate groups of copro’gen III are yet to be discovered, but the 
reaction mechanism has been determined using isotopic labelling (Layer et al., 2006). The 
5’-deoxyadenosyl radical abstracts the pro-S-hydrogen at the β-position of the propionate 
side chain of the substrate, which forms an allylic coproporphyrinogenyl radical and 5’-
deoxyadenosine. After the formation of the substrate radical the first of the two 
decarboxylations can occur using an unknown electron acceptor. The crystal structure of 
HemN was the first radical SAM enzyme to have its crystal structure solved and was shown 
to be a monomeric enzyme which contained two SAM binding sites (Layer et al., 2003). It 
has also been shown that turnover of copro’gen III to proto’gen IX requires two molecules of 
SAM for completion, i.e. one for the oxidative decarboxylation of each propionate group 
(Layer et al., 2005). 
 
Some proteins from bacteria, plants and animals have been annotated as HemN due to high 
sequence similarity although they lack CPO/CPDH function and have since been annotated 
as HemW (Abicht et al., 2012). Indeed, HemW from Lactococcus lactis has ~50% similarity 
to E. coli HemN but is not active (Abicht et al., 2012). However, it does bind haem and is 
suspected to play a role in haem transport. 
 
Prior to iron insertion the ring system is oxidised to form a fully conjugated, aromatic, and 
planar macrocycle. Proto’gen IX is converted to protoprophyrin IX by the action of one of 
three proto’gen IX oxidases, HemY, HemG or HemJ, which remove six electrons and six 
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protons (two from the imino groups and one from each of the four bridging carbon atoms) 
from the substrate (Dailey & Dailey, 1996, Sasarman et al., 1993, Boynton et al., 2011). 
 
HemY is an oxygen- and flavo-dinucleotide (FAD) dependent enzyme found in most 
organisms as a membrane bound protein [inner mitochondrial membrane in eukaryotes, and 
cytoplasmic membrane in prokaryotes; (Dailey & Dailey, 1996, Dailey & Dailey, 1997)], 
although a soluble form has been described in Bacillus subtilis (Corrigall et al., 1998). 
HemY is present in monomeric or dimeric forms depending on the organism and has been 
crystallised from various sources revealing a non-covalently bound FAD cofactor in each of 
them (Koch et al., 2004, Corradi et al., 2006, Heinemann et al., 2007). Little is known about 
the reaction mechanism of HemY other than the involvement of FAD, formation of H2O2 
and oxygen being the terminal electron acceptor (Layer et al., 2010). 
 
The second proto’gen IX oxidase, HemG, is unique to γ-proteobacteria and allows synthesis 
of haem in both oxic and anoxic environments (Boynton et al., 2009). HemG is able to 
utilise a range of compounds as terminal electron acceptors including oxygen, fumarate or 
nitrate and is coupled to electron transport chains leading to the generation of ATP instead of 
H2O2 as a by-product (Jacobs & Jacobs, 1976, Mobius et al., 2010). 
 
The third proto’gen oxidase, HemJ, has only recently been identified and very little is 
currently known about it (Kato et al., 2010). However, it has been shown through 
comparative genomics that bacteria that contain the classical haem synthesis pathway but 
lack both hemY and hemG tend to contain a hemJ gene and that deletion of hemJ in 
Actinobacter baylyi causes haem auxotrophy (Boynton et al., 2011). 
 
The conclusion of classical haem synthesis is the chelation of iron into the macrocycle of 
protoprophyrin IX to form protohaem (haem b). The ferrochelatase HemH catalyses iron 
chelation independent of additional cofactors or metal ions. Some HemH proteins have been 
found to contain [2Fe-2S] centres, the role of which is yet to be determined (Wu et al., 
2001). Ferrochelatase enzymes can be found as monomeric or dimeric enzymes, both 
membrane-associated and cytoplasmic depending on the organism (Dailey et al., 2000). 
Several crystal structures of HemH have been solved including those from human, yeast and 
B. subtilis (Wu et al., 2001, Al-Karadaghi et al., 1997, Karlberg et al., 2002). The exact 
mechanism for iron chelation is unknown but it has been shown that HemH can accept a 
wide range of porphyrin substrates with differing substituents on rings A and B; however, 
the propionate groups on rings C and D appear essential for activity (Dailey et al., 1989). 
HemH shares structural homology to other chelatase enzymes including those involved in 
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sirohaem synthesis and cobaltochelatases from the anaerobic cobalamin synthesis pathway, 
suggesting that they share a common ancestral source (Romao et al., 2011). 
 
An additional protein (HemQ) has recently been discovered that is essential for haem 
synthesis in Gram-positive bacteria (Dailey et al., 2010). The study showed that HemQ is 
required along with HemY and HemH to form haem both in vitro and in vivo. Exactly what 
HemQ does is currently unclear, although it has been proposed to be involved in removal of 
H2O2 generated by HemY. 
 
1.3.5 Biosynthesis of sirohaem 
To introduce the alternative haem biosynthesis pathway the route to the precursor sirohaem 
must first be discussed. Sirohaem follows a comparatively simple biosynthetic pathway from 
uro’gen III containing three stages: (1) addition of SAM derived methyl groups to carbons 
C2 and C7 of uro’gen III to form precorrin-2, (2) oxidation of precorrin-2 to 
sirohydrochlorin, (3) chelation of iron into the macrocycle (Fig. 1.6). A variety of enzymes 
are employed by different organisms to catalyse these reactions. For example, Bacillus 
megaterium contains individual enzymes for each stage of the process, a SAM-dependent 
uro’gen III methyltransferase (SUMT) SirA, a precorrin-2 dehydrogenase SirC and a 
ferrochelatase SirB (Raux et al., 2003). S. cerevisiae, however, contains two enzymes, a 
SUMT (Met1p) and a bi-functional precorrin-2 dehydrogenase and ferrochelatase Met8p 
(Raux et al., 1999a). E. coli contains a single multifunctional enzyme (CysG) that is capable 
of converting uro’gen III to sirohaem alone (Warren et al., 1994). CysG contains two 
domains, CysG
A
 which is homologous to SUMT enzymes SirA and Met1p, and CysG
B
 
which is homologous to the precorrin-2 dehydrogenases and ferrochelatases. 
 
As with haem and chlorophyll, the sirohaem pathway shares intermediates with other 
tetrapyrrole biosynthesis pathways. Precorrin-2 is converted to precorrin-3 by CobI, to 
initiate aerobic cobalamin biosynthesis (Warren et al., 2002), as well as being an 
intermediate in the as yet uncharacterised biosynthesis of coenzyme F430 (Warren et al., 
2009). The anaerobic pathway of cobalamin synthesis diverges at the point of 
sirohydrochlorin with the chelation of cobalt into the macrocycle by the enzymes CbiK or 
CbiX (Raux et al., 2003). A summary of the branch points of tetrapyrrole biosynthesis is 
displayed in Figure 1.7. 
 





Figure 1.7. An overview of branch points in tetrapyrrole biosynthesis. The known 
branch points for the synthesis of modified tetrapyrroles starting from the common precursor 
uro’gen III. Functional tetrapyrroles are highlighted with their natural colouration. 
 
The synthesis of sirohaem in many of the bacteria and archaea that use the alternative haem 
biosynthesis pathway is yet to be fully characterised. Many archaeal genomes appear to have 
a SUMT, although annotations are varied between cobA, cysG-1, cysG-2, cysG, uroM, or 
hemX. Similarly, the gene encoding precorrin-2 dehydrogenase is referred to as sirC, hemX, 
cysG, or cysG1 (Storbeck et al., 2010). Archaeal genomes also lack a dedicated sirohaem 
ferrochelatase, although it has been demonstrated that the short cobaltochelatase CbiXS from 
Methanosarcina barkeri and Methanobacter thermoautotrophicum is capable of chelating 
iron into sirohydrochlorin, although at a lower rate to that of cobalt insertion (Brindley et al., 
2003). It is therefore possible that this protein has a dual role in cobalt and iron chelation. 
The sulphate reducing bacterium Desulfovibrio vulgaris possesses a bi-functional uro’gen III 
synthase/methyltransferase (HemD-CobA) and a precorrin-2 dehydrogenase and is therefore 
capable of synthesising sirohydrochlorin (Lobo et al., 2009). A unique sirohaem 
ferrochelatase is absent in the D. vulgaris genome. However, D. vulgaris does possess two 




), which have been shown to chelate both 
cobalt and iron into sirohydrochlorin (Lobo et al., 2008). Genomes of other δ-proteobacteria 
also contain genes encoding these proteins including members of the groups Desulfovibrio, 
Desulfobulbus, Desulfatibacillum, and Desulfobacterium (Lobo et al., 2012). 
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1.3.6 Biosynthesis of haem d1 
Again, a brief introduction to the biosynthesis of haem d1 is required in order for a fuller 
understanding of the alternative haem biosynthesis pathway. As mentioned previously haem 
d1 is only required as a cofactor for one enzyme, cytochrome cd1 nitrite reductase, which is 
encoded by the gene nirS (Bali et al., 2014). The essential genes for haem d1 synthesis 
belong to the nir family and can be found in the region downstream of nirS and include the 
genes nirFDLGHJE (Suzuki et al., 2006, Palmedo et al., 1995). NirE represents the most 
well characterised Nir protein and shares high sequence homology with known SUMT 
enzymes including the C-terminal region of CysG, CobA (methyltransferase of the 
cobalamin pathway), SirA, and Met1p (Warren et al., 2009).  
 
NirD, NirL, NirG and NirH are all cytoplasmic proteins which share a high degree of 
sequence homology (Bali et al., 2014). In some cases nirD and nirL are found fused 
resulting in the production of a single protein. Despite their homology all four enzymes are 
not functionally redundant, and have been shown to be essential for nitrite reductase function 
(Palmedo et al., 1995, Kawasaki et al., 1997). The roles of NirDL-G-H were elucidated at 
the same time as the alternative haem biosynthesis pathway. NirDL-G-H from Paracoccus 
pantotrophus were found to catalyse the double decarboxylation of sirohaem to 
didecarboxysirohaem (Bali et al., 2011). NirDL was found to produce a monodecarboxylated 
intermediate; however no structural analysis of this product was undertaken. 
 
The roles of NirJ and NirF are currently unknown. NirJ is a radical SAM protein containing 
two cysteine motifs for iron sulphur clusters. It has been postulated that NirJ catalyses the 
elimination of the propionate side chains of didecarboxysirohaem at carbons C3 and C8 by 
activating the alkyl leaving groups using radical chemistry. However, NirJ may also catalyse 
the two electron oxidation of the propionate side chain at carbon C17 yielding an acrylate 
functionality. NirF has been shown to form a complex with NirS and another protein NirN, 
and also binds haem d1 in vitro (Nicke et al., 2013). This lead to the hypothesis that NirF is 
involved in the terminal stages of haem d1 synthesis and formation of holo-NirS, although it 
is currently unknown which reaction it would carry out.  
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1.3.7 The alternative haem biosynthesis pathway 
D. vulgaris was the first organism to be found to synthesise haem via an alternative route 
some 20 years ago, although the pathway was not unravelled until many years later. The 
discovery of the alternative pathway was by serendipity when labelled methionine was 
unexpectedly incorporated into the haem prosthetic group of cytochrome c3 (Akutsu et al., 
1993). To measure redox potentials of cytochrome c3 selective deuteration of methionine 
residues was performed by culturing D. vulgaris in minimal media supplemented with L-
methionine-methyl-d3. During NMR assignment of the haem groups in the labelled 
cytochrome c3 it was noted that two methyl groups had a diminished signal in comparison to 
the others, signifying that they had acquired labelled methyl groups derived from deuterated 
methionine. All methyl groups of haem synthesised via the classical pathway are derived 
from ALA, suggesting an alternative haem biosynthesis pathway exists in this organism 
utilising methionine for the formation of some methyl groups. It was discovered that the 
diminished signal belonged to methyl groups at carbons C2 and C7 and it was proposed that 
the pathway proceeds via precorrin-2, and possibly sirohydrochlorin, where these methyl 
groups are derived from SAM (Scott, 1990). The same process has also been confirmed for 
the biosynthesis of haem d1 (Yapbondoc et al., 1990). 
 
Extraction of labelled tetrapyrroles from cultures of D. vulgaris supplemented with 
deuterated L-methionine-methyl-d3 further confirmed the presence of an alternative pathway 
(Ishida et al., 1998). Several potential pathway intermediates were isolated, including 
sirohydrochlorin, coproporphyrin III, and protoporphyrin IX as well as a previously 
unknown hexacarboxylic acid termed 12,18-didecarboxysirohydrochlorin. From these 
findings the pathway was proposed to proceed from uro’gen III to precorrin-2 and then re-
join the classical pathway after the formation of copro’gen III. Following this pathway 
would require 6 steps from uro’gen III as opposed to the 4 present in the classical pathway 
and would proceed as follows: (1) methylation of carbons C2 and C7 of uro’gen III to form 
precorrin-2, (2) decarboxylation of carbons C12 and C18, to form 12,18-
didecarboxyprecorrin-2, (3) elimination of acetate groups from carbons C2 and C7 to form 
copro’gen III, (4) decarboxylation of propionate side chains on carbons C3 and C8 to vinyl 
groups forming proto’gen IX, (5) oxidation of ring system to form protoporphyrin IX, (6) 
insertion of ferrous iron to form haem. As with the classical pathway insertion of iron was 
proposed to be the final stage in the process as metal-chelated intermediates may be 
cytotoxic.  
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The search for the enzymes catalysing the alternative haem biosynthesis pathway was greatly 
aided by the growing number of sequenced bacterial and archaeal genomes, which were also 
able to reveal that the alternative pathway is not restricted to sulphate-reducing bacteria as 
originally thought (Panek & O'Brian, 2002, Cavallaro et al., 2008, Storbeck et al., 2010). 
Indeed, it was shown using similar labelling studies as in D. vulgaris, that haem in M. 
barkeri also contains two SAM-derived methyl groups, suggesting the use of the same 
pathway in both organisms (Buchenau et al., 2006). Through genome wide searches for 
homologs of the classical haem synthesis pathway, it was discovered that some bacteria and 
archaea only contain the genes required for early haem biosynthesis up to uro’gen III (i.e. 
hemA, hemL, hemB, hemC, and hemD; Fig. 1.5) and lack the necessary genes to convert 
uro’gen III to haem via the classical pathway [hemE, hemF/N, hemY/G/J, and hemH; Fig. 
1.6; (Cavallaro et al., 2008, Panek & O'Brian, 2002, Storbeck et al., 2010)]. Therefore the 
theory that the alternative pathway re-entered the classical pathway with copro’gen III could 
not be upheld and the alternative pathway was proposed to have a unique set of enzymes that 
catalyse the conversion of uro’gen III to haem.  
 
D. vulgaris was among the bacteria found to only contain genes required for uro’gen III 
synthesis. Further genomic analysis revealed it also contained homologs of nirD and nirJ 
(Lobo et al., 2009), which had been shown to be involved with haem d1 synthesis (Kawasaki 
et al., 1997), a somewhat surprising discovery given that D. vulgaris does not contain 
cytochrome cd1 nitrite reductase. Analysis of archaeal genomes revealed clusters containing 
early hem genes with genes encoding SUMT and precorrin-2 dehydrogenase, further 
supporting the use of sirohydrochlorin as an intermediate in alternative haem synthesis 
(Storbeck et al., 2010). Similarly, many of these gene clusters also contained homologs of 
nirD, nirH and nirJ, despite the fact only 3 of 27 of the species containing these genes also 
contained a potential cytochrome cd1 nitrite reductase. It was therefore suspected that these 
genes may be involved in alternative haem biosynthesis.  
 
Given their different role these genes were re-annotated as the ahb (alternative haem 
biosynthesis) genes and will be referred to as such throughout. The genes ahbA and ahbB are 
homologous to nirD and nirH, respectively, and ahbC and ahbD are homologous to nirJ. 
Following these discoveries a new pathway was proposed based on previously suggested 
roles for the Nir proteins (Kawasaki et al., 1997, Storbeck et al., 2010): (1) decarboxylation 
of the acetate side chains at carbons C12 and C18 of sirohydrochlorin by AhbA and AhbB, 
(2) removal of the acetate side chains at carbons C2 and C7 by AhbC, (3) the oxidative 
decarboxylation of propionate side chains on carbons C3 and C8 to vinyl groups by AhbD, 
(4) chelation of iron into the macrocycle by an unidentified ferrochelatase. 




The lack of a dedicated ferrochelatase was somewhat confusing until the final piece of 
puzzle was discovered some 20 years after the initial revelation of the alternative pathway. 
The iron chelated form of sirohydrochlorin, sirohaem, was found to be the true initial 
substrate of the alternative haem biosynthesis pathway (Bali et al., 2011). Once regarded as 
the end product of a biosynthesis pathway, the use of sirohaem was unexpected, but equally 
so was the link between the alternative haem and haem d1 pathways. Indeed, both NirDL-G-
H and AhbA/B were found to convert sirohaem to the intermediate didecarboxysirohaem, at 
which point the two pathways diverge. Total conversion of sirohaem to haem was achieved 
using cell lysates of D. vulgaris which resulted in the isolation of haem as well as the 
intermediates monodecarboxysirohaem, didecarboxysirohaem and a monovinyl iron 
coproporphyrin. 
 
A dedicated pathway for the formation of sirohaem for the alternative pathway is unlikely to 
exist given that many of the organisms that utilise the alternative pathway also have a 
requirement for sirohaem as a cofactor in nitrite and sulphite reductases (Susanti & 
Mukhopadhyay, 2012), or are able to produce cobalamin.  Indeed, in a previous study of 
archaeal genomes only four organisms (Aeropyrum pernix K1, Ignicoccus hospitalis KIN4/I, 
Methanosphaerula palustris E1-9c, and Hyperthermus butylicus DSM 5456) were shown to 
contain ahbA, B, C, and D homologues but did not have evidence of a sirohaem-containing 
sulphite or nitrite reductase or lacked cobalamin biosynthesis genes (Storbeck et al., 2010). 
The use of iron chelated sirohaem may explain why a ferrochelatase dedicated to the 
alternative haem biosynthesis pathway was not discovered. The discovery that sirohaem is an 
intermediate as well as a functional tetrapyrrole has raised questions about the potentially 
complex regulatory pathways required by organisms that utilise sirohaem and/or 
cobalamin/coenzyme F430 and also contain the alternative haem or haem d1 synthesis 
pathways. Use of precorrin-2, sirohydrochlorin and sirohaem must be tightly regulated to 
allow flux along all of the pathways. 
 
1.3.8 Completion of haem synthesis via the alternative pathway 
The alternative haem biosynthesis pathway is now known to proceed in three stages and can 
be assigned to specific enzymes although mechanistic studies are yet to be completed. (1) 
Acetate side chains at carbons C12 and C18 of sirohaem are decarboxylated by AhbA and 
AhbB to form didecarboxysirohaem, although the specificity and order of decarboxylation is 
unknown. (2) AhbC catalyses the oxidative loss of the northern acetic acid side chains at 
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carbons C2 and C7 in a SAM dependent manner (Bali et al., 2011). AhbC is a member of the 
radical SAM family mentioned previously and contains two motifs for iron sulphur clusters 
although it is unknown whether both are required for functionality. (3) The final step 
requires the oxidative decarboxylation of the propionate groups at carbons C3 and C8 of iron 
coporporphyrin to vinyl groups producing haem, which is catalysed by the enzyme AhbD. 
This reaction is suspected to occur in a homologous fashion to the conversion of 
coproprophyrinogen III to protoporphyrinogen IX seen in the classical pathway, which is 
catalysed by HemN. Like HemN, AhbD is also a radical SAM enzyme and catalyses the 
conversion of iron coproporphyrin III to haem in a SAM dependent manner (Bali et al., 
2011). 
 
1.4 Organisms of interest 
This study focuses on the characterisation enzymes derived from two sulphate reducing 
bacteria, Desulfovibrio desulfuricans and D. vulgaris, and the methanogenic archaeon M. 
barkeri.   
 
1.4.1 Sulphate reducing bacteria – Desulfovibrio species 
Desulfovibrio belongs to the δ-proteobacteria and is one of the best studied genera of 
sulphate reducing bacteria (SRB). SRB are a large, heterogeneous  group of prokaryotes 
capable of dissimilatory sulphate reduction, i.e. they obtain energy by coupling the anaerobic 
oxidation of organic compounds or molecular hydrogen to the reduction of sulphate to 
hydrogen sulphide (Muyzer & Stams, 2008). It is likely that some of the oldest forms of life 
on Earth belong to this group of microorganisms, given that the process of dissimilatory 
sulphate reduction is a very ancient process (Shen et al., 2001). SRB are found in a variety of 
habitats, usually in sulphate-rich anoxic environments including soil, marine and fresh 
waters, and the gut of animals including humans. Despite their name sulphate reducers are 
also able to use other terminal electron acceptors for anaerobic respiration, such as sulphur, 
fumarate, dimethylsulphoxide, Mn (IV), and Fe (III) (Thauer et al., 2007).  
 
As well as their natural habitat SRB also reside in industrial niches including water systems 
and oil pipelines. The most prevalent in oil and gas industries are strains belonging to the 
Desulfovibrio genus (Voordouw, 2008). High concentrations of hydrogen sulphide are 
produced by Desulfovibrio reducing the quality of oil in a process known as souring. The 
sulphide reacts with Fe
2+
 forming corrosive iron sulphides which can damage pipelines and 
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industrial equipment. Control of these species is therefore of industrial interest to increase oil 
quality and reduce costs associated with metal corrosion.  In contrast to the negative 
influence in the oil and gas industry bacteria from the Desulfovibrio genus also play a major 
role in bioremediation of toxic metals (Hockin & Gadd, 2007). SRB are able to reduce a 
range of toxic metals including uranium(VI), copper(II), chromium(VI) and manganese(II) 
(Cabrera et al., 2006). Reducing these heavy metals to their insoluble form greatly facilitates 
their removal from contaminated water. Therefore the further understanding of sulphate 
reducers and their metabolic pathways can lead to their control in industrial settings or 
exploitation in the case of bioremediation. 
 
1.4.2 Methanogenic archaea – Methanosarcina barkeri 
M. barkeri belongs to the methanogenic archaea, a diverse group of strictly anaerobic 
Euryarchaeota. Methanogenic archaea are characterised by their ability to form methane as a 
metabolic end product from a restricted range of substrates that include CO2 and H2, formate, 
methanol, methylamines and/or acetate (Thauer et al., 2008). These methanogens inhabit a 
range of anoxic environments including freshwater sediments, swamps, paddy fields, land-
fills and the intestinal tracts of ruminants and termites and contribute to the global carbon 
cycle through the production of an estimated 1 billion tons of methane annually (Thauer, 
1998). 
 
The Methanosarcina species have been viewed as key organisms for the production of 
methane during anaerobic digestion (De Vrieze et al., 2012) due to their high growth rates 
and relative robustness in comparison to other methanogens. The genome of M. barkeri has 
been published (Maeder et al., 2006) which has aided the use of M. barkeri as a model 
organism for methanogenesis. 
 
1.5 Aims and objectives 
The research reported in this thesis aimed to expand upon the knowledge of the enzymes 
involved in the alternative haem biosynthesis pathway. Of specific interest was the first step 
in the pathway that is catalysed by the two proteins AhbA and AhbB. A wide range of 
molecular and biophysical techniques have been employed including molecular biology, 
recombinant DNA technology, enzymology, crystallography and spectroscopy in order to 
achieve the following goals: 
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 investigate biochemical characteristics of AhbA and AhbB from a range of sources;  
 ascertain the activity of individual AhbA and AhbB enzymes and AhbA/B 
complexes using in vitro assays; 
 confirm the sites of decarboxylation of sirohaem; 
 determine kinetic properties of AhbA/B; 
 perform structural analysis of apo- and product bound complexes of AhbA/B using 
X-ray crystallography; 
 assess product binding capabilities of AhbA/B; 
 use site-directed mutagenesis to analyse influence of specific amino acids on 
substrate binding and catalysis; 
 analyse AhbA/B properties and interactions by generation of chimeric complexes. 
 
The results of this investigation have enhanced the overall understanding of the early stages 
of the alternative haem biosynthesis pathway by providing structural and functional 
information about the AhbA and AhbB enzymes and the cross-species variation within this 
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2.1.1 Chemicals  
Most chemicals, DEAE-sephacel and antibiotics were purchased from Sigma-Aldrich Ltd. 
Other materials were purchased from manufacturers as follows: IPTG and ampicillin from 
Melford Laboratories Ltd; chelating fast flow sepharose, disposable and empty PD10 
columns from GE Healthcare; MiniElute™ Gel Extraction Kit, QIAprep® Spin Miniprep 
Kit, and QIAquick® Gel Extraction Kit from Qiagen; restriction enzymes were purchased 
from Promega and from New England Biolabs Inc; cloning vectors from Novagen; tryptone, 
yeast and bacterial agar from Oxoid Ltd; QuickChange® II Site-Directed Mutagenesis Kit 
from Agilent Technologies; Roche FastStart High Fidelity PCR System from Roche 
Diagnostics GmbH. Crystallisation screens were purchased from Molecular Dimensions Ltd. 
and Hampton Research. 
2.1.2 Bacterial strains 
Bacterial strains were purchased from Novagen or Promega. 
Table 2.1. Bacterial strains. 
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Table 2.2. Plasmids. Mb: M. barkeri, Bm: B. megaterium, Mth: Methanothermobacter 
thermautotrophicus, Dv: D. vulgaris, Dd: D. desulfuricans. 
Name Plasmid Description Reference or 
source 
pET3a pET3a Overproduction 





pET14b pET14b Overproduction N-
terminal His6tag 
fusion protein vector 





pETcoco-2 pETcoco-2 Protein 
overproduction 
vector, regulation of 
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origins of replication 
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Dr. Susana Lobo 
pSL203 pET23b-ahbA
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 Dd ahbA cloned into 
pET23b using NdeI 
and XhoI 
Dr. Susana Lobo 
pSL204 pET23b-ahbB
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 Dd ahbB cloned into 
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and XhoI 
Dr. Susana Lobo 
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cloned into NdeI and 
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cloned into NdeI and 
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cloned into NdeI and 
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Link and Lock of Dd 
ahbA R74A, Dd ahbB 









Link and Lock of Dd 
ahbA H115A, Dd 
ahbB with His6-tag 








Link and Lock of Dd 
ahbA Y117A, Dd 
ahbB with His6-tag 








Link and Lock of Dd 
ahbA R119A, Dd 
ahbB with His6-tag 









Link and Lock of Dd 
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A list of all primers used for amplification in this study can be found in Table 2.3. All 
primers were obtained from Invitrogen Life Technologies. Nucleotide bases in bold letters 
refer to restriction enzyme site and nucleotides in lower case and red denote mutations to 
genomic sequence. 
Table 2.3. List of primers. Ec: E. coli, Dv: D vulgaris, Dd: D. desulfuricans, Mb: M. 
barkeri. 
Primer name Sequence Restriction 
site 
Ec cysG for 5’ CAGCATATGGATCATTTGCCTATATTTTGCC 3’ NdeI 
Ec cysG rev 3’ CATACTAGTTTAATGGTTGGAGAACCAG 5’ SpeI 
Dd ahbA for 5’ CAGCATATGACCACGCAAACATCTG 3’ NdeI 
Dd ahbA rev 3’ CATACTAGTCTAGCTGTCATTGTCCATG 5’ SpeI 
Dd ahbB for 5’ CAGCATATGAGCCATCAATTCAGCC 3’ NdeI 
Dd ahbB rev 3’ CGGACTAGTCTAGGTAAAATACGTCATG 5’ SpeI 
Dv ahbA for 5’ CAGCATATGACGGAAGCGCACAAC 3’ NdeI 
Dv ahbA rev 3’ CATACTAGTCTAATCCATCCTGAAGTC 5’ SpeI 
Dv ahbB for 5’ CAGCATATGAGCCGTTACGATGAC 3’  NdeI 
Dv ahbB rev 3’ CGGACTAGTtTAGAAATAGGTCATGGATG 5’ SpeI 
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Mb ahbA for 5’ CGGCATATGATTGACATTGATAATTTAAAAGA 
TCAGCTC 3’ 
NdeI 
Mb ahbA rev 3’ CGGACTAGTTCACCTGATATCAAATTTTACC 5’ SpeI 
Mb ahbB for 5’ CGGCATATGGATAAAACGGATGTAAAACTGC 
3’ 
NdeI 





R73A for 5’ CAAGATCATCgcGCGACTCGGGGC 3’ - 
Dd ahbA
 
R73A rev 3’ GCCCCGAGTCGcgCGATGATCTTG 5’ - 
Dd ahbA
 
R74A for 5’ GATCATCAGGgcACTCGGGGCCAAC 3’ - 
Dd ahbA
 
R74A rev 3’ GTTGGCCCCGAGTGCCCTGATGATC 5’ - 
Dd ahbA
 
H115A for 5’ CGGGCGTTACCgcCAACTACCTGC 3’ - 
Dd ahbA
  
H115A rev 3’ GCAGGTAGTTGgcGGTAACGCCCG 5’ - 
Dd ahbA
  
Y117A for 5’ GTTACCCACAACgcCCTGCGCGAGC 3’  - 
Dd ahbA
  
Y117A rev 3’ GCTCGCGCAGGgcGTTGTGGGTAAC 5’ - 
Dd ahbA
  
R119A for 5’ CACAACTACCTGgcCGAGCACGACTAC 3’ - 
Dd ahbA
  
R119A rev 3’ GTAGTCGTGCTCGgcCAGGTAGTTGTG 5’ - 
Dd ahbB
 
R55A for 5’ GTCCGGGGCCATCgcTCGCTTCGGGGC 3’ - 
Dd ahbB
 
R55A rev 3’ CGCCCCGAAGCGAgcGATGGCCCCGGAC 5’ - 
Dd ahbB
 
R56A for 5’ GGCCATCCGTgcCTTCGGGGCGAG 3’ - 
Dd ahbB
 
R56A rev 3’ CTCGCCCCGAAGgcACGGATGGCC 5’ - 
Dd ahbB
 
H63A for 5’ GCGAGCATCAAGgcCCAGAAAACAGG 3’ - 
Dd ahbB
 
H63A rev 3’ CCTGTTTTCTGGgcCTTGATGCTCGC 5’ - 
Dd ahbB
 
H98A for 5’ GCCATATTTCGgcCGTCTATTATCG 3’ - 
Dd ahbB
 




 5’ CCATATTTCGCACGTCgcTTATCGCCCCAGC 3’ - 
Dd ahbB
 
Y100A rev  3’ GCTGGGGCGATAAgcGACGTGCGAAATATGG 5’ - 
Dd ahbB
 
R102A for 5’ GCACGTCTATTATgcCCCCAGCTCCGC 3’ - 
Dd ahbB
 
R102A rev 3‘ GCGGAGCTGGGGgcATAATAGACGTGC 5’ - 
Dd ahbB
 
H118A for 5’ GTACACCATGATAgcCGGCCGCAGCG 3’ NaeI 
Dd ahbB
 
H118A rev 3’ CGCTGCGGCCGgcTATCATGGTGTAC 5’ - 
 
2.1.5 Media and solutions used for bacterial work 
Luria-Bertani (LB) broth: Tryptone 10 g 
 Yeast extract 5 g 
 NaCl 5 g 
 
 
Made up to 1 L with dH2O and autoclaved.  
 
 
2YT broth: Tryptone 16 g 
 Yeast extract 10 g 
 NaCl 5 g 
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Super optimal broth + catabolite repression 
(SOC): 
Tryptone 20 g 
 Yeast extract 5 g 
 1 M NaCl 10 mL 
 2 M Mg
2+
 stock (see 
below) 
10 mL 
 20% (w/v) glucose 10 mL 
 1 M KCl 2.5 mL 
    
Mg
2+ 
stock: MgCl2(H2O)6 2 g 
 MgSO4(H2O)7 2.5 g 
Made up to 10 mL with dH2O.    
For SOC media tryptone and yeast extract were dissolved in 967.5 mL dH2O and autoclaved 
prior to the addition of the other components. All components that were not autoclaved were 
filter sterilised (0.2 µm pore size) prior to use.  
 
 
Luria-Bertani agar:  
 
15 g of Bacterial agar were added to 1 L LB broth before autoclaving. 
 
10x M9 salts: Na2HPO4 60 g 
 KH2PO4 30 g 
 NH4Cl 10 g 
 NaCl 5 g 
 
Made up to 1 L with dH2O and autoclaved.  
 
Trace elements solution: 
   
 EDTA 5 g 
 FeCl3.6H2O 0.5 g 
 ZnSO4.7H2O 177 mg 
 CuCl2.2H2O 10 mg 
 Co(NO3)2.6H2O 10 mg 
 (NH4)6Mo7O24.4H2O 10 mg 
    
All metals were dissolved separately in a small quantity of dH2O before being mixed, 
adjusted to pH 7 and made up to 1 litre. The solution was then autoclaved before use. 
 
Selenomethionine labelling media: 10x M9 salts 100 mL 
 Trace elements 10 mL 
 50% (v/v) Glycerol 20 mL 
 1 M MgSO4 1 mL 
 1 M CaCl2  0.4 mL 
 Biotin (1 mg mL
-1
) 1 mL 
 Thiamine (1 mg mL
-1
) 1 mL 




1  mL 
 Selenomethionine 125 mg 
 dH2O 865.6 mL 
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All solutions were made up separately and autoclaved (M9 salts, trace elements, glycerol) or 
filter sterilised (MgSO4, CaCl2, biotin, thiamine, ampicillin; 0.2 µm pore size) prior to 
mixing. 
Table 2.4. Additives and antibiotics. 
Additive Stock concentration Final concentration 
IPTG 1 M in dH2O 100 mM 
Ampicillin 100 mg mL
-1 
in dH2O 100 µg mL
-1
 
Chloramphenicol 34 mg mL
-1




2.1.6 Solutions used for DNA work 
TE buffer: Tris-HCl, pH 8.0 10 mM 
 EDTA, pH 8.0 1 mM 
 
6 x DNA loading buffer Bromophenol blue (w/v) 0.25%  
 Glycerol (v/v) 50%  
 TE buffer (v/v) 50%  
 
 
Figure 2.1. 5 µl Hyperladder 1 kb (Bioline) applied to a 1% (w/v) TBE/agarose gel 
visualised using ethidium bromide. 
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2.1.7 Solutions used for protein work 
2.1.7.1 Solutions for nickel affinity chromatography  
Charge buffer: NiSO4(H2O)6 100 mM 
    
Binding buffer: Tris-HCl, pH 8.0 20 mM 
 NaCl 100 mM 
 Imidazole 5 mM 
    
Wash buffer: Tris-HCl, pH 8.0 20 mM 
 NaCl 100 mM 
 Imidazole 50 mM 
    
Elution buffer: Tris-HCl, pH 8.0 20 mM 
 NaCl 100 mM 
 Imidazole 400 mM 
    
Strip buffer: Tris-HCl, pH 8.0 20 mM 
 NaCl 500 mM 
 EDTA 100 mM 
 
Buffers used for purification of D. desulfuricans AhbA/B for crystallography contained 
HEPES in place of Tris-HCl at identical pH and concentrations. 
 
2.1.7.2 Solutions for protein polyacrylamide gel electrophoresis. 
10x running buffer: Tris-HCl 30 g L
-1
 
 Glycine 144 g L
-1
 
    
10 mL L
-1
 10% (w/v) SDS added to 1x running buffer for SDS gels. 
    
2x SDS sample buffer: 0.5 M Tris-HCl, pH 6.8 6.0 mL 
 Glycerol 4.8 mL 
 SDS 10% (w/v) 9.6 mL 
 Bromophenol blue 0.05% 
(w/v) 
1.2 mL 
 dH2O 24.0 mL 
14 µL β-mercaptoethanol added per mL 2x SDS sample buffer. 
 
2x Native sample buffer: 0.5 M Tris-HCl, pH 6.8 6.0 mL 
 Glycerol 4.8 mL 
 SDS 10% (w/v) 9.6 mL 
 Bromophenol blue 0.05% 
(w/v) 
1.2 mL 
 dH2O 24.0 mL 
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Denaturing molecular weight marker - Dalton VII (Sigma):   
 Protein Molecular weight (Da) 
 Bovine serum albumin 66,000 
 Ovalbumin 45,000 
 G-3-P dehydrogenase 36,000 
 Carbonic anhydrase 29,000 
 Trypsin inhibitor 20,100 
 Α-Lactalbumin 14,200 
 
Denaturing molecular weight marker – Prestained protein marker, broad range (New 
England BioLabs): 
 Protein Molecular weight (Da) 
 MBP-β-galactosidase 175,000 
 MBP-parayosin 80,000 
 MBP-CBD 58,000 
 CBD-Mxe Intein-2CBD 46,000 
 CBD-Mxe Intein 30,000 
 CBD-BmFKBP13 25,000 
 Lysozyme 17,000 
 Aprotinin 7,000 
 
MBP: maltose-binding protein, CBD: chitin binding domain. BmFKBP13: Bombyx mori 
FK506-binding protein. 
 
Denaturing molecular weight marker – Untained protein molecular weight marker (Fisher 
Scientific): 
 Protein Molecular weight (Da) 
 β-galactosidase 116,000 
 Bovine serum albumin 66,200 
 Ovalbumin 45,000 
 Lactate dehydrogenase 35,000 
 REase Bsp981 25,000 
 β-lactoglobulin 18,400 
 Lysozyme 14,400 
 
 
Molecular weight marker for native electrophoresis (GE Healthcare): 
 
 Protein Molecular weight (Da) 
 Thyroglobulin 669,000 
 Ferritin 440,000 
 Catalase 232,000 
 Lactate dehydrogenase 140,000 
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Coomassie blue stain: Trichloroacetic acid (100%) 250.00 mL 
 Coomassie blue R250 0.60 g 
 SDS 0.10 g 
 Tris-HCl 0.25 g 
 Glycine 0.15 g 
Made up to 500 mL with dH2O. 
 
Table 2.5. SDS and native gel compositions. 
SDS gels 
Running gels 12.5% 15% Stacking gel 5% 
dH2O (mL) 3.4 2.2 dH2O (mL) 3.4 
30% Acrylamide (mL) 
Acryl/Bis™ 29:1 
6.3 7.5 30% Acrylamide (mL) 
Acryl/Bis™ 29:1 
1.5 
1.5 M Tris-HCl pH 8.8 
(mL) 
3.8 3.8 1.5 M Tris-HCl pH 6.8 
(mL) 
1.9 
10% (w/v) SDS (mL) 1.5 1.5 10% (w/v) SDS (mL) 0.75 
10% (w/v) APS (mL) 0.15 0.15 10% (w/v) APS (mL) 0.075 
TEMED (mL) 0.01 0.01 TEMED (mL) 0.01 
Native gels 
Running gels 7% 9% Stacking gel 5% 
dH2O (mL) 7.8 6.7 dH2O (mL) 4 
30% Acrylamide (mL) 
Acryl/Bis™ 29:1 
3.45 4.56 30% Acrylamide (mL) 
Acryl/Bis™ 29:1 
1.5 
1.5 M Tris-HCl pH 8.8 
(mL) 
3.8 3.8 1.5 M Tris-HCl pH 6.8 
(mL) 
1.9 
10% (w/v) APS (mL) 0.15 0.15 10% (w/v) APS (mL) 0.075 
TEMED (mL) 0.01 0.01 TEMED (mL) 0.01 
 
2.1.7.3 Solutions for in-gel haem staining 
Fixing solution: 12.5% (w/v) Trichloroacetic 
acid  
  
    
Staining solution: o-dianisidine 0.2 g 
 Acetic acid 20.0 mL 
 dH2O 160.0 mL 
 0.5M sodium citrate, pH 4.4 20.0 mL 
 30% (w/w) H2O2 0.4 mL 
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2.1.7.4 Solutions for gel filtration chromatography (FPLC) 
Sample buffer: AhbA/B complex size 
estimation 
Tris-HCl, pH 8.0 20 mM 
 NaCl 100 mM 
    
Sample buffer: AhbA/B purification - 
crystallisation 
HEPES, pH 8.0 20 mM 
 NaCl 100 mM 
    
Wash buffers: NaOH 0.2 M 
 Ethanol 20.0% 
    
All solutions were filtered prior to use. 
 
Table 2.6. Molecular weight markers for gel filtration chromatography (Sigma). 
Protein Approximate molecular weight 
(Da) 
Concentration 
Carbonic anhydrase, bovine 
erythrocytes 
29,000 3 mg mL
-1
 
Albumin, bovine serum 66,000 10 mg mL
-1
 
Alcohol dehydrogenase, yeast 15,0000 5 mg mL
-1
 
β-amylase, sweet potato 200,000 4 mg mL-1 
Apoferritin, horse spleen 443,000 10 mg mL
-1
 
Thyroglobulin, bovine 669,000 8 mg mL
-1
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2.1.7.5 Solutions for HPLC-MS 
Tetrapyrrole HPLC-MS analysis: 
 
Solution A: Trifluoroacetic acid (v/v) 0.1%  
    
Solution B: Acetonitrile 100%  
 
 
Protein HPLC-MS analysis: 
 
Solution A: Trifluoroacetic acid (v/v) 0.05%  
    
Solution B: Acetonitrile 80.000%  
 Trifluoroacetic acid (v/v) 0.045%  
 
All solutions were filtered prior to use. 
 
2.1.7.6 Solutions for crystallisation 
 
 Ammonium acetate 2 M 
 Sodium acetate, pH 4.8-5.6 1 M 
 Tri-sodium citrate, pH 4.8-5.6 1 M 
 Polyethylene glycol MW 4000 50% (w/v) 
 Polyethylene glycol MW 3350 50% (w/v) 
 Barium chloride 0.1 M 
 
Solutions other than polyethylene glycol (PEG) were filtered (0.2 µm pore size) prior to use. 
Buffers were pH corrected using glacial acetic acid and diluted appropriately before 
screening. Original crystal screen compositions are listed in the Appendix. 
 
2.1.7.7 Haemin solution 
 Haemin 0.1 g 
 Tween 80 2.5 mL 
 dH2O 22.5 mL 
 NaOH (10N) 2 drops 
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2.1.7.8 Pyridine haemochrome solutions 
Pyridine solution: NaOH 200 mM 
 Pyridine (v/v) 40%  
    
Oxidising solution: Potassium ferricyanide 0.1 M 
 
2.2 Microbiological methods 
2.2.1 Sterilisation 
Unless stated otherwise media and buffers were sterilised for 15 min at 121 °C and 1 bar 
pressure in an autoclave. Temperature sensitive substances were filter sterilised (0.2 µm pore 
size). 
 
2.2.2 Storage of bacteria 
For long-term storage of bacteria, glycerol stocks were prepared. Glycerol was added to an 
overnight bacterial culture to a final concentration of 25% (v/v). The culture was then 
incubated on ice for 30 min before storage at -80 °C. 
 
2.2.3 Plate cultures 
Bacteria were usually streaked directly from a glycerol stock onto agar plates and antibiotics, 
ALA was added where required. The agar plates were incubated overnight at 37 °C. 
 
2.2.4 Liquid cultures 
Liquid cultures were inoculated with a single colony from an agar plate culture. The medium 
was supplemented with antibiotics and ALA where required. Liquid cultures were shaken at 
≈ 160 rpm in baffled flasks overnight at 37 °C. 
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2.2.5 Preparation of E. coli competent cells 
Competent E. coli cells were prepared based on a method previously described (Sambrook et 
al., 1989). A bacterial overnight starter culture derived from a single colony was inoculated 
into 10 mL fresh LB broth and grown to an OD600 of 0.3. The cells were cooled on ice for 15 
min and centrifuged at 850 x g at 4 °C. The pellets were gently resusupended in 25 mL of 
ice-cold 0.1 M CaCl2 and incubated on ice for 30 min. Cells were collected again by 
centrifugation and resuspended in 0.25 mL of 0.1 M CaCl2 containing 25% (v/v) glycerol. 
Aliquots of 30 µL were frozen rapidly and stored at -80 °C. 
 
2.2.6 Transformation of E. coli competent cells 
Competent cells were defrosted on ice for 10 min before adding 1 µL plasmid DNA. The 
mixture was incubated on ice for 15 min and then heat-shocked by incubation at 42 °C for 50 
sec before rapid transfer to ice and incubation for 2 min. After the addition of 250 µL SOC 
media, the cells were incubated at 37 °C for 20-60 min to allow antibiotic resistance 
expression. The mixture was then spread on a LB agar plate containing the required 
antibiotics and incubated at 37 °C overnight. 
 
2.2.7 Recombinant protein overproduction in E. coli 
The E.coli strains BL21 (DE3) and BL21 (DE3) pLysS were transformed with a vector 
containing the gene(s) of interest cloned in frame. The recombinant strain was grown in LB 
with ampicillin (and chloramphenicol for pLysS strain) at 37 °C and shaken at ≈160 rpm 
until the culture reached an OD600 of approximately 0.6. Protein production was induced with 
0.4 mM IPTG overnight at 19 °C. The cells were collected by centrifugation at 3,500 x g for 
20 min at 4 °C. The pellet was resuspended in 15 mL of binding buffer (Section 2.1.7.1) and 
either directly used for protein purification (Section 2.4.1) or stored at -80 °C. 
 
Cultures containing trapping strain plasmid constructs were grown for 24 hours at 19 °C in 
2YT media supplemented with ampicillin. Production of tetrapyrroles was enhanced by the 
addition of 1 mL of ALA (20 mg mL
-1
) 6 hours prior to harvest. Cells were harvested and 
stored as described previously. 
 
 Chapter 2 - Materials and Methods 
45 
 
2.2.8 Production of selenomethionine labelled protein 
Selenomethionine labelled protein was produced using the KRX strain of E. coli. 250 mL LB 
media, containing 0.8% (w/v) glucose and 100 mg/L ampicillin, were inoculated with a 5 mL 
overnight culture of E. coli KRX transformed with plasmid pDP031. This culture was grown 
overnight at 37 ˚C (<18 hours) before being harvested and resusupended in labelling media 
(Section 2.1.5). Cells were incubated at 25 ˚C for 30-60 mins before induction with 0.2% 
(w/v) rhamnose for 1 day. Incorporation of selenomethionine was confirmed by mass 
spectrometry (Section 2.5.2.2). 
 
2.2.9 Lysis of cells by sonication 
Harvested cells were lysed by sonication using a Sonics Vibracell Unltrasonic processor, 
with an output watt of between 20 and 30 in 30 sec bursts with 30 sec breaks repeated 6 
times. The sonicated cells were centrifuged at 35, 000 x g for 20 min at 4 °C to remove cell 
debris. For anaerobic protein purification harvested cells were transferred into an anaerobic 
chamber 1 hour prior to sonication. Sonication was carried out with 10 sec bursts with 30 sec 
breaks and repeated 18 times to prevent overheating of the sample. 
 
2.3 Molecular biological methods 
2.3.1 PCR reactions 
All PCR reactions were performed in an Eppendorf Mastercycler 5341 PCR machine using 
the FastStart High Fidelity PCR System (Roche). The basic PCR reaction and the cycles 
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Table 2.7. Basic PCR reaction. 
Component µL 
dH2O 37.5-36.5 




5 mM dNTPs each 2 
10 µM 5’ primer 2 
10 µM 3’ primer 2 
DNA template 1 




Table 2.8. Temperature protocol for PCR reactions. 
Step Temp Time Cycles Function 
1 96 °C 2 min 1 Initial 
denaturation of 
DNA 





3 55-58 °C 30 sec Annealing of 
primers 
4 72 °C 1 min per 1000 
bp 
Elongation 
5 72 °C 5 min 1 Final elongation 
Stop 4 °C Constant 
 
Once the PCR reaction was completed the product was subjected to agarose gel 
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2.3.2 Electrophoresis of DNA 
DNA fragments were separated by agarose gel electrophoresis. 
 
2.3.2.1 Agarose gel 
The agarose gel percentage was chosen according to the size of the DNA fragments to be 
separated [0.7-1.5% (w/v) agarose in TAE buffer]. Routinely, a 1% (w/v) agarose gel was 
used. Agarose gels were set with the appropriate amount of agarose in 1x TAE buffer with 
the addition of ethidium bromide to a final concentration of 0.5 µg mL
-1
. The DNA samples 
containing 20% (v/v) DNA loading buffer were loaded into the agarose gel wells and 
electrophoresis was carried out at 70 V for approximately 1 hour using a SubCell GT 
electrophoresis tank (BioRad) connected to a Power PAC 300 power supply (BioRad). 
 
2.3.2.2 Visualisation of DNA 
Ethidium bromide is a fluorescent dye that intercalates between the DNA base pairs.  UV 
radiation (312 nm) is absorbed by the ethidium bromide and re-emitted at 590 nm in the red-
orange wavelength range. This allows visualisation of the DNA using a UV transilluminator.  
 
2.3.3 Isolation and purification of a DNA fragment 
The DNA band of interest was excised from an agarose gel using a scalpel blade. 
Purification was carried out using a QIAquick® Gel Extraction Kit (Qiagen) according to the 
protocol for using a microcentrifuge as stated in the handbook. 
 
Digests of PCR products were purified using a QIAquick® Gel Extraction Kit (Qiagen) 
according to the protocol for QIAquick® PCR purification using a microcentrifuge. 
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2.3.4 Ligation of DNA 
Vectors and inserts were digested with the relevant restriction enzymes as described in 
Section 2.3.6 and purified (Section 2.3.3). The ligation of DNA fragments into the vector 
was carried out at room temperature for 2 hours or at 4 °C overnight using the following 
components: 





 2x rapid ligation buffer 
(Promega) 





2.3.5 Isolation of plasmid DNA 
A QIAprep® Miniprep Kit (Qiagen) was used for the purification of plasmid DNA as 
described in the handbook according to the protocol for using a microcentrifuge. 
 
2.3.6 Restriction digests 
Plasmid or PCR product DNA was digested using the relevant enzymes (10 U µL
-1
) and the 
optimal buffer chosen according to either the Promega or New England Biolabs information 
provided. The reactions were incubated for 2 hours at the temperature required by the 
restriction enzyme before being subjected to electrophoresis. 
 
Table 2.9. Typical DNA digest protocol 
Component Single digest Double digest 
dH2O 4 µL 3.5 µL 
Restriction enzyme 1 1 µL 0.5 µL 
Restriction enzyme 2 - 0.5 µL 
10x buffer 1 µL 1 µL 
Plasmid/PCR DNA 4 µL 4 µL 
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2.3.7 Cloning into vectors 
2.3.7.1 Single gene cloning into vectors 
The vectors and the genes of interest were digested at their restriction sites, which were 
introduced into the PCR product (Section 2.3.1) via the 5’ and 3’ primers, respectively 
(Section 2.3.6). After isolation and purification of the required DNA fragments (Section 
2.3.3.1), vectors and genes were ligated together (Section 2.3.4). Competent E. coli (JM109 
or DH5α™) were transformed with the ligation mixture and plated onto appropriate media. 
Single colonies were selected, grown and the recombinant plasmids amplified and sequenced 
to verify the DNA sequence (GATC Biotech AG). The vector pET14b provides the gene 
product with an N-terminal short peptide sequence containing a stretch of six consecutive 
histidine residues, whereas the pET3a vector does not. 
 
2.3.7.2 Multiple gene cloning 
Multiple gene constructs were formed by the consecutive cloning of genes into pET3a via 
the ‘Link and Lock’ cloning strategy developed by Dr. Evelyne Deery and Dr. Helen 
McGoldrick (McGoldrick et al., 2005). The ‘Link and Lock’ method exploits compatible 
cohesive ends allowing fusion of two fragments digested by different enzymes forming a site 
which cannot be recleaved by either of the original enzymes. This permits the systematic 
addition of genes to a plasmid construct using the same restriction sites. Figure 2.2 
summarises the ‘Link and Lock’ process. A PCR was performed and the genes were 
individually cloned into pET3a introducing a SpeI site at the 3’ end of the genes via the 3’ 
primers (Table 2.3). The ribosome binding site and genes to be subcloned into the ‘Link and 
Lock’ construct were excised using the restriction enzymes XbaI and EcoRI (Fig. 2.2B). The 
recipient plasmid containing the initial gene(s) was digested using SpeI and EcoRI. Ligating 
the two fragments caused the fusion of SpeI and XbaI, as they have compatible cohesive 
ends, leading to an un-cleavable site, whereas the EcoRI sites fused as normal (Fig. 2.2C). 
The removal of the SpeI site means the newly formed construct only contained one SpeI site 
so the process could be repeated again to add more genes. 
 





Figure 2.2. Schematic of the ‘Link and Lock’ cloning technique. A. Target genes are 
cloned into identical vectors and digested with appropriate restriction enzymes. B. Recipient 
plasmid and donor fragment containing gene and ribosome binding site (RBS) are ligated. C. 
Construct is formed with compatible cohesive ends (XbaI and SpeI) ligating and forming an 
uncleavable site. The new construct is then capable of undergoing the process again to add a 
new gene of interest. 
 
2.3.7.3 Generation of mutants 
The mutations of D. desulfuricans AhbA and AhbB were created by Dr. Susanne Schroeder 
(University of Kent) using the QuikChange
®
 II Site-Directed Mutagenesis Kit (Aligent). 
Briefly the method is described as follows. QuikChange
®
 II Site-Directed Mutagenesis Kit 
can be used to introduce point mutations that switch amino acids as well as delete and insert 
single or multiple base pairs. The mutagenesis method was performed using PfuUltra™ 
high-fidelity (HF) DNA polymerase. The basic procedure utilises a supercoiled double-
stranded DNA vector with an inset of interest and two synthetic oligonucleotide primers 
(Table 2.3), both of which contain the desired mutation. The oligonucleotide primers, each 
complementary to opposite strands of the vector, were extended during temperature cycling 
by PfuUltra™ HF DNA polymerase. Extensions of the oligonucleotide primers generated a 
mutated plasmid containing staggered nicks. Following temperature cycling, the product was 
treated with DpnI. The DpnI endonuclease (target sequence: 5’ –GmATC-3’) is specific for 
methylated and hemimethylated DNA and was used to digest parental DNA template and to 
select for mutation-containing synthesised DNA. The nicked vector DNA containing the 
desired mutations was then transformed into XL1-Blue supercompetent cells and the nicks 
were repaired. Figure 2.3 represents a schematic diagram of the procedure. Clones were 
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purified and sequenced prior to formation of a mutant pET3a-ahbA/B construct using the 
Link and Lock technique. 
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2.4 Biochemical methods 
2.4.1 Protein purification by immobilised metal ion affinity 
chromatography 








3+. Chelating Sepharose™ Fast Flow resin (GE Healthcare) loaded with the 
suitable metal ion will therefore selectively retain protein with exposed histidines, which 
form complexes with the metal ions. The bound protein can be isolated by competitive 
elution with increasing concentrations of imidazole. 
 
Proteins were purified at room temperature, but were kept on ice as much as possible. 
Columns containing approximately 3 to 5 mL of the resin were used to purify proteins from 
a 1 L culture. The resin was initially rinsed with dH2O, charged with NiSO4 (charge buffer) 
and equilibrated with 50 mL of binding buffer. Soluble cell extract acquired after sonication 
and centrifugation (Section 2.2.9) was applied to the resin and allowed to flow through by 
gravity. Unbound proteins were washed away with 15 mL of binding buffer and 15 mL of 
wash buffer. Elution buffer was applied to the column to recover the protein which was 
collected in 2 mL fractions. The resin was regenerated with 15 mL strip buffer and washed 
with dH2O. Composition of buffers can be found in Section 2.1.7.1 
 
2.4.2 Buffer exchange 
Purified protein was desalted on a pre-packed disposable Sephadex G25 column (PD-10, bed 
volume 8.3 mL; GE Healthcare). In brief the method consists on the following steps: (1) 
column equilibration with 25 mL of buffer into which the protein was to be exchanged, (2) 
application of 2.5 mL protein solution, (3) elution of protein sample in 3.5 mL of desired 
buffer, (4) restoration of column using dH2O. 
 
2.4.3 Gel filtration chromatography 
Gel filtration chromatography was performed using an ÄKTA P-920 FLPC system 
(Amersham Biosciences). Samples were resolved on a SuperdexTM 200 10/300 GL column 
(GE Healthcare) equilibrated in 20mM Tris HCl, pH8, 100mM NaCl. 1 mL sample was 
loaded onto the column and the protein was eluted using a flow rate of 0.5 mL min
-1
. 
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Calibration of the column was achieved using MWGF-1000 gel filtration molecular weight 
marker kit (Sigma; Table 2.6). 
2.4.4 Bradford protein assay 
The Bradford assay relies on the dye Coomassie brilliant blue G-250 binding to proteins, 
most readily to arginyl and aromatic residues, causing a shift in the absorbance maxima of 
the dye from the red cationic form (470-650 nm) to the blue anionic form (590-620 nm) in 
the presence of protein. Therefore, the quantity of the protein can be estimated by measuring 
the amount of dye in the blue form at 595 nm (Bradford, 1976). The protein assay dye from 
BioRad was added to diluted protein solution, and the reaction carried out as per the 
instructions. The reaction was left at room temperature for 10-30 min and the OD595 was 
measured. Simultaneously a standard curve with bovine serum albumin (0, 5, 10, 15, 20 and 
25 mg mL
-1
) was generated.  
 
2.4.5 A280 protein concentration estimation 
Protein concentrations were estimated using readings of the OD280 and estimated protein 
extinction coefficients derived by ProtParam on the ExPASy server (Gasteiger et al., 2005). 
Protein concentrations were calculated using the following equations: 
 
A280 = Concentration x Extinction coefficient 
 




Protein concentration (mg mL
-1
) = Molecular mass x Concentration 
 
2.4.6 Polyacrylamide gel electrophoresis 
2.4.6.1 SDS-PAGE 
The composition of the gel, buffers and stain were previously described in Section 2.1.7.2. 
Polyacrylamide gels were run as previously described (Laemmli, 1970). The sample was 
denatured by 1:1 addition of SDS sample buffer and boiling for 5 min. 
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Between 5 and 10 µL of denatured sample was loaded into each well and 7 µL molecular 
mass marker was run on each gel to estimate the relative molecular mass of the protein of 
interest. Electrophoresis was performed at a constant voltage of 200 V using an Atto Dual 
Mini Slab AE6450 electrophoresis apparatus and an Atto Mini Power electrophoresis power 
supply SJ1082 (GRI Ltd.). The gel was stained with coomassie blue stain and detained using 
dH2O. 
2.4.6.2 Native PAGE 
The composition of the gel and buffers were previously described in Section 2.1.7.2. After 
the 1:1 addition of native sample buffer 5-10 µL of the sample was directly loaded onto the 
gel. 7 µL native molecular marker was run on each gel to estimate relative molecular mass of 
the protein of interest. Electrophoresis was carried out at a constant voltage of 100 V using 
the same apparatus as described in Section 2.4.6.1.  
 
2.4.6.3 Haem staining protocol 
A standard 12.5% (v/v) acrylamide gel was run as described in Section 2.4.6.1. Instead of 
staining with coomassie blue the gel was fixed and stained using the following protocol. The 
acrylamide gel was washed in 200 mL 12.5% (w/v) TCA for 30 min and then for a further 30 
min in dH2O. Bands were developed using haem staining solution (Section 2.1.7.3) and 
appeared within 5-15 min. Cytochrome c was used as a positive control. 
  
2.4.7 Anaerobic techniques 
Anaerobic work was carried out under the nitrogen environment of the glove box (Belle 
Technologies) containing less than 2 ppm oxygen. Liquids such as water and buffer stocks 
were degassed under argon prior to transfer into the glove box. Chemicals were taken into 
the glove box as powders and were made up with degassed dH2O. Resins such as PD-10 
columns and DEAE columns were brought into the glove box 24 hours prior to use and 
equilibrated with at least 50 mL of anaerobic buffer. 
 
2.4.8 In vitro preparation of sirohaem 
Sirohydrochlorin was prepared using a multi-enzyme approach as previously described (Bali 
et al., 2011). The plasmid pETcoco-2-cobA-hemBCD-sirC is a multi-gene construct 
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engineered by Dr. Evelyne Deery carrying genes for the enzymes ALA dehydratase (HemB), 
porphobilinogen deaminase (HemC), uro’gen III synthase (HemD), SUMT (CobA) and 
precorrin-2 dehydrogenase (CobA), all of which are fused to His6-tags. Lysate of an E. coli 
strain carrying the plasmid was purified (Section 2.4.1) and the most concentrated eluted 
protein fraction was transferred into the glove box. Following buffer exchange of the protein 
into anaerobic buffer using a PD-10 column (Section 2.4.2) the protein was pooled with 1 
mL cofactor mix. The cofactor mix consisting of 20 mg mL
-1





 ALA in 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, was adjusted to pH 8.0 
using 2 M NaOH prior to use. The reaction was incubated at room temperature overnight.  
 
Sirohaem was formed by the addition of a 10-fold excess of FeSO4 to the sirohydrochlorin 
and subsequent incubation at room temperature for 4 hours. Sirohaem was purified from 
excess iron and porphyrins using a DEAE column (equilibrated in 20 mM Tris-HCl, pH 8.0, 
100 mM NaCl) in a stepwise gradient from 100 mM to 800 mM NaCl. Sirohaem was eluted 
in 20 mM Tris-HCl, pH 8.0 with 1M NaCl. 
 
2.4.9 In vitro preparation of didecarboxysirohaem for NMR 
Didecarboxysirohaem was prepared enzymatically from sirohaem under anaerobic 
conditions (<2 ppm O2). Sirohaem was incubated with a 100-fold excess of purified D. 
vulgaris AhbA/B overnight at 37 °C. Didecarboxysirohaem was purified from the protein 
using a DEAE column. The column was equilibrated in 20 mM Tris-HCl, pH 8.0, 100 mM 
NaCl prior to sample loading. The column was then washed with acidified dH2O with a pH 
gradient from 8 to 2.5, at which point the tetrapyrrole was eluted. The sample was then 
freeze-dried, resuspended in 0.5 ml 100% deuterium oxide and sealed in a septum screw-
capped 5 mm NMR tube while maintaining anaerobic conditions. 
 
2.4.10 Calculating activity of D. desulfuricans AhbA/B 
The following method was carried out in an anaerobic glove box (Belle Technology). 23 µM 
of sirohaem were incubated at 37 °C for 10 min prior to protein addition. Purified D. 
desulfuricans AhbA/B was then added to the reaction mixture to a final concentration of 2.3 
µM and incubated at 37 °C for the duration of the reaction. 100 µL aliquots of the reaction 
mixture were removed at time points and added to an equal volume of acetonitrile to stop the 
reaction. These samples were then incubated at 4 °C for 10 min before being centrifuged at 
2000 x g for 10 min to pellet the precipitated protein. The samples were then sealed in a 
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HPLC vial, removed from the glove box and analysed using HPLC-MS (Section 2.5.2). Peak 
integration was performed using Compass™ Data Analysis (Bruker). Data were fitted using 
in-house software developed by Dr. Andrew Lawrence, to the following equations: 
 
ν1 =                      Vmax1 S1 
         Km1 (1 +  S2/ Km2 + S3/Ki) + S1 
ν2 =                      Vmax2 S2 
         Km2 (1 +  S1/ Km1 + S3/Ki) + S2 
where ν1 is rate of sirohaem decarboxylation, S1 is the concentration of  sirohaem, ν2 is the 
rate of monodecarboxysirohaem decarboxylation, S2 is the concentration of 
monodecarboxysirohaem, S3 is the concentration of didecarboxysirohaem, Ki is the tight-
binding constant of  didecarboxysirohaem to the enzyme and Vmax1 / Vmax2 and Km1 / Km2 are 
the kinetic parameters of each reaction respectively. 
 
2.4.11 Pyridine haemochrome assay 
Pyridine haemochrome assays were performed as previously described (Berry & 
Trumpower, 1987). Spectra were recorded between 520 and 620 nm. 0.5 mL 200 mM NaOH 
and 40% (v/v) pyridine and 3 μL 0.1 M potassium ferricyanide were placed in a cuvette. 0.5 
mL sample (~10 mg mL
-1
) was then added and mixed thoroughly before an oxidised 
spectrum was recorded. Solid sodium dithionite was added (2-5 mg) and several reduced 
spectra were taken. The oxidised spectrum was subtracted from the first stable reduced 
spectrum to provide the final pyridine haemochrome spectrum. 
 
2.4.12 Haem extraction protocol 
Haem extractions were carried out as previously described (Lubben & Morand, 1994). Non-
covalently bound haem was extracted from 0.05 ml of sample (membrane suspensions or 
protein solutions) with 0.45 mL of acetone-HCl (19:1, v:v) at room temperature for 20 min. 
After centrifuging for 2 min at 14,000 x g, 1.0 mL of ice-cold dH2O and 0.3 mL of ethyl 
acetate were added to the supernatant, and the sample was vortexed and centrifuged again. 
The ethyl acetate phase was recovered and the solvent removed by a vacuum centrifuge 
(miVac DUO Concentrator; Genevac). The residues were dissolved in 100 µL of dH2O and 
analysed by mass spectrometry according to the method in Section 2.4.14.1. 
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2.4.13 UV-visible spectrophotometry 
All UV-visible spectra were recorded on a Varian Cary 50 Bio UV/visible 
spectrophotometer over a range of 200-800 nm. Spectra of anaerobic samples were recorded 
inside a glove box (Belle Technology Ltd.) using a fibre optic probe. 
 
2.4.14 HPLC-MS 
2.4.14.1 HPLC-MS of tetrapyrrole derivatives 
Protein was removed prior to analysis by HPLC-MS either by acidification with equal 
volumes of 0.1% (v/v) TFA and purification on a TELOS C18 column, eluting in 100% 
acetonitrile, or by diluting with equal volumes of acetonitrile before centrifugation at 2000 x 
g. 
 
Samples were resolved on an ACE 5AQ column (2.1 x 150 mm; Advanced Chromatography 
Technologies) attached to an Agilent 1100 series HPLC equipped with diode array detector 
and coupled to a micrOTOF-Q mass spectrometer (Bruker). The column was developed with 
a binary gradient at a flow rate of 0.2 mL per min. Solvent A was 0.1% (v/v) TFA and 
solvent B was acetonitrile. 
 
For sirohaem and sirohaem derivatives the column was equilibrated with 5% B. Following 
sample injection the concentration of B was increased to 20% over 6 min and then to 30% at 
25 min and 100% at 35 min where it was held for 5 min before returning to starting 
conditions. The total length of each run was 50 min. For samples containing haem a linear 
gradient was used starting at 20% B and reaching 100% B in 30 min. Data was processed 
using Compass™ Data Analysis (Bruker). 
 
2.4.14.2 HPLC-MS of proteins 
Samples were resolved on a Jupiter® 5 µm C4 column (2 x 50 mm; Phenomenex Inc) 
attached to an Agilent 1100 series HPLC equipped with diode array detector and coupled to 
a micrOTOF-Q (Bruker) mass spectrometer. The column was developed with a binary 
gradient at a flow rate of 0.2 mL per min. Solvent A was 0.05% (v/v) TFA and solvent B 
was 0.045% (v/v) TFA and 80% (v/v) acetonitrile. 
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The column was equilibrated with 5% solvent B prior to the injection of 15 µg of protein. 
The concentration of B was increased to 100% over 5 min where it was held for 5 min before 
returning to starting conditions. 
 
Data was processed using Compass™ Data Analysis (Bruker). Selenomethionine labelling 
efficiency was determined using the following equation: 
 
% Labelling Efficiency = 100 × (MWlabeled_experimental – MWunlabeled_experimental) 
                                                       (MWlabeled_theoretical – MWunlabeled_theoretical) 
 
2.4.15 Nuclear Magnetic Resonance (NMR) spectroscopy 
The NMR sample was prepared as previously described (Section 2.4.9). NMR data were 
collected by Dr. Mark Howard (University of Kent), and analysed by Dr. Andrew Lawrence 
(University of Kent). All NMR data were obtained at 298 K using a 14.1 T (600 MHz 
1
H) 
Bruker Avance III NMR spectrometer equipped with a TCI cryoprobe. NMR assignments 
were obtained using 
1
H homonuclear DQF-COSY, NOESY (500 ms), rotating-frame 
Overhauser effect spectroscopy [ROESY (200 ms)], and total correlation spectroscopy 




H heteronuclear sequential quantum correlation (HSQC), 
computed tomography-HSQC (27 ms), heteronuclear multiple bond correlation, and HSQC-
TOCSY (80 ms) experiments. Mixing/constant time periods are shown in parentheses. NMR 
data processing was achieved using TopSpin 3.0 and NMR data analysis using the 
didecarboxysirohaem analysis suite, version 2.0. 
 
2.4.16 Redox potentiometry 
Determination of the midpoint redox potentials was undertaken in collaboration with Prof. 
Andy Munro and Dr. Kirsty McLean (University of Manchester). Briefly, the method used is 
as follows and is essentially as described previously (Munro et al., 2001). Redox titrations 
were performed in a Belle Technology glove box under a nitrogen atmosphere, and all 
solutions were degassed under vacuum with argon. Oxygen levels were maintained at less 
than 2 ppm. The protein in 100 mM phosphate buffer, 200 mM KCl, 10% (v/v) glycerol pH 
7.0, was titrated electrochemically according to the method of Dutton (Dutton, 1978) using 
sodium dithionite as the reductant and potassium ferricyanide as the oxidant. Mediators (2 
μM phenazine methosulphate, 5 μM 2-hydroxy-1,4-naphthoquinone, 0.5 μM methyl 
viologen and 1 μM benzyl viologen) were included to mediate the range between +100 to - 
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480 mV, as described previously (Ost et al., 2001, Munro et al., 2001). At least 10 min was 
allowed to elapse between each addition of reductant or oxidant to allow stabilisation of the 
electrode. Spectra (250-800 nm) were recorded using a Cary UV-50 Bio UV-visible 
spectrophotometer via a fibre optic absorption probe immersed in the enzyme solution. The 
electrochemical potential of the solution was measured using a Mettler Toldeo FiveEasy 
meter coupled to a Pt/Arganthan electrode at 25 °C. The electrode was calibrated using the 
Fe
3+/2+
 EDTA couple (+108 mV). A factor of +207 mV was used to correct relative to the 
standard hydrogen electrode. 
 
2.4.17 Electron paramagnetic resonance spectroscopy (EPR) 
EPR spectra were recorded and analysed in collaboration with Dr. Steve Rigby (University 
of Manchester). EPR experiments were performed on a Bruker ELEXSYS E500 
spectrometer operating at X-band employing a Super High Q cylindrical cavity (Q factor 
~16,000) equipped with an Oxford Instruments ESR900 liquid helium cryostat linked to an 
ITC503 temperature controller. Signals were recorded at 12 K employing a microwave 
power of 1 mW, modulation frequency of 100 kHz and modulation amplitude of 5 G (unless 
otherwise stated). Protein samples were prepared as described previously (Section 2.4.1) 
under anaerobic conditions and transferred into EPR tubes. Samples were then rapidly frozen 
in liquid nitrogen. 
 
2.4.18 Crystallisation and X-ray crystallography 
2.4.18.1 Crystallisation by hanging drop method 
The hanging drop variant of the vapour diffusion method of protein crystallisation 
(McPherson, 1976) was employed. Proteins were purified using nickel affinity 
chromatography as previously described (Section 2.4.1), and subjected to further purification 
by FPLC, with the largest homogenous peak (correlating to a heterodimeric species) being 
selected for crystallisation. Protein was then concentrated to 8-20 mg mL
-1
 using an Amicon 
Ultra-15 centrifugal filter unit (Merck Millipore) with a molecular weight cut-off of 10,000 
Da. 
 
Initial crystallisation screens were performed using pre-formulated Structure Screen 1™, 
Structure Screen 2™ and MIDAS™ (Molecular Dimensions Ltd.) in an attempt to cover a 
wide range of precipitants to determine the conditions in which crystals would grow. Further 
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development of crystallisation conditions was performed using Clear Strategy Screen I™, 
Clear Strategy Screen II™ (Molecular Dimensions Ltd.) and Additive Screen (Hampton 
Research) according to the manufacturers descriptions. 
 
For a standard aerobic crystallisation experiment 1 mL reservoir solution was placed in each 
well of a 24-well XRL plate (Molecular Dimensions Ltd.). Protein was mixed with reservoir 
solution on a siliconised coverslip (Hampton Research) either at 2 µL : 2 µL or 1 µL : 1 µL, 
typically with 2 drops per well and a final protein concentration of 4-10 mg mL
-1
. The 
coverslip was then inverted over the well and sealed to the plate using a thin layer of high-
vacuum grease (Dow Corning). Crystallisation was carried out in a 19 °C constant 
temperature room. Conditions producing crystalline precipitant were selected and 
components were varied in concentration and pH leading to improvements in crystal growth. 
The original screen compositions are listed in the Appendix. 
 
Anaerobic crystallisation experiments were carried out in an anaerobic glove box using 
identical techniques and reagent volumes. However, experiments were set up in EasyXtal 
15-well plates (Qiagen) which use plastic screw capped lids instead of glass and grease, and 
3 reagent/protein drops per well. All plates and reagents were taken into the glove box 24 
hours prior to use. Reagents were left open in the glove box for 2-3 hours to allow oxygen to 
diffuse out of the solutions while reducing the amount of evaporation as degassing all 
solutions was impractical. Co-crystallisation experiments were performed using a 10-fold 
excess of sirohaem to protein. 
 
2.4.18.2 Crystal seeding experiments 
To enhance the growth of crystals seeding experiments were performed. For this a ‘seed’ 
crystal was taken from a previous drop and transferred into 10 µL of mother liquor (well 
solution). The crystal was then crushed using a pipette tip before the addition of 90 µL 
mother liquor. The crystal was further broken down by vigorous vortexing and serially 











Crystallisation experiments were then performed as previously described using an altered 
drop formulation. For seeding experiments 1 µL protein was mixed with 0.3 µL seed stock 
and 0.7 µL well solution with 2 drops per well. These experiments were then incubated as 
previously described. 
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2.4.18.3 Tetrapyrrole soaking experiments 
Native protein crystals were grown in an anaerobic chamber using the anaerobic 
crystallisation and seeding methods (Section 2.4.17.1 and Section 2.4.17.2). The crystal seed 
was grown aerobically before being transferred into the anaerobic chamber. Sirohaem was 
prepared using the method previously described in Section 2.4.8 and anaerobically freeze 
dried from a sufficient volume such that resuspension in well solution with 10% (v/v) 
glycerol would yield a 10 mM soaking solution. After crystals had grown to a sufficient size 
(~3-5 days) 1 µL sirohaem soaking solution was added to the drop. The crystals were 
incubated for 1 day in the sirohaem solution prior to being harvested and frozen (Section 
2.4.17.5). Soaking of sirohaem into the crystals was confirmed by the crystal turning purple 
(previously colourless). 
 
2.4.18.4 Preparation of heavy metal soaked crystals 
In an attempt to solve the AhbA/B structure using anomalous scattering experiments heavy 
atom derivatives were produced using the quick-soak method as previously described (Sun et 
al., 2002). Native protein crystals were selected and soaked in a range of heavy metal 
solutions (see Appendix) for 10 min to 2 hours before being harvested and frozen (Section 
2.4.17.5). 
 
2.4.18.5 Crystal harvest and storage methods 
Crystals were removed from the drop and immersed in cryo-protectant [typically well 
solution with 10% (v/v) glycerol, although a range of glycerol was tested] using appropriate 
sized Litholoops™ (Molecular Dimensions Ltd.) or CyroLoops™ (Hampton Research). 
After cryo-protection the crystals were flash frozen in liquid nitrogen and subsequently 
stored under liquid nitrogen until data collection. 
 
2.4.18.6 X-ray diffraction experiments 
The native and SeMet datasets were collected on beamlines IO4-1 and IO2, respectively, at 
the Diamond Light Source (Oxfordshire). The tetrapyrrole soaked dataset was collected on 
beamline ID23-1 at the European Synchrotron Radiation Facility (ESRF; Grenoble, France). 
Structure determination and refinement statistics are described in Chapter 4. 
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2.4.19 Thermal shift assay 
Protein stability was determined by thermal shift assay. This technique uses a fluorescent 
dye (SYPRO Orange®) that is quenched when free in solution but fluorescence increases 
upon binding to hydrophobic surfaces of proteins. Protein is incubated with a fluorescent dye 
and the temperature is increased stepwise. As the protein becomes denatured the dye binds 
and a fluorescent signal is produced. This allows the production of a melting curve and the 
melting temperature (Tm) can be determined. By using a range of buffers, salt concentrations 
and additives the ideal buffer conditions can be determined. 
 
Initially, D .desulfuricans was incubated at a final concentration of 0.2 mg mL
-1
 in 100 mM 
NaCl with a range of buffers from pH 4.2 to 9.8 (see Appendix for list of buffers). The 
protein was heated from 25 to 85 °C in a 96 well PCR plate using an iCycler iQ™ Real-
Time PCR Detection System (Bio-Rad) and fluorescence was measured. Data was 
normalised and melting points were determined with the aid of Dr. Stephen Irving (Argenta). 
Once an optimum buffer and pH was determined a second screen was performed to analyse 
the effect of salt concentration, glycerol and reducing agents using identical experimental 
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Evidence for the alternative haem biosynthesis pathway was revealed more than 20 years ago 
with the fortuitous discovery that the methyl groups of haem (at carbons C2 and C7) are 
derived from L-methionine (rather than ALA) in the sulphate reducing bacterium D. vulgaris 
(Akutsu et al., 1993). Furthermore, labelled tetrapyrroles, including the novel intermediate 
12, 18-didecarboxysirohydrochlorin, were isolated from D. vulgaris that indicated the 
alternative pathway proceeded via precorrin-2 (Ishida et al., 1998). Incorporation of 
methionine into haem was also demonstrated in the archaeon M .barkeri (Buchenau et al., 
2006), suggesting a variety of organisms may synthesise haem using this pathway via 
precorrin-2. With the release of many sequenced genomes, candidates for the alternative 
haem biosynthesis pathway were discovered in D. vulgaris and the archaea (Lobo et al., 
2009, Storbeck et al., 2010). Due to sequence similarity the candidate genes were annotated 
as members of the nir family (nirD, H and J). NirDLGH are involved in haem d1 synthesis 
(Fig. 3.1). However, D. vulgaris and many of the archaea do not require haem d1 as they do 
not contain the genes encoding the cytochrome cd1 nitrite reductase (NirS). The nirD/H/J 
homologues were therefore suspected to be involved in haem synthesis. The gene products 
of nirD/H/J1/J2 from D. vulgaris were shown to convert sirohaem to haem, constituting the 
alternative haem biosynthesis pathway [Fig. 3.1; (Bali et al., 2011)].  As such the genes were 
re-annotated ahb (alternative haem biosynthesis) A, B, C and D. 
 
Figure 3.1. The alternative haem and proposed haem d1 pathways. Chemical 
modifications are highlighted in red. 
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The activity of AhbA and AhbB as sirohaem decarboxylases was confirmed when 
recombinant E. coli cell lysates containing either D. vulgaris or D. desulfuricans AhbA and 
AhbB were shown to quantitatively convert sirohaem into didecarboxysirohaem (Bali et al., 
2011). Subsequently, incubations with purified AhbA and AhbB also resulted in the 
complete transformation of sirohaem to didecarboxysirohaem (Bali et al., 2011). These 
results were unexpected for two reasons. Firstly, the substrate contained iron chelated in the 
macrocycle, which was expected to be inserted in the final stage of the pathway, analogous 
to the classical pathway. Secondly, the same study also found that this initial reaction is 
conserved in the haem d1 pathway catalysed by the enzymes NirDLGH. AhbC from M. 
barkeri was shown to be active using E. coli cell lysates containing the enzyme and purified 
didecarboxysirohaem, leading to the production of Fe-coproporphyrin III. Finally purified 
AhbD from D. vulgaris demonstrated turnover of Fe-coproporphyrin III to haem. 
 
The decarboxylations of the C12 and C18 acetic acid side chains carried out by AhbA and 
AhbB are analogous to two of the decarboxylations catalysed by HemE (UROD) from the 
classical haem synthesis pathway (Whitby, 1998). HemE catalyses the removal of the four 
acetate side chains of uro’gen III at carbons C2, C7, C12 and C18 in a cofactor independent 
fashion (Dailey, 2002). Analysis of the non-enzymatic decarboxylation of a substrate model 
(pyrrolyl-3-acetate), suggests that the spontaneous reaction proceeds with a half-life of 
2.3x10
9
 years (Lewis & Wolfenden, 2008). A comparison of the non-enzymatic reaction to 
the enzyme catalysed reaction shows HemE enhances the rate of substrate decarboxylation 
by a factor of 1.2 x 10
17
, one of the largest rate enhancements reported for an enzyme that 
acts independently of cofactors, leading to HemE being described as a ‘benchmark for the 
catalytic proficiency of enzymes’. In the enzyme catalysed reaction the pyrrole nitrogens are 
used as electron sinks, with a protonated basic residue (Arg37 in human HemE) aiding 
carboxylate removal (Silva et al., 2010). Like HemE, AhbA and AhbB decarboxylate a 
kinetically stable tetrapyrrole (sirohaem) independently of any cofactors or metal ions (Bali 
et al., 2011). Therefore, the further understanding of these enzymes is of great interest. 
 
The work described in this chapter was undertaken in order to gain further insights into the 
AhbA and AhbB proteins. A comparative analysis of the proteins from three different 
organisms: D. desulfuricans, D. vulgaris and M. barkeri was performed. Experiments were 
carried out to determine if the individual proteins are capable of both decarboxylation 
reactions and whether the order of side chain decarboxylation could be ascertained. The 
formation of a quaternary AhbA/B complex was also investigated, revealing cross-species 
variation in oligomeric states, haem binding capabilities and redox regulation of the 
complexes. Methods were developed to allow the determination of kinetic parameters for the 
 Chapter 3 - Biochemical characterisation of AhbA and AhbB 
66 
 
double decarboxylation reaction. Finally, sites of decarboxylation were confirmed by NMR 
analysis of the AhbA/B reaction product didecarboxysirohaem. 
  




3.2.1 Overproduction and purification of AhbA and AhbB 
The ahbA and ahbB genes from D. desulfuricans and D. vulgaris were amplified by PCR 
from template DNA (pSL201-4) supplied by Dr. Susana Lobo (ITQB, Lisbon), whereas the 
M. barkeri ahbA and ahbB genes were amplified from genomic DNA provided by Dr. 
Evelyne Deery (University of Kent). The genes were cloned individually into the vector 
pET14b using NdeI and SpeI restriction sites (Section 2.3.7; Table 2.2). The pET14b vector 
encodes an N-terminal His6-tag allowing purification of the fusion protein by nickel affinity 
chromatography. 
 
In order to overproduce the individual AhbA and AhbB proteins E. coli BL21 (DE3) was 
transformed with a vector containing the gene of interest (i.e. pET14b-ahbA or pET14b-
ahbB). The resulting strain was grown in LB media supplemented with ampicillin and 
constant shaking (~160 rpm) at 37 °C to a cell density of A600 ≈ 0.6. Protein overproduction 
was induced with the addition of 0.4 mM IPTG and the cells were left to grow overnight at 
19 °C before harvesting by centrifugation (Section 2.2.7). After harvesting by centrifugation 
the cell pellets were resuspended in Tris buffer and lysed by sonication (Section 2.2.9). The 
soluble proteins were removed from cell debris by centrifugation. Protein purification was 
achieved using nickel affinity chromatography. Briefly, the resulting supernatant was passed 
over a nickel charged sepharose column and non-specific proteins were removed by the 
addition of Tris buffer containing a low concentration of imidazole. Purified protein was 
eluted in 400 mM imidazole in 2 ml fractions before buffer exchange using a PD10 column.  
 
M. barkeri AhbA was insoluble and remained in the cell pellet after sonication and 
centrifugation (Fig. 3.2). The AhbA proteins from D. desulfuricans and D. vulgaris were 
soluble; however, a high level of precipitation occurred while the proteins were immobilised 
on the nickel column. Low yields of purified D. desulfuricans and D. vulgaris AhbA proteins 
were obtained (~ 4 mg L
-1
 each). After purification both proteins continued to precipitate 
over time. The presence of the purified proteins was confirmed using SDS-PAGE, although 
both aggregation and degradation of the proteins can be observed (Fig. 3.2). 
 
As with AhbA, the M. barkeri AhbB protein was insoluble and the majority remained in the 
cell pellet (Fig. 3.2). Attempts to purify the M. barkeri AhbB protein from the soluble 
fraction did not realise any protein. The AhbB proteins from D. desulfuricans and D. 
vulgaris were soluble, but precipitated on the nickel column in an identical fashion to AhbA, 
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and continued to precipitate after purification. Slightly higher yields of the AhbB proteins 
were obtained in comparison to the AhbAs, with ~ 13 mg L
-1 
of the D. desulfuricans AhbB 
produced and ~ 7 mg L
-1 
of the D. vulgaris homologue. Again, confirmation of the purified 
proteins was obtained using SDS-PAGE, although fewer bands relating to aggregation states 
were observed for these proteins (Fig. 3.2). Due to the instability of the individual AhbA and 
AhbB proteins, no gel filtration studies were performed. 
 
                                                
Figure 3.2. 12.5% (v/v) SDS gels of AhbA and AhbB proteins. A. Cell pellet containing 
M. barkeri AhbA (23 kDa), B. Cell pellet containing M. barkeri AhbB (20 kDa), C. Purified 
D. desulfuricans AhbA (21 kDa), D. Purified D. desulfuricans AhbB (20 kDa), E. Purified 
D. vulgaris AhbA (22 kDa), F. Purified D. vulgaris AhbB (21 kDa). Both aggregation and 
degradation of the purified protein can be observed. 
 
3.2.2 In vitro activity of AhbA and AhbB 
3.2.2.1 Production of substrate 
Sirohaem was produced and purified as outlined in Section 2.4.8. In brief, the enzymes ALA 
dehydratase (HemB), porphobilinogen deaminase (HemC), uro’gen III synthase (HemD), 
SUMT (CobA) and precorrin-2 dehydrogenase (CobA) were purified aerobically and buffer 
exchanged into anaerobic buffer inside an anaerobic chamber (<2 ppm O2).  These enzymes 
were then incubated overnight at room temperature with 1 mL cofactor mix which contained 
SAM, NAD and ALA. Sirohaem was produced after the addition of a 10-fold excess of 
FeSO4 to the sirohydrochlorin and incubation at room temperature for 4 hours. In the 
presence of excess iron chelation into the macrocycle occurs without the need for chelatase 
enzymes. Sirohaem was purified by ion exchange chromatography using a DEAE column. 
The column was washed with the stepwise addition of NaCl from 100 mM to 800 mM, and 
finally sirohaem was eluted in 1 M NaCl. All buffers contained Tris-HCl, pH 8, to maintain 
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the pH of the solutions. DEAE purification of sirohaem resulted in a final volume of ~7 mL 
and at a concentration of ~60 μM. 
 
3.2.2.2 In vitro assays of individual AhbA and AhbB from D. desulfuricans and D. 
vulgaris 
To test in vitro activity of the individual proteins sirohaem (25 µM) was incubated overnight 
(~16 hours) with an equimolar amount of the protein of interest (i.e an AhbA or AhbB 
protein). After incubation the remaining soluble protein was precipitated by the addition of 
an equal volume of 100% acetonitrile at 4 °C for 10 min. The precipitate was removed from 
the sample by centrifugation at 2000 x g prior to analysis. Sirohaem and its derivatives were 
analysed by HPLC-MS using an ACE 5AQ column as described in Section 2.4.14. Using the 
sirohaem derivative gradient on the HPLC sirohaem is eluted first (~16 min), followed by 
monodecarboxysirohaem (~19.5 min) and finally didecarboxysirohaem (~25 min). 
 
HPLC chromatograms of the individual in vitro assays are shown in Figure 3.3. D. 
desulfuricans AhbA displayed a significant ability to convert sirohaem into 
didecarboxysirohaem (85%) with a small quantity of monodecarboxysirohaem remaining 
(10%). AhbA from D. vulgaris also demonstrated the ability to carry out both 
decarboxylation reactions. Although a lower quantity of didecarboxysirohaem was present 
(44%), a higher quantity of monodecarboxysirohaem remained (19%). 
 
D. desulfuricans AhbB was capable of converting the majority of sirohaem to 
didecarboxysirohaem (58%) and a high level of monodecarboxysirohaem (27%). However, 
D. vulgaris AhbB displayed very little activity for both decarboxylation reactions with only 
16% monodecarboxysirohaem present and a miniscule 1% didecarboxysirohaem. 
 
  






























Figure 3.3. Reaction profiles of individual AhbA and AhbB proteins. HPLC traces, 
recorded at a wavelength of 380 nm, after incubation of sirohaem with purified proteins. A. 
D. desulfuricans AhbA, B. D. desulfuricans AhbB, C. D. vulgaris AhbA, and D. D. vulgaris 
AhbB. E. shows a no enzyme control. The arrows indicate the peaks relating to sirohaem 
(SH, ∼16 min), monodecarboxysirohaem (MDSH, ∼19.5 min) and didecarboxysirohaem 
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The problem with this method is that, due to the instability of the proteins, it is unclear 
whether this is a true representation of activity or an anomaly caused by the differing levels 
of soluble protein in each reaction, i.e. AhbB may have denatured quicker than the other 
proteins and therefore displayed lower activity. It does however represent the first use of the 
AhbA and B proteins in an in vitro assay and demonstrates that all of the proteins tested are 
capable of double decarboxylations of sirohaem to varying degrees. Unfortunately, it was not 
possible to separate monodecarboxysirohaem from the solutions so the order of 
decarboxylation could not be ascertained. 
 
To test if the combination of AhbA and AhbB produced an enhanced reaction the activity 
assays were repeated with a 50:50 mix of the two proteins (from a single organism). In both 
cases (i.e. using AhbA and AhbB proteins from D. desulfuricans or D. vulgaris), incubations 
of sirohaem with the two proteins resulted in almost complete conversion of sirohaem to 
didecarboxysirohaem (Fig. 3.4). The increase in activity observed when both AhbA and 
AhbB are present in the reaction demonstrates that they are capable of acting cooperatively, 
facilitating the double decarboxylation of sirohaem. 
 
 
Figure 3.4. Reaction profiles of combined AhbA and AhbB proteins. HPLC traces, 
recorded at a wavelength of 380 nm, after incubation of sirohaem with purified proteins. A. 
D. desulfuricans AhbA and AhbB and B. D. vulgaris AhbA and AhbB. The arrow indicates 
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3.2.3 Overproduction and purification of the AhbA/B complex 
The high level of activity observed when the AhbA and AhbB proteins were combined led to 
the hypothesis that they may interact and that this may also stabilise the proteins. It has been 
reported previously that in most archaea harbouring these genes, ahbA and ahbB are found as 
a fusion (Storbeck et al., 2010), consistent with the idea that the two proteins may form a 
complex together. 
 
A construct was made containing D. desulfuricans ahbA and ahbB as described in Section 
2.3.7, allowing overexpression of both genes from a single vector. Using the Link and Lock 
technique a fragment containing a ribosome binding site followed by ahbB fused to an N-
terminal His6-tag was inserted into pET3a downstream of ahbA to form a single vector 
encoding the two ahb genes with independent ribosome binding sites (Fig. 2.2). Using the D. 
desulfuricans ahbA/B Link and Lock construct, a pull-down assay was performed. As only 
AhbB is produced with an N-terminal His6-tag using the ahbA/B plasmid, AhbA should not 
interact with the nickel column and should therefore be removed in the wash steps of 
purification. However, if AhbA forms a complex with AhbB, both proteins should remain 
bound to the nickel column and be eluted in the final stage of purification. The AhbA/B 
proteins were overproduced and purified as described for the individual enzymes (Section 
3.2.2.1).  
 
A high yield (~ 53 mg L
-1
) of colourless protein was purified from E. coli transformed with 
the D. desulfuricans pET3a-ahbA/B vector. SDS-PAGE analysis showed two individual 
bands with estimated masses corresponding to AhbA (~19 kDa) and AhbB with a His6-tag 
(~20 kDa; Fig. 3.5). This demonstrated that AhbA and AhbB from D. desulfuricans co-
purify and form a stable heteromeric complex. Gel filtration studies revealed that the 
AhbA/B complex from D. desulfuricans forms a single heterodimeric species with a mass of 
~40 kDa which correlates closely with the expected mass of 39.2 kDa (Fig. 3.6). Native 
polyacrylamide gels were attempted with this complex (data not shown). However, excessive 



























Figure 3.5. 12.5% SDS gels of purified AhbA/B complexes and pictures of the purified 
protein solutions. The AhbA/B complexes from D. desulfuricans (A.), D. vulgaris (B.) and 
M. barkeri (C.) were purified using the pull-down method. In each case the higher band in 
the SDS gel is AhbB and the lower is AhbA (individual M. barkeri protein bands are labelled 
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Figure 3.6. Gel filtration UV trace recorded at a wavelength of 280 nm of purified 
AhbA/B complexes. Major peaks correspond to a single dimeric D. desulfuricans AhbA/B 
complex (red), dimeric and tetrameric D. vulgaris AhbA/B complexes (green), and a dimeric 
M. barkeri AhbA/B complex (blue) with high molecular weight aggregates. Peaks after 20 
minutes are low molecular weight contaminants.  
 
In light of the discovery of the D. desulfuricans AhbA/B complex the ahbA/B genes from D. 
vulgaris were cloned into a single vector in an identical manner to those from D. 
desulfuricans using the Link and Lock technique, with only AhbB fused to an N-terminal 
His6-tag. Again, co-expression of the two genes yielded much higher quantities of stable 
protein (~ 79 mg L
-1
) after purification by nickel affinity chromatography. The co-
purification of D. vulgaris AhbA/B was confirmed by SDS-PAGE (Fig. 3.5). Surprisingly, 
gel filtration of the AhbA/B complex from D. vulgaris revealed the presence of a dimeric 
complex as well as a tetrameric complex with masses of ~44 kDa and ~94 kDa, respectively, 
close to the estimated masses of 40 kDa and 81 kDa (including the His6-tag; Fig. 3.6). 
Interestingly, D. vulgaris AhbA/B purified with a light brown colour in contrast to the 
colourless isolated D. desulfuricans protein complex (Fig. 3.5). 
 
UV-visible analysis of the D. vulgaris AhbA/B complex revealed an absorption peak at 420 
nm, suggesting the presence of either an Fe-S complex or a haem group (Fig. 3.7).  However, 
analysis of the protein sequences showed no CX3CX2C motif which is conserved in many 
iron sulphur centre containing proteins (Sofia et al., 2001). Furthermore, EPR analysis of the 
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protein complex did not show any signal consistent with an iron sulphur centre (data not 
shown). It was, therefore, postulated that the absorption at 420 nm may be due to a bound 
haem group in low occupancy.  
 
To investigate this further haemin (6 mM) was added to the resuspended cell pellet of the 
strain overproducing the D. vulgaris AhbA/B prior to sonication in an attempt to load the 
complex with the prosthetic group. This approach resulted in purified protein with a 
significantly stronger brown/orange colouration. The UV-visible spectrum of haem-loaded 
D. vulgaris AhbA/B had a Soret band at 423 nm and αβ bands at 527 nm and 555 nm 
(reduced spectrum; Fig. 3.7). The haem was retained with the protein during gel filtration 
and did not affect the oligomeric state of the complex (data not shown). Supplementation of 
cultures with ALA (20 mg L
-1
) prior to induction of protein production also led to an 
increased colouration of the purified complex and a subsequent increase in the A420 (data not 
shown). However, the haem occupancy using ALA supplementation was over 50% lower 
than that produced using haemin addition. 
                      
Figure 3.7. UV-visible spectra of purified sirohaem decarboxylases. The spectra of M. 
barkeri AhbA/B (green), D. vulgaris AhbA/B (blue), and D. desulfuricans AhbA/B (red) are 
shown. 
 
The observation that co-expression of AhbA and AhbB from D. desulfuricans and D. 
vulgaris causes enhanced stability and co-purification of the proteins led to the investigation 
as to whether this would be the case for the homologues from M. barkeri which, as 
mentioned earlier, had been found to be highly insoluble when produced individually. As 
with the genes from the sulphate reducers, a single plasmid construct was produced using the 
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Link and Lock technique, containing M. barkeri ahbA and ahbB with the latter encoding an 
N-terminal His6-tag. The AhbA/B proteins were overproduced in E. coli and a pull-down 
assay was used to test complex formation. 
 
Surprisingly, a distinct red band was observed during the nickel affinity purification. The 
colour eluted from the column with the protein. The M. barkeri AhbA/B complex was 
purified at a slightly lower yield of ~31 mg L
-1
. SDS-PAGE analysis showed that both 
proteins co-purified (Fig. 3.5). The UV-visible spectra of the purified protein solution had a 
distinctive haem profile with peaks at 426 nm, 530 nm, and 559 nm (Fig. 3.7). The haem-
loaded D. vulgaris AhbA/B haem UV-visible spectrum is slightly shifted in comparison to 
the M. barkeri AhbA/B. The M. barkeri complex displays an intense haem signal without the 
addition of haemin, suggesting it has a higher affinity for haem. Size exclusion 
chromatography of M. barkeri AhbA/B revealed it forms a single dimeric species with an 
observed mass of 37 kDa (estimated mass 40 kDa including His6-tag) as well as high 
molecular weight aggregates (Fig. 3.6). 
 
In order to confirm the presence of haem in the D. vulgaris and M. barkeri complexes and to 
ascertain the type of haem bound (a/o, b, or c), pyridine haemochrome assays were 
undertaken [Section 2.4.11; (Berry & Trumpower, 1987)]. These assays were performed 
with both the M. barkeri AhbA/B and the exogenous haem-loaded D. vulgaris AhbA/B 
proteins. First the haemichromes were formed by the addition of 0.5 mL 200 mM NaOH, 
40% (v/v) pyridine to 0.5 mL protein (~10 mg mL
-1
), oxidised with 3 µL 0.1 M potassium 
ferricyanide, and the spectra were recorded from 520-620 nm. Next the haemochromes were 
produced by the reduction of the haemichromes with 2-5 mg sodium dithionite and the 
spectra were recorded at 520-620 nm. The difference spectrum of haemochrome (reduced) 
minus haemichrome (oxidised) relates to the type of haem present in the sample. The 
pyridine haemochrome from M. barkeri displayed a peak at 556 nm (Fig. 3.8), which 
corresponds to a b type haem (Berry & Trumpower, 1987). The haem-loaded complex from 
D. vulgaris again showed a slightly shifted spectrum with a haemochrome peak at 554 nm, 
shorter than that reported for haem b, but longer than that of a haem c (≈ 550 nm; Fig. 3.8).  
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Figure 3.8. Pyridine haemochrome difference spectra (reduced-oxidised) of M. barkeri 
and D. vulgaris AhbA/B complexes. Exogenous haem-loaded D. vulgaris AhbA/B (green) 
and M. barkeri AhbA/B (blue). Peaks are observed at 554 nm and 556 nm, respectively. 
 
To obtain further confirmation of the presence of haem, extraction methods were employed 
for analysis of the compound by mass spectrometry. Haem extractions were carried out as 
previously described [Section 2.4.12; (Lubben & Morand, 1994)]. Using acidified acetone, 
non-covalently bound haem molecules can be extracted from membrane suspensions and 
protein solutions. Addition of ice-cold dH2O and ethyl acetate causes the tetrapyrrole to 
separate into the organic layer which can then be recovered and the solvent removed using a 
vacuum centrifuge. The residues can then be analysed by mass spectrometry after 
resuspension in dH2O (Section 2.4.14.1). 
 
Low levels of haem could be removed from the D. vulgaris AhbA/B complex using haem 
extraction methods. For this experiment the haem content of D. vulgaris AhbA/B was 
increased by adding ALA (20 mg L
-1
) to the growth media of the transformed E. coli at the 
point of induction of protein overproduction. The presence of the extracted haem was 
confirmed by mass spectrometry (Fig. 3.9); however, the majority of the haem remained 
bound to the denatured protein. Samples were resolved on an ACE 5AQ column with a 
gradient of 0.1% (v/v) TFA and acetonitrile. The gradient used for analysis of haem is 
different to that used for the separation of sirohaem and its derivatives due to the increased 
hydrophobicity of haem. The haem gradient starts with the column equilibrated in 20% 
acetonitrile allowing earlier elution of haem at ~16.5 min. 




Protein bound haem could not be detected on an SDS gel using a haem staining protocol 
(Section 2.4.6.3) suggesting that it is likely to be a haem b bound to D. vulgaris AhbA/B. 
Further attempts to remove the haem using urea and SDS were not successful with the haem 
remaining bound to the protein. The tight binding of haem to the enzyme complex may 
explain the shift observed in the UV-visible spectra of the proteins and their pyridine 
haemochrome derivatives. In contrast, it was much easier to remove the haem from the M. 
barkeri AhbA/B complex using heat or urea (Fig. 3.9). Dimer formation and haem binding 
properties of the M. barkeri AhbA/B was recently published confirming the results reported 
in this thesis (Kuhner et al., 2014). 
 
 
Figure 3.9. Haem extractions from D. vulgaris and M. barkeri AhbA/B proteins. HPLC 
traces, recorded at a wavelength of 420 nm, after haem extractions from purified D. vulgaris 
AhbA/B (A.) and M. barkeri AhbA/B (B.). The peaks at ~17 minutes relate to haem with a 
m/z of 616. For this experiment haem content of D. vulgaris AhbA/B complex was increased 
by adding ALA to E. coli growth media during protein overproduction. 
 
3.2.4 In vitro activity of the AhbA/B complex 
To demonstrate that the AhbA/B proteins are active as a complex they were incubated with a 
ten-fold excess of purified sirohaem (Section 2.4.8) overnight (≈ 16 hours) at 37 °C in an 
anaerobic chamber (<2 ppm O2). Protein was precipitated by addition of acetonitrile and 
centrifugation before samples were analysed using HPLC-MS. Both AhbA/B complexes 
from sulphate reducing bacteria showed quantitative conversion of sirohaem to 
didecarboxysirohaem (Fig. 3.10). The haem-loaded D. vulgaris AhbA/B complex was 
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equally as active as the apo-protein suggesting that the presence of the haem does not affect 




Figure 3.10. Reaction profiles of AhbA/B complexes from sulphate reducing bacteria. 
HPLC traces, recorded at a wavelength of 380 nm, after incubation of 10-fold excess of 
purified sirohaem with purified A. D. desulfuricans AhbA/B, B. D. vulgaris AhbA/B. The 




Figure 3.11. Reaction profile of haem-loaded AhbA/B complex from D. vulgaris. HPLC 
trace, recorded at a wavelength of 380 nm, after incubation of 10-fold excess of purified 
sirohaem with haem-loaded AhbA/B complex from D. vulgaris. The arrow indicates the 
peak relating to didecarboxysirohaem (DDSH, ∼24 min). 
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Surprisingly, similar incubations of M. barkeri AhbA/B with sirohaem showed low turnover 
(Fig. 3.12). Repeating the assay in the presence of a ten-fold excess of sodium dithionite 
gave a 6.5-fold increase in activity (quantified using HPLC peak integration), indicating that 
the haem bound to the AhbA/B complex must be reduced in order for the enzyme to be most 
active. To investigate this further the reaction was repeated with AhbA/B protein that had 
been oxidised by exposure to potassium ferricyanide prior to buffer exchange. Again low 
activity was observed with the oxidised protein, which could be recovered by the addition of 
sodium dithionite (Fig. 3.12). These data demonstrate that the redox state of the haem b in 
the M. barkeri AhbA/B modulates the activity of the enzyme. Addition of sodium dithionite 
to the haem-loaded D. vulgaris AhbA/B complex did not affect activity (data not shown). 
Also, a high degree of activity was displayed using aerobically purified haem-loaded protein 











Figure 3.12. Reaction profile of AhbA/B complex from M. barkeri in different oxidation 
states. HPLC traces, recorded at a wavelength of 380 nm, after incubation of 10-fold excess 
of purified sirohaem with A. purified protein, B. purified protein with a 10 fold excess of 
sodium dithionite, C. protein oxidised with addition of a 10 fold excess ferricyanide which 
was removed prior to reaction by buffer exchange, D. the same oxidised protein with a 10 
fold excess of sodium dithionite. The arrows indicate the peaks relating to sirohaem (SH, 
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3.2.5 Redox titration of M. barkeri AhbA/B 
Redox potentiometry of the M. barkeri AhbA/B complex was carried out by Dr. Kirsty 
McLean (University of Manchester). The M. barkeri complex was purified using the pull-
down method as previously described (Section 3.2.3). The purified protein was buffer 
exchanged in an anaerobic chamber (<2 ppm oxygen) into degassed phosphate buffer (100 
mM), pH 7.0, containing 200mM KCl and 10% (v/v) glycerol. Subsequently, the proteins 
were reversibly reduced and oxidised using sodium dithionite as a reducing agent and 
potassium ferricyanide for re-oxidation (Section 2.4.16). Mediators (phenazine 
methosulphate, 2-hydroxy-1,4-naphthoquinone, methyl viologen and benzyl viologen) were 
included to mediate the range between +100 to -480 mV. Spectra were recorded at different 
applied potentials. The maximal overall absorption changes between oxidised and reduced 
species were plotted versus the applied potential (mV versus the normal hydrogen electrode, 
NHE). Data were fitted using the Nernst equation for a single electron reduction, yielding the 
respective midpoint reduction potentials. The proteins remained stable throughout the 
titrations. A redox potential of -98 ± 3 mV at 426 nm was observed for the haem bound to 
the M. barkeri AhbA/B complex (Fig. 3.13).  
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Figure 3.13. Redox titration of M. barkeri AhbA/B complex. A. UV-visible spectra 
recorded during the redox titration. The arrows show direction of maximal changes during 
the reductive titration. B. Plot of absorbance at 426 nm against redox potential versus normal 




couple of the bound haem 
iron is -98 ± 3 mV. 
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3.2.6 D. desulfuricans AhbA/B kinetics 
The decarboxylation of sirohaem to 12,18-didecarboxysirohaem has little impact on the 
conjugation of the macrocycle and therefore causes no noticeable change in the UV-visible 
absorbance spectrum between sirohaem, monodecarboxysirohaem and didecarboxysirohaem. 
Sirohaem and its derivatives are also oxygen sensitive and the use of alternative non-
spectroscopic techniques to measure reaction rates in a continuous fashion, such as 
isothermal calorimetry, are impractical. Therefore the only method of quantifying the 
reaction was to perform stopped assays inside an anaerobic glove box and measure the 
reaction intermediates by HPLC-MS. 
 
Kinetic parameters for D. desulfuricans AhbA/B were determined using the methods 
outlined in Section 2.4.10. Sirohaem (23 µM) was incubated at 37 °C for 10 minutes prior to 
the reaction before D. desulfuricans AhbA/B was added to a final concentration of 2.3 µM. 
The mixture was incubated at 37 °C for the duration of the reaction. Samples were taken 
from a bulk reaction and mixed with an equal volume of acetonitrile to stop the reaction and 
precipitate the protein. The sample was then left at 4 °C for 10 min before being centrifuged 
to remove any precipitated protein. The supernatant was analysed using HPLC-MS. To 
determine the quantity of the tetrapyrroles in the sample the elution peaks were integrated 
using Compass™ data analysis software (Bruker) and normalised. Normalising the data 
allowed for variations in peak intensity which would otherwise cause large outliers. 
Normalisation worked on the principal that the sum of all peaks must represent the total 
concentration of tetrapyrrole in the system (i.e. 23 µM) and therefore individual peaks 
represented an equivalent fraction of the total concentration. 
 
Initial experiments were performed to ascertain the time period over which the reaction is 
completed (data not shown). From this it was noted that the majority of the reaction occurred 
during the first 10 min, and the reaction was near completion after 30 min. Therefore time 
points were taken at 0, 0.5, 1, 2, 3, 4, 5, 10, 15, 20, 30 min to allow an enhanced view of the 
initial phase of the reaction. The results were fitted to a single active site model with two 
competitive substrates. A further inhibitory constant was added which gave a better fit for 
the data and represents the tight binding nature of the product (discussed in Chapter 5). Data 
were fitted using in house software developed by Dr. Andrew Lawrence (University of Kent) 
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ν1 =                    Vmax1 S1 
         Km1 (1 +  S2/ Km2 + S3/Ki) + S1 
ν2 =                      Vmax2 S2 
         Km2 (1 +  S1/ Km1 + S3/Ki) + S2 
 
where ν1 is the rate of sirohaem decarboxylation, S1 is the concentration of  sirohaem, ν2 is 
the rate of monodecarboxysirohaem decarboxylation, S2 is the concentration of 
monodecarboxysirohaem, S3 is the concentration of didecarboxysirohaem, Ki is the tight-
binding constant of  didecarboxysirohaem to the enzyme and Vmax1 / Vmax2 and Km1 / Km2 are 
the kinetic parameters of each reaction respectively. 
 
From this analysis the following constants were determined: 
Km1 = 11.74 ± 3.36 μM, Vmax1 = 44.63 ± 4.78 μM min
−1
, Km2 = 9.94 ± 1.19 μM, Vmax2 = 33.22 
± 3.78 μM min−1, Ki = 1.77 ± 0.32 μM. The data were averaged from three replicates (Fig. 
3.14). These data show that both decarboxylation reactions have very similar parameters. 
Although the initial reaction has a higher Vmax, this is compensated for by the intermediate 
having a slightly increased affinity for the enzyme, which prevents the build-up of 
monodecarboxysirohaem. The binding constant for the product is significantly lower than 
that of the substrates, concurrent with the tight binding of the product to the enzyme 
(described in Chapter 5). 
 
 
Figure 3.14. Kinetic analysis sirohaem decarboxylase. Data from the reaction of sirohaem 
(23 μM) with D. desulfuricans AhbA/B (2.3 μM). Initially, sirohaem (circles) is 
decarboxylated to monodecarboxysirohaem (triangles), which is in turn decarboxylated to 
didecarboxysirohaem (squares). These reactions follow a competitive inhibition model for 
both substrates and the product. Data were fitted using in-house software. 
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3.2.7 AhbA/B decarboxylates at carbons 12 and 18 
It had been postulated that AhbA and AhbB would remove the acetic acid side chains of 
sirohaem at carbons C12 and C18 (Storbeck et al., 2010), although the decarboxylation of 
acetate side chains at carbons C2 and C7 would give an equal mass difference. Confirmation 
of the location of decarboxylations was achieved using NMR. 
 
Sirohaem was incubated with AhbA/B from D. vulgaris in excess for ≈ 16 hours at 37 °C in 
an anaerobic chamber (<2 ppm O2). The resulting product was then purified from the protein 
using a DEAE column. The column was equilibrated with Tris HCl, pH 8, containing 100 
mM NaCl prior to the loading of the sample. After sample loading, the column was washed 
with acidified dH2O with a pH gradient from 8 to 3. Finally, the tetrapyrrole was eluted from 
the column in dH2O, pH 2.5. The purified sample was freeze-dried before being resuspended 
anaerobically in 0.5 ml 100% deuterium oxide and sealed in a septum screw-capped 5 mm 
NMR tube. 
 
NMR data were collected by Dr. Mark Howard (University of Kent) as described in Section 
2.4.15. All NMR data were obtained at 298 K using a 14.1 T (600 MHz 1H) Bruker Avance 
III NMR spectrometer equipped with a TCI cryoprobe. NMR assignments were obtained 
using 
1
H homonuclear DQF-COSY, NOESY (500 ms), rotating-frame Overhauser effect 




H heteronuclear sequential quantum correlation (HSQC), computed tomography-HSQC 
(27 ms), heteronuclear multiple bond correlation, and HSQC-TOCSY (80 ms) experiments. 
Mixing/constant time periods are shown in parentheses. NMR data processing was achieved 
using TopSpin 3.0 and NMR data analysis using the didecarboxysirohaem analysis suite, 
version 2.0.  
 
Data analysis and assignment was performed by Dr. Andrew Lawrence (University of Kent). 
Figure 3.15 shows the structure of 12,18-didecarboxysirohaem labelled with the atom 
definitions used for assignment and the NMR data including the NOE contacts observed in 




H HSQC with major 
resonances labelled. These data confirmed that the AhbA/B complex does indeed 
decarboxylate sirohaem at carbons C12 and C18. 





Figure 3.15. NMR analysis of 12,18-didecarboxysirohaem. A. The structure of 12,18-
didecarboxysirohaem labelled with the atom definitions used for the assignment of the NMR 
chemical shifts (Table 3.1). B. The structure of 12,18-didecarboxysirohaem with the NOE 





H HSQC of didecarboxysirohaem with major resonances labelled. 
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Table 3.1. NMR chemical shift assignments for 12,18-didecarboxysirohaem. 




C2A 2.94 41.1 
C2A 3.23 41.1 
C2-Me 1.52 18.9 
C3 3.28 48.9 
C3A 3.14 22.9 
C3A 3.28 22.9 
C3B 2.72 38.7 
C3B 2.78 38.7 
C5 7.08 98.5 
C7A 1.96 49.0 
C7A 2.09 49.0 
C7-Me 1.79 18.3 
C8 3.97 55.0 
C8A 2.16 35.1 
C8A 2.23 35.1 
C8B 1.89 28.1 
C10 7.40 97.3 
C12-Me 2.49 10.3 
C13A 3.48 22.0 
C13B 2.67 39.6 
C15 8.01 96.9 
C17A 3.48 22.0 
C17B 2.67 39.6 
C18-Me 2.53 10.1 
C20 7.72 94.7 
 
  




The AhbA and AhbB proteins from the sulphate reducing bacteria D. vulgaris and D. 
desulfuricans and the archaeon M. barkeri have been overproduced individually with N-
terminal His6-tag fusions in E. coli. However, the M. barkeri AhbA and AhbB proteins were 
found to be insoluble. Furthermore, the AhbA and AhbB proteins from both sulphate 
reducing bacteria were unstable and only low concentrations of purified samples could be 
obtained after metal affinity purification. Incubation of excess AhbA and AhbB proteins 
from the sulphate reducers with purified sirohaem led to the production of 
monodecarboxysirohaem and didecarboxysirohaem in varying quantities depending on the 
enzyme. The relative activity of the individual enzymes in isolation may be an artefact 
caused by differences stability rather than a true characteristic of the enzymes, although this 
would be extremely difficult to prove experimentally. Nonetheless, this has demonstrated 
that both AhbA and AhbB are able to perform both decarboxylation reactions on their own in 
an in vitro assay. Interestingly, mixing individually purified AhbA and AhbB proteins 
together in the same incubation with sirohaem resulted in nearly 100% conversion to 
didecarboxysirohaem. The enhanced activity observed when the proteins are combined 
demonstrates co-operativity between the two proteins. It may be that the observed activity of 
the single proteins is due to the action of poorly formed homomeric complexes, as opposed 
to a single monomeric species. Evidence to support this view would have to come from 
structural studies, as undertaken in Chapter 4. 
 
Plasmid constructs were produced allowing the simultaneous recombinant overexpression of 
both ahbA and ahbB from all three sources in E. coli. In these constructs only the ahbB genes 
were fused to a sequence encoding an N-terminal His6-tag to test if AhbA could be co-
purified with AhbB. Purification of protein from E. coli overexpressing these constructs led 
to the co-purification of AhbA and AhbB in all three cases. The production of high yields of 
stable protein suggested that these proteins naturally form complexes, and explains the poor 
stability of the individual proteins. Purification of the three homologous complexes led to the 
discovery of cross-species variation within this protein family. The AhbA/B complexes can 
be found in different oligomeric states. The complexes from D. desulfuricans and M. barkeri 
purify exclusively as dimeric species, whereas the complex from D. vulgaris is present in 
both dimeric and tetrameric species. Similarly, the complexes have differing haem binding 
capabilities, with the M. barkeri complex co-purifying with a high occupancy of haem, but 
D. vulgaris purifying with a much lower level of haem. D. desulfuricans AhbA/B on the 
other hand does not co-purify with haem at all.  
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The AhbA/B complexes from sulphate reducers are highly active. However, the M. barkeri 
complex demonstrates poor turnover in the absence of a reducing agent. The haem in the M. 
barkeri complex appears to modulate the activity, with the enzyme being more active when 
the haem is in the reduced state. The midpoint redox potential of the haem group found in 
the M. barkeri AhbA/B complex was found to be -98 ± 3 mV (at 426 nm), suggesting that 
the haem group would normally be present in the reduced form in vivo. These results suggest 
haem regulation may be present in archael AhbA/B complexes. In the case of D. vulgaris 
haem binding has no effect on activity suggesting there may be a different role for the haem 
bound to this enzyme complex. A comparison of the redox potential of the haem bound to D. 
vulgaris to that of M. barkeri would be interesting and may shed further light on the unusual 
properties of this enzyme. Binding constants of haem to the D. vulgaris and M. barkeri 
AhbA/B complexes would also further the understanding of their association. However, due 
to the advantageous binding of haem to the complexes during production and purification, 
the isolation of apo-protein has not been possible.  
 
The kinetic parameters of the D. desulfuricans AhbA/B complex were determined via a 
stopped assay. The results fit a single active site model with both sirohaem and 
monodecarboxysirohaem being competitive substrates. The initial reaction appears to have a 
higher Vmax but this is compensated by the higher affinity for the monodecarboxysirohaem. A 
greater fit was achieved when a third inhibitory constant was added which, represents the 
tight binding of the product to the enzyme (discussed in Chapter 5). The fact that 
monodecarboxysirohaem can be observed at high concentrations, and that it fits a single 
active site model, suggests that the intermediate may be released and rebinds before the 
second decarboxylation is performed. Therefore, there may be a specific order of 
decarboxylation, although this order has not been investigated. By employing NMR it has 
been shown that the AhbA/B complex selectively decarboxylates sirohaem at carbons C12 
and C18 to form 12,18-didecarboxysirohaem. This provides further confirmation that the 
next enzyme in the pathway, AhbC, removes the acetate side chains found at carbons C2 and 
C7 to form iron coproporphyrin. 
 
In summary, the results presented in this chapter have contributed to the current 
understanding of the function, and properties of the AhbA and AhbB enzymes. It has been 
demonstrated that these proteins form a complex that enhances the stability and activity of 
the individual subunits. Cross-species variations between complexes have been discovered 
including differences in oligomerisation state, haem binding and activity. The haem bound to 
M. barkeri AhbA/B appears to be regulatory although this is not the case with D. vulgaris 
AhbA/B. Further work is required to understand the role of haem in the D. vulgaris complex. 
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Analysis of AhbA/B complexes from other organisms may provide a more coherent view of 
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In 1914 Max von Laue was awarded the Nobel Prize in Physics for the discovery of the 
diffraction of X-rays by crystals. Now, 100 years on with over 20 Nobel Prizes related to it, 
X-ray crystallography lies at the forefront of structure determination of proteins and small 
molecules. To date, over 100,000 protein structures have been deposited in the Protein Data 
Bank (PDB), which has been facilitated by the development of new and enhanced tools for 
crystallisation, data collection and structure determination.  
 
All of the haem biosynthesis proteins from the classical pathway with the exception of 
oxygen-independent protoporphyrinogen IX oxidase (HemG) and the recently discovered 
protoporphyrinogen IX oxidase HemJ, have had their structures solved by X-ray 
crystallography (Layer et al., 2010). Solution of the three dimensional structures of these 
proteins has led to an enhanced view of the function of these enzymes, allowing the 
determination of many reaction mechanisms, as well as the structural basis of diseases 
caused by mutations in the human pathway. 
 
The AhbA/B proteins have been annotated as members of the Lrp/AsnC family of 
transcriptional regulators based on sequence homology for a helix-turn-helix domain (Pfam 
13404). Further evidence supporting the idea that the AhbA/B proteins may be regulators 
comes from the closely related protein NirL from Heliophilum fasciatum. NirL was shown to 
be able to bind the putative promoter of the nir operon (Xiong et al., 2007). It has been 
demonstrated that NirL is essential for the production of didecarboxysirohaem during haem 
d1 synthesis by acting as a decarboxylase (Bali et al., 2011) meaning that this protein plays 
both regulatory and catalytic roles. 
 
Lrp/AsnC proteins are involved in the regulation of a variety of metabolic processes 
including catabolism and anabolism of amino acids (Brinkman et al., 2003). AsnC is a 
specific regulator of the asnA gene required for the production of asparagine synthetase, 
which converts aspartate to asparagine in an ATP-dependent manner (Kolling & Lother, 
1985). AsnC binds asparagine causing auto-repression of asnA. Lrp proteins are global 
regulators and are able to control expression of a wide range of operons (Ren et al., 2007). 
Similarly, Lrp proteins are regulated by amino acid binding; however, this can be either in an 
agonistic or antagonistic manner and a number of amino acids are employed depending on 
the protein including leucine, asparagine, alanine, valine, lysine and proline (Brinkman et al., 
2003). Members of the Lrp/AsnC family display a range of oligomeric species in solution 
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including dimers, tetramers, octamers and hexadecamers, formed from repeats of the same 
subunit (Brinkman et al., 2000, Chen et al., 2001, Madhusudhan et al., 1995, Thaw et al., 
2006, Willins et al., 1991). Several structures of Lrp/AsnC proteins have been published 
with E. coli AsnC being the first bacterial homologue to be crystallised as a regulator-
effector complex (Fig. 4.1). 
 
 
Figure 4.1. E. coli AsnC, PDB 2CG4. A. Monomeric E.coli AsnC, B. Homodimer of E. coli 
AsnC with bound asparagine (Thaw et al., 2006). 
 
No structural information has been published for proteins from either the haem d1 or 
alternative haem pathways leaving questions as to whether the AhbA/B proteins contain the 
helix-turn-helix domain and if they have any structural homology to proteins belonging to 
the Lrp/AsnC family of transcriptional regulators. 
 
The results outlined in this chapter describe crystallisation experiments carried out on 
AhbA/B homologues from D. vulgaris, M. barkeri and D. desulfuricans. Optimisation of 
crystallisation conditions, data collection and phasing experiments led to the solution of the 
AhbA/B complex from D. desulfuricans. Furthermore, substrate soaking was achieved 
allowing the determination of a product-bound complex. The structural data from this 
chapter were submitted to the PDB with accession codes 4CZD and 4UN1. 
 




4.2.1 Crystallisation of AhbA/B complexes 
All proteins were overproduced in E. coli BL21 (DE3) and purified using nickel affinity 
chromatography as outlined in Sections 2.2.7 and 2.4.1. Composition of the original crystal 
screens used can be found in the Appendix. 
 
4.2.1.1 Crystallisation of D. vulgaris AhbA/B 
Crystallisation was attempted using purified AhbA/B from D. vulgaris. The protein was 
concentrated to 8-20 mg mL
-1
 prior to crystallisation and hanging drop vapour diffusion 
experiments were set up as described in Section 2.4.18.1. Structure Screen 1™ and Structure 
Screen 2™ (Molecular Dimensions Ltd.) were used to find conditions that produced crystals 
or crystalline precipitant. Initially, all screens were performed anaerobically in EasyXtal 15-
well plates (Qiagen). 
 
The best initial hit was obtained in 0.2 M lithium sulphate, 0.1 M Tris, pH 8.5, containing 
30% (w/v) polyethylene glycol (PEG) 4000. Globular structures were observed with needle-
like protrusions and a high degree of precipitant (Fig. 4.2). Optimisation was performed 
using Clear Strategy Screen I™ and Clear Strategy Screen II™ (Molecular Dimensions 
Ltd.), resulting in a range of conditions that produced similar needle-like crystals. 
Interestingly these hits could not be reproduced aerobically using siliconised coverslips 
(Hampton Research) and 24-well XRL plates (Molecular Dimensions Ltd.). After a wide 
variety of custom screening, including separation of dimeric and tetrameric fractions by 
FPLC prior to screening and use of Clear Strategy Screen 1™ and Clear Strategy Screen 2™ 
(Molecular Dimensions Ltd.), the thickness of the needles and high level of background 
precipitation could not be altered to produce diffraction quality crystals.  
 
 





Figure. 4.2. D. vulgaris AhbA/B crystals. Needle-like crystals of AhbA/B from D. vulgaris 
produced in 0.2 M sodium acetate trihydrate, 0.1 M Tris, pH 8.5, containing 30% (w/v) PEG 
4000. No further improvement of crystal size or thickness was achieved.  
 
Re-screening was performed with the addition of haemin as the protein was previously 
shown to bind haem (Chapter 3). Addition of ligands often leads to the stabilisation of 
proteins and improvements in crystallisation. Unfortunately rescreening with haemin did not 
provide any hits. Further attempts were made using the MIDAS™ screen (Molecular 
Dimensions Ltd.). Several hits were obtained but further optimisation did not yield any 
protein crystals. Due to the problems encountered with these proteins other protein 
homologues were purified and screened in the hope that they may be more amenable to 
crystallisation. 
 
4.2.1.2 Crystallisation of M. barkeri AhbA/B 
Crystallisation was attempted using purified AhbA/B from M. barkeri. The proteins were 
further purified by FPLC with the dimeric fraction being purified from the aggregates. The 
protein was then concentrated to 8-20 mg mL
-1
 prior to crystallisation and hanging drop 
vapour diffusion experiments were set up aerobically using siliconised coverslips and 24-
well XRL plates. Structure Screen 1™ and Structure Screen 2™ were used to find conditions 
that produced crystals or crystalline precipitant. Unfortunately, no hits were observed during 
initial screening and no further attempts to crystallise these proteins were made. 
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4.2.1.3 Crystallisation of D. desulfuricans AhbA/B 
4.2.1.3.1 Initial crystallisation of D. desulfuricans AhbA/B 
Prior to screening the AhbA/B complex from D. desulfuricans was further purified by FPLC 
to remove any potential contaminants. The protein was then concentrated to  8-20 mg mL
-1
 
prior to crystallisation and hanging drop vapour diffusion experiments were set up 
aerobically as described for M. barkeri AhbA/B (Section 4.2.1.2). 
 
Initial hits were observed with conditions 7 [30% (w/v) PEG 4000, 0.2 M ammonium 
acetate, 0.1 M tri-sodium citrate, pH 5.6] and 43 [30% (w/v) PEG 4000, 0.2 M ammonium 
sulphate] from Structure Screen 1™. Custom follow-up screens led to the production of a 
cluster of thin crystals from a derivative of condition 7 and high quantities of tiny crystals 
from derivatives of condition 43. After further screening the high levels of nucleation 
observed in condition 43 derivatives could not be sufficiently reduced and crystal size could 
not be increased, therefore this condition was not investigated further. 
 
Using condition 7 as a starting point, a custom pH screen was performed in the pH range 5.0-
7.6. This resulted in the formation of thin plate like crystals at pH 5.0 and 5.2 (Fig. 4.3). 
High throughput screening was attempted using a Mosquito® Crystal liquid handling system 
(TTP Labtech; in collaboration with Prof. David Brown, University of Kent / Argenta) and 
100 nL: 100 nL drop ratios. However, the conditions did not respond well to drop size 
reduction and no crystals were observed. Therefore screening was continued using manual 
methods. 
 
In an attempt to increase crystal quality further screening was performed in the pH range 5.0-
5.4 with variables such as drop size, PEG mass, PEG concentration, dilution seeding 
(described in Section 2.4.18.2) and acid used for buffer pH adjustment (glacial acetic acid, 
HCl or citric acid). These screens resulted in individual crystals with sufficient size and 
thickness for diffraction experiments. The best conditions used were as follows: 10 mg mL
-1
 
protein, 26% (w/v) PEG 3350, 0.2 M ammonium acetate, 0.1 M tri-sodium citrate (glacial 
acetic acid), pH 5.2 using dilution seeding. To prepare the crystals for data collection they 
were picked and cryoprotected using well solution containing 10% glycerol before being 
flash frozen in liquid nitrogen. Unfortunately, the diffraction limit of the crystals produced 
was 3.6 Å and a high degree of anisotropy was observed. Further attempts to produce higher 
quality crystals using these conditions were unsuccessful. 
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Figure 4.3. Optimisation of D. desulfuricans AhbA/B crystallisation. From initial 
crystalline precipitant (left), to production of stacked plates (middle) and finally single 
diffraction quality crystals (right). Optimised condition (right): 26% (w/v) PEG 3350, 0.2 M 
ammonium acetate, 0.1 M tri-sodium citrate (glacial acetic acid), pH 5.2, protein purified in 
Tris-HCl, pH 8.0. 
  
4.2.1.3.2 Buffer optimisation using thermal shift assay 
Access to the equipment required for a thermal shift assay became available through 
collaboration with Prof. David Brown (University of Kent / Argenta). By assessing the 
melting temperature of the complex in a range of conditions, the stability of the D. 
desulfuricans AhbA/B complex could be determined, allowing the selection of the optimum 
purification buffer. 
 
The thermal shift assay was performed as outlined in Section 2.4.19. In brief, a range of 
buffers with differing pH (4.2-9.8) were used and the protein melting point was determined 
using the fluorescent dye Sypro® Orange to measure protein unfolding (Fig. 4.4). The 
optimum pH range was pH 7.2-8.0. Tris pH 7.2 provided the highest melting temperature; 
however, HEPES provided stability over a wider range of pH with the average melting 
temperature of 57 degrees as opposed to 55 for Tris buffers. Therefore HEPES pH 8.0 was 
selected as the optimum buffer. 
 
After finding the optimum buffer and pH a second screen was performed using differing salt 
conditions and additives including glycerol and reducing agents (data not shown). No further 
enhancement of stability was achieved using the additives, therefore a standard buffer of 20 
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mM HEPES, pH 8, 100 mM NaCl was used to purify all D. desulfuricans AhbA/B protein 
used for crystallography after this experiment. Buffers and additives used for the thermal 
shift assay can be found in the Appendix. 
                   
Figure 4.4. Melting curves of D. desulfuricans AhbA/B in a range of buffers with 
differing pH. Sodium citrate pH 4.6 (dark red), pH 5.0 (dark green) and pH 5.4 (gold). 
Sodium cacodylate pH 6.5 (blue). Tris pH 7.6 (black), pH 8.0 (red). HEPES pH 8.0 (purple). 
Glycine pH 9.4 (cyan). 
 
4.2.1.3.3 Crystallisation of D. desulfuricans AhbA/B in HEPES pH 8 
Rescreening of the D. desulfuricans AhbA/B complex was performed as described 
previously (Section 4.2.1.3.1) using protein purified in HEPES, pH 8 and Structure Screen 
1™ and Structure Screen 2™ (Molecular Dimensions Ltd.). A number of previously unseen 
hits were observed with condition 2 [30% (w/v) PEG 4000, 0.2 M ammounium acetate, 0.1 
M sodium acetate, pH 4.5], which produced needle like crystals, being the best. Again all 
conditions were optimised using a custom pH screen from 4.5-8.0, however only condition 2 
yielded adequate crystals. Further screening was performed including variation of drop size, 
PEG mass, PEG concentration, and dilution seeding leading to the optimum condition of 1 
µL : 1 µL drop, 26% (w/v) PEG 4000, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 
5. The Hampton Research Additive Screen was then employed resulting in a large wedge-
like crystal with the addition of 0.01 M barium chloride (Fig. 4.5).  The crystal was picked 
and cryoprotected using well solution containing 10% glycerol before being flash frozen in 
liquid nitrogen. A full data set was collected with a diffraction limit of 2.2 Å (see Section 
4.2.2). 




            
Figure 4.5. Optimisation of D. desulfuricans AhbA/B crystallisation using HEPES 
purified protein. Optimisation from initial needle crystals (left), to increased nucleation of 
crystals (middle) and finally diffraction quality crystals using additive screen (right). 
Optimised condition (right): 26% (w/v) PEG 4000, 0.2 M ammonium acetate, 0.1 M sodium 
acetate, pH 5, 0.01 M barium chloride, protein purified in HEPES, pH 8. 
 
4.2.1.4 Production of D. desulfuricans AhbA/B crystals for experimental phasing 
As there are no protein structures published with sufficient sequence homology for 
molecular replacement, experimental phasing data had to be collected. Two methods were 
employed in an attempt to obtain data for phasing, isomorphous replacement (using heavy 
atom protein derivatives) and multiple wavelength anomalous dispersion (MAD; using 
selenomethionine labelled protein).  
 
For isomorphous replacement native crystals were grown in 26% (w/v) PEG 4000, 0.2 M 
ammonium acetate, 0.1 M sodium acetate, pH 5, using 11 mg mL
-1
 protein and 1 µL : 1 µL 
drop size. Crystals were then soaked in the well solution containing a range of heavy metal 
solutions (see Appendix) for 10-120 min, before cryoprotecting with 10% (v/v) glycerol and 
flash freezing in liquid nitrogen. 
 
Selenomethionine labelled protein was produced using the method outlined in Section 2.2.8. 
After overproduction in E.coli KRX the protein was purified in an identical manner as 
described previously, with the purified protein buffer exchanged into in 20 mM HEPES, pH 
8, 100 mM NaCl. Again the protein was purified by FPLC and concentrated to 20 mg mL
-




.The protein was crystallised in 26% (w/v) PEG 4000, 0.2 M ammonium acetate, 0.1 M 
sodium acetate, pH 5, using 11 mg mL
-1
 protein, and the seeding technique described in 
Section 2.4.18.2. Crystals of selenomethionyl protein grew smaller than those of native 
protein. Crystals were again cryoprotected using 10% (v/v) glycerol before being flash 
frozen in liquid nitrogen. 
 
Selenium incorporation was confirmed by HPLC-MS analysis of the protein. An equivalent 
of 15 µg protein was injected on to a Jupiter® 5 µm C4 column (2 x 50 mm; Phenomenex 
Inc). The column was developed with a binary gradient at a flow rate of 0.2 mL min
-1
. 
Solvent A was 0.05% (v/v) TFA and solvent B was 0.045% (v/v) TFA and 80% (v/v) 
acetonitrile. The column was equilibrated with 5% solvent B prior to the protein injection of 
protein on the column. Proteins were eluted as a single peak. 
 
Data was processed using Compass™ Data Analysis (Bruker). As selenomethionine has an 
increased mass of 46.89 Da in comparison to methionine, incorporation can be determined 
by comparing the mass of native protein with that of selenomethionyl protein. 
Selenomethionine labelling efficiency was determined using the following equation: 
 
% labelling efficiency = 100 × (MWlabelled_experimental – MWunlabelled_experimental) 
                                                     (MWlabelled_theoretical – MWunlabelled_theoretical) 
 
The N-terminal methionines of the proteins were removed during the experiment (a common 
occurrence during protein MS). Therefore it was not possible to confirm whether the proteins 
were fully labelled. However, discounting the N-terminal methionines 100% labelling 
efficiency was achieved for both proteins. 
 
4.2.1.5 Production of tetrapyrrole soaked crystals 
All attempts to co-crystallise the AhbA/B complex with sirohaem were unsuccessful, 
therefore crystal soaking was performed. Crystals were produced as described in Section 
2.4.18.1. Identical reagents and volumes were used as above (Section 4.2.1.3.3); however, 
crystallisation was carried out in EasyXtal 15-well plates. All plates and reagents were taken 
into the glove box 24 hours prior to use. Reagents were left open in the glove box for 2-3 
hours, allowing oxygen to diffuse out of the solutions whilst minimising the amount of 
evaporation, as degassing all solutions was impractical. 
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Native crystals were grown in 26% (w/v) PEG 4000, 0.2 M ammonium acetate, 0.1 M 
sodium acetate, pH 5, using 11 mg mL
-1
 protein and the seeding technique as described in 
Section 2.4.18.2. After the crystals had formed they were soaked in well solution with an 
additional 10% (v/v) glycerol and a 10-fold excess of purified sirohaem. The crystals were 
left to soak for 24 hours before being directly flash frozen in liquid nitrogen. 
 
4.2.2 Crystallographic data collection and refinement 
All native and phasing data were collected at the Diamond Light Source (Oxfordshire, 
England; on beamlines IO4-1 and IO2, respectively) in collaboration with Prof. David 
Brown (University of Kent / Argenta). Native crystals diffracted to 2.2 Å and a full data set 
was collected. Heavy metal soaked crystals did not provide adequate diffraction for phasing 
data. However, data sets were collected using selenomethionyl crystals at three wavelengths 
to a resolution of 2.7-2.8 Å. These data allowed phasing using MAD data. Both native and 
selenomethionine crystals were found to belong to the space group P212121 and had a 
Matthews coefficient predicted to have 2 copies of the AhbA/B heterodimer in the 
asymmetric unit. Selenium substructure and initial chain tracing was determined with 
Autosolve (Solve/Resolve) software from the PHENIX package (Adams et al., 2010) using 
the MAD data. 
 
Initial models were rebuilt in Coot (Emsley et al., 2010) using maps and phases calculated 
by Solve/Resolve to a resolution of 2.8 Å and further validated using Buccaneer (Cowtan, 
2006). Initial model building and refinement used loose non-crystallographic symmetry 
(NCS) restraints, which were relaxed in final refinement. The native AhbA/B model was 
built using molecular replacement of the selenomethionine model using PhaserMR (McCoy 
et al., 2007) in the CCP4 suite (Winn et al., 2011), and refined using Refmac5 (Murshudov 
et al., 1997) and manual model rebuilding in Coot. Final refinement was performed using 
BUSTER (Global Phasing Ltd). AhbA/B was refined at 2.23 Å to a crystallographic R-factor 
of 19.8% (Rfree = 23.6%).  
 
Diffraction data from tetrapyrrole soaked crystals was collected in collaboration with Prof. 
Richard Pickersgill (Queen Mary University of London) at the European Synchrotron 
Radiation Facility (Grenoble, France; on beamline ID23-1). Substrate soaked crystals were 
refined using Refmac5 at a resolution of 1.97 Å to an R-factor of 20.4% (Rfree = 26.6%). 
Soaked crystals had an occupancy of ~60%. 
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All data collection and refinement statistics can be found in Table 4.1. Data were processed 
using XDS with a resolution cut-off at CC1/2 0.5. Native and selenomethionine data were 
processed using the xia2 pipeline. Coordinates and structure factor amplitudes have been 
deposited in the protein data bank with accession codes 4CZD (AhbA/B) and 4UN1 
(AhbA/B bound to didecarboxysirohaem). 
 
Data were validated using the wwPDB X-ray Validation Server as part of the Autodep 
deposition process. Ramachandran plots of the final structures can be seen in Figures 4.6 and 
4.7. For the native structure 96.8% (573/592) of all residues are in favoured regions with 3 
outliers, Gln64B, His70B and Ser121B. Residues 64 and 70 are in the disordered linking 
region of AhbB, while Ser121 is in a loop. For the tetrapyrrole bound structure 95.8% 
(567/592) of all residues are in favoured regions with 4 outliers, Lys162A, Lys65B, Trp68B 
and His70B. Again the residues of AhbB are located in the disordered loop region. Lys162A 
is at the C-terminal end of AhbA in a disordered loop region.  
  




Table 4.1. Summary of crystallographic data and refinement statistics. RMSD - root 































0.92 0.972997 0.97917 0.97935 0.97854 

















Multiplicity 5.0 (3.8) 5.3 (4.9) 12.7 (9.9) 12.8 (10.1) 13.0 (11.9) 
Mean 
(I)/sd(I) 























Rmerge 4.6 (69.3) 8.2 (80.4) 8.9 (70.7) 8.7 (69.6) 8.9 (66) 
Completeness 
(%) 




- 60 - - - 
Refinement 
Rfactor (%) 19.8 20.4 - - - 
Rfree (%) 23.6 26.6 - - - 
Bond length 
(Å; RMSD) 
0.0156 0.017 - - - 
Bond angles 
(°; RMSD) 
1.6 2.2 - - - 
No. residues 704 704 - - - 
No. waters 252 576 - - - 




Figure 4.6. Ramachandran plot of native AhbA/B (PDB 4CZD). 96.8% (573/592) of all 
residues are in favoured regions with outliers labelled on the plot. Plot generated using 
MolProbity (Lovell et al., 2003). 
 
 
Figure 4.7. Ramachandran plot of product-bound AhbA/B (PDB 4UN1). 95.8% 
(567/592) of all residues are in favoured regions with outliers labelled on the plot. Plot 
generated using MolProbity (Lovell et al., 2003). 
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4.2.3 The structure of the AhbA/B complex 
4.2.3.1 Overall structure of the AhbA/B complex 
The initial structure confirmed the formation of a heterodimer of AhbA and AhbB (Fig. 4.8) 
with two copies of the heterodimer in the asymmetric unit. The full sequence of AhbB was 
correctly traced in the structure except for the histidine tag, which was disordered. The 
majority of AhbA was also identified with only the first 20 and last 10 amino acids in 
disordered regions. The AhbA/B heterodimer is formed from two similar protein subunits 
that share a near identical fold (Fig. 4.9). Both proteins consist of an N-terminal and a C-
terminal domain joined by a linking region (Fig 4.8).  
 
 
             
Figure 4.8. The structure of the AhbA/B complex from D. desulfuricans. The complex is 
formed from AhbA (blue) and AhbB (yellow). 
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Figure 4.9.  Structures of the individual AhbA and AhbB subunits. The monomers of 
AhbA (left) and AhbB (right) are coloured by secondary structural elements (helices = red, 
sheets = blue) and labelled by secondary structure. The termini are indicated N and C. 
 
The N-terminal domain of the proteins contain 3 helices (α1–α3), two of which (α2 and α3) 
form a helix–turn–helix (HtH) motif. Helix α1 interacts with this motif via a hydrophobic 
core. The N-terminal domain then continues with a β-strand (β1) before the linking region 
joins the two domains. The AhbA linker contains a single turn helix (α4) that is not observed 
in AhbB. This AhbA α4-helix is stabilized by the N-terminal methionine of AhbB. The 
linker region of AhbB consists of a longer loop region the flexibility of which is inferred 
from the poorer electron density observed. 
 
The C-terminal domains of each protein are reminiscent of the previously described RAM 
(regulation of amino acid metabolism) domain and the closely related ‘ACT domain’ with a 
βαββαβ fold (Chipman & Shaanan, 2001, Ettema et al., 2002). However, as there is no 
evidence that AhbA/B is related to amino acid metabolism it will be subsequently referred to 
as a ‘RAM-like’ domain. A four stranded β sheet is formed from β2-5 with 2 helices packed 
against one face (AhbA α5 and α6, AhbB α4 and α5) stabilising the β-sheets through 
hydrophobic interactions. In AhbA α5 interacts with β3 and β4, and α6 with β2. Similarly, in 
AhbB α4 interacts with β3 and β4, and α5 interacts with β2 and β4. After a short loop, one 
final strand (β6) is formed at the C-terminal end of each monomer.  
 
The Ahb monomers form a closely associated complex (Fig.4.8). At the base of the N-
terminal domain, β1 from each protein forms an anti-parallel β-ribbon by direct hydrogen 
bonding at the start of the linking region. At the C-terminus the two RAM-like domains 
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dimerise via hydrophobic interactions at the base of each domain forming a sandwich of β-
sheets with a hydrophobic cleft. Finally, the C-terminal β-strand (β6) directly hydrogen 
bonds to β3 of the opposing monomer to form a tight interaction. The different linkers of 
each subunit allow one side of the dimer to adopt an open conformation allowing access to 
the central cavity formed between two RAM-like domains. This cavity forms the substrate-
binding domain (see Section 4.2.3 for substrate binding). 
 
4.2.3.2 Comparison of the AhbA/B complex to AsnC/Lrp proteins 
As mentioned previously, based on sequence similarity, the AhbA and AhbB proteins were 
both annotated as members of the Lrp/AsnC transcriptional regulator family, prior to the 
discovery that they were in fact involved in alternative haem synthesis. It is interesting to 
note that despite their catalytic role the AhbA and AhbB proteins have an identical 3D 
structural arrangement as members of the Lrp/AsnC family (Fig. 4.1 and 4.9).  
 
The Lrp/AsnC proteins contain an N-terminal HtH motif and a C-terminal RAM domain 
linked by a β-sheet. Lrp/AsnC proteins form homodimers which can then be assembled into 
multimeric complexes via associations at the RAM domain of the subunits. The associations 
formed between subunits of the dimers are identical to those observed in the AhbA/B 
complex with a beta sheet interaction at the start of the linker region, hydrophobic 
interactions at the base of each RAM domain and finally hydrogen bonding by β-strands to 
the opposing RAM domains. 
 
Structural similarity can be demonstrated by superimposing protein structures and measuring 
the root mean squared deviation (RMSD) of amino acid Cα atoms. Superimpositions were 
performed in CCP4 Molecular Graphics (McNicholas et al., 2011) using the secondary 
structure method (SSM). Using E. coli AsnC (PDB entry 2CG4) as a template gives RMSD 
values of 3.8 Å (for 123 Cα atoms) and 2.6 Å (for 138 Cα atoms) for AhbA and AhbB, 
respectively. These values indicate that AhbB has a much better secondary structure 
alignment with AsnC than AhbA, which is clearly visible in Figure 4.10. By splitting AhbA 
into domains and aligning them with AsnC it is evident that the poor alignment is due to the 
arrangement of the domains in the protein, not their secondary structure. The HtH domain 
(amino acids 24-79) has an RMSD of 1.3 Å, whereas the RAM-like domain (amino acids 87-
162) has an RMSD of 1.7 Å, showing that both domains share a high degree of structural 
similarity. The HtH domain of AhbA is angled towards the HtH domain of AhbB. This 
movement, combined with the flexible linker of AhbB, effectively opens up one side of the 
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dimer, allowing access to the cleft formed by the C-terminal domains. E. coli AsnC and 




Figure 4.10. Structural alignments of E. coli AsnC and D. desulfuricans AhbA and B 
proteins. E. coli AsnC (green; PDB 2CG4) aligned with A. AhbA (blue; RMSD 3.8 Å) and 
B. AhbB (yellow; RMSD 2.6 Å). Arrow indicates the movement of AhbA HtH domain 
between the two structures. 
 
The structural similarity of AhbA/B with E. coli AsnC suggests that they may still function 
as transcriptional regulators as well as enzymes. This hypothesis is strengthened by the fact 
NirL from H. fasciatum has been shown to bind DNA; specifically to the putative promoter 
of nirJ2, which encodes a protein homologous to AhbC and AhbD (Xiong et al., 2007). The 
structure of an Lrp homologue in complex with DNA (the feast/famine transcription factor 
FL11 from the hyperthermophilic archaeon Pyrococcus OT3; PDB 2E1C) was used to model 
the AhbA/B complex onto DNA (Fig. 4.11). AhbB appears to be in the correct position to 
bind DNA (Fig. 4.11B), whereas the angle of the HtH domain of AhbA results in a 
significant clash with the DNA (Fig. 4.11A). Therefore it is unlikely that the AhbA/B 
complex would bind DNA without major conformational change. Lrp homologues have been 
noted to bind a variety of amino acids which effect DNA affinity, DNA bending, and the 
alteration/stabilisation of  tertiary and quaternary protein structure (Brinkman et al., 2002, 
Calvo & Matthews, 1994, Chen et al., 2001, Madhusudhan et al., 1997, Ren et al., 2007, 
Thaw et al., 2006, Jeong et al., 2013). Therefore, it is possible that effector binding could 
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induce conformational changes to allow repositioning of the AhbA HtH domain, or induce 
multimerisation of AhbA/B complexes, which may represent a DNA binding state.  
 
 
Figure 4.11. DNA binding model of AhbA/B using transcription factor FL11 from 
Pyrococcus OT3 bound to DNA as a template (PDB 2E1C). Superimposed structures of 
transcription factor FL11 from Pyrococcus OT3 (pink) bound to DNA with A. AhbA (blue) 
and B. AhbB (yellow). Structures superimposed as a dimer but displayed separately for 
clarity. While AhbB is in the correct alignment for DNA binding AhbA has large clashes 
with the DNA molecule. 
 
4.2.4 The structure of the product bound AhbA/B complex 
Sequence alignments of AhbA and AhbB and their homologues show a conserved HXYXR 
motif (Fig. 4.12). These conserved residues face the central cavity supporting their 
involvement in substrate binding and catalysis. This provides a pseudo-symmetrical binding 
pocket with positively charged residues suitable for binding the negatively charged 
tetrapyrrole substrate. To investigate this idea attempts were made at producing crystals with 
bound substrate. Co-crystallisation attempts were unsuccessful; however native crystals 
soaked with sirohaem diffracted to 1.97 Å and contained additional density consistent with 
the presence of a tetrapyrrole. As with the apo-crystals, two AhbA/B dimers were present in 
the asymmetric unit, both containing the additional electron density. 
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Pa_NirD         ---------------------------------MDDLSRRLLARYQKGLPICAEPYRRMA 
Ps_NirD         -------------------------------MQIDTLSRRLIDRYQHGMPLCAEPYRAMA 
Mb_A            MIDIDNLKDQLKKEAADFSCDMDTNDREVPVIELDETDKKILNLIQQEVPLEVEPFAKLG 
Dv_A            -----MTEAHNACCHPSGTAAGHHGAGKASTDMMDAVDRRLLDIIQTGFPIEPRPYAVLG 
Li_Tr           ---------------------------------MDNIDKKLLDIIQTGFPIVPRPYAEIG 
Dd_A            -----------MTTQTSAATGSPTQQNNAALADMDSMDRQLLDIIQTGFPLSPRPYAELG 
Dm_Tr           ---------------------------------MDATDKRILDVIQTGFPIAPHPYAAIG 
Do_AsnC         -------------------------------MHLDDTDRAILNAVQSDFPLAPRPFSAIG 
Dv_B            ---------------------------MSRYDDFTEVERAILRIVQSNLPDSLTPYADIA 
Dd_B            -----------------------------MSHQFSPEEQAVLRIVQANLPDSLTPYADLA 
Mb_B            ---------------------------------MDKTDVKLLKLVQDGIPITHSPFKGFA 
 
 
Pa_NirD         ETLGCSEAEVLERLRRLEADGALSRVGPVLRHQRAG--ASTLAALAVPEERLQRVAERIS 
Ps_NirD         EELGCSEGEVLACLERLQAAGGLSRIGPVFEHSRAG--ASTLVALAVPEARLEHVAARIN 
Mb_A            EILGLSETEVIERLRELNRKGAVRRVGPVLSMRNMGG-VSTLVALKVPESRIEEVAIFIN 
Dv_A            ETLGITECEALARVRALRERKVIRRLGANFDSWKLGF-RSTLCAAKVPEDRIDAFVAEVN 
Li_Tr           EKLGITEAEALSRVRALKGKKIIRRLGANFQSSKLGF-RSTLCAAKVPDEKMELFTTEVN 
Dd_A            QRLGLDEQEVLDRVRGLKARKIIRRLGANFQSAKLGF-VSTLCAAKVPQDKMDAFVAEVN 
Dm_Tr           EQVGLTEAETLARVRALRASGIIRRIGANFQSAKIGF-KSTLCAASVPEDKFEAFTKAVN 
Do_AsnC         EQLGLDEDEVVRRMARLKREGIIRRIGGNFVPEKLGY-VSTLCAASVPEDRIETFALAVN 
Dv_B            REVGTDEETVLALLRSLKEEGPIRRFGASIKHQRAGWNHNAMVAWKVDPAIVEEAGTKAA 
Dd_B            EQAGMTEAQVLELLGRLKASGAIRRFGASIKHQKTGWTHNAMVAWKVTPDQVDDCGRKAA 
Mb_B            SELGISEQEVVDRLKNLQKAGKIRRFAASIGHRAIGITANAMCVWNVPDEQIETVGNIMA 
 
 
Pa_NirD         QYAEVNHNYQR-----EHRYNLWFVLTAGDRAQLDRVLAEIAADTGLQ-PLDLPMQEAYC 
Ps_NirD         AFPEVNHNYLR-----EHRYNLWFVLTGPDRAHIDRLLAEIEADTGLV-PLDLPMQQAFR 
Mb_A            EYPEVSHNYLRS----ASQYNLWFTLSAPNKNRLERILSEIREKTGCP-LLDLPTKHLFK 
Dv_A            RHVNVTHNYLR-----NHEYNIWFTCICPSWEQVCSLLDGITERTGIP-ILNLPATKLYK 
Li_Tr           KLPGVTHNYIR-----DHVYNVWFTLIGPSWEEVCSTLDGVTERTGIK-ILNLPATRMYK 
Dd_A            AKPGVTHNYLR-----EHDYNIWFTLISPSREETQAILDGITQATGVP-ILNLPATKLFK 
Dm_Tr           EHPGVTHNYLR-----AHGYNIWFTMIGPSREAIRQDLAAITEQTGVA-ILNLPADRLFK 
Do_AsnC         EYPGVTHNYIR-----DNTYNVWFTFIAPSRDAIEESLAEIAKKTGVTRIINLPATRVFK 
Dv_B            EHPHISHVYYRPSSAPDWPYELYTMIHGRHATAHMDVIEQLRRETPLEEFAVLESLRELK 
Dd_B            EHSHISHVYYRPSSAPDWPYEMYTMIHGRSEAECLGVVEDVKRTTSLKEHAILRSLKELK 
Mb_B            EFPEVTHCYERPR-YPDWPYNLFTMVHSYTPEDCEKVAVRISEATGIRDYTLFFSEREFK 
 
 
Pa_NirD         IDLAFPLEASR 
Ps_NirD         IDLGFPLGDIR 
Mb_A            IQVKFDIR--- 
Dv_A            IRVDFRMD--- 
Li_Tr           IRVDFRMDDE- 
Dd_A            IRVDFRMDNDS 
Dm_Tr           IRVDFAMSD-- 
Do_AsnC         IRAAFNL---- 
Dv_B            KTSMTYF---- 
Dd_B            KTSMTYFT--- 
Mb_B            KTGVRL----- 
                            
Figure 4.12. Sequence alignment of known and predicted AhbA and AhbB proteins and 
the haem d1 biosynthesis protein NirD. Alignments were produced using clustalW. 
Identical residues are highlighted in green, with residues with similar properties highlighted 
in grey. The HXYXR motif is highlighted using a red box. Pa = Pseudomonas aeruginosa, 
Ps = Pseudomonas stutzeri, Mb = M. barkeri, Dv = D. vulgaris, Li = Lawsonia 
intracellularis, Dd = D. desulfuricans, Dm = Desulfovibrio magneticus, Do = Desulfococcus 
oleovorans. Annotations A= AhbA, B = AhbB, Tr = transcriptional regulator. 
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The electron density of the bound tetrapyrrole suggests the decarboxylations at carbons C12 
and C18 have occurred and the bound molecule is actually the product didecarboxysirohaem. 
The observation also indicates that the crystals are functional as a decarboxylase. Overall, 
little movement is observed upon substrate/product binding as there is only a RMSD of 0.3 
Å between native and product bound complexes. Generally large conformational changes 
during catalysis would result in cracking of crystals. Therefore, it is likely that the protein 
undergoes little or no conformational change during catalysis. As predicted the tetrapyrrole 
is located in the C-terminal beta sheet domain of AhbA/B in the cleft formed between the 
two protein subunits (Fig. 4.13). This is consistent with the results from the kinetics data 
(Section 3.2.6), which suggest a single active site mechanism.  
 
 
Figure 4.13. Crystal structure of didecarboxysirohaem bound to the AhbA/B complex. 
Didecarboxysirohaem (atom coloured) binds AhbA (blue) and AhbB (yellow) in the cleft 
between the two RAM-like domains. Electron density of the tetrapyrrole is displayed as a 
dark grey mesh, with protein surface rendered in light grey. 
 
The structure shows that His115A coordinates the iron in the macrocycle (2.8 Å) and 
Arg119A is positioned such that it interacts with the propionate group from ring D of 
sirohaem (2.8 Å; Fig. 4.14). Lys152B appears to interact with the acetate group from ring A, 
although the electron density for this side-chain is poor suggesting it is in disordered state in 
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this product complex. These side-chains help to position didecarboxysirohaem with the 
methyl group of ring C (at carbon C12) within range of Arg102B. 
 
 
Figure 4.14. Close-up of the active site of AhbA/B and amino acid interactions with 
didecarboxysirohaem. A. Close up view of the active site formed by AhbA (blue) and 
AhbB (yellow) with protein rendered in space fill and cartoon with conserved HXYXR 
residues and Lys152B as sticks. B. Conserved HXYXR residues and Lys152 with 
interactions shown as dashed lines. Residues and carbons 12 and 18 are labelled. 
 
Due to its positioning it is believed that Arg102B is a catalytic residue responsible for 
initiating the decarboxylation of the acetate side chain at carbon C12. Given that both 
decarboxylations have occurred in the crystal structure it is likely that this represents the 
positioning of the tetrapyrrole required for the second decarboxylation event to occur. 
Therefore the proposed mechanism for decarboxylation of sirohaem is based on acetate side-
chain at C18 being decarboxylated first although this is yet to be experimentally proven.  
 
For the initial decarboxylation at C18 the substrate will need to bind in a position such that 
the tetrapyrrole is flipped over by 180 degrees about the C5-C15 axis to bring C18 into a 
similar position to that currently occupied by C12. Rearrangement of the double bonds must 
occur to allow electrons to run to the pyrrole nitrogen which may be facilitated by Tyr100B 
or His98B. His98B is mobile in the structure, as judged from its poorly defined electron 
density compared with the adjacent residues, and is in a position where it can act as an 
acid/base. The role of His98B could be the initial protonation of C19 and later its 
deprotonation. Arg102B could then stabilise carboxylic acid of the acetic acid on C18, 
allowing decarboxylation to occur whilst providing a proton for the developing methyl group 
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(Fig. 4.15). Alternatively, Tyr100B could act as the acid, protonating the side-chain to give 
the C18 methyl group. After the initial decarboxylation at C18 the substrate ring will need to 
unbind and rebind flipped over to the position to that is observed in Figure 4.14 before the 
reaction is repeated for the decarboxylation at C12.  
 
An alternative to tetrapyrrole flipping mechanism is one where sirohaem binds to the second 
pseudo-symmetrical active site where Arg119A, Tyr117A and His115A may perform 
equivalent roles to Arg102B, Tyr100B and His98B. After the decarboxylation of C18 the 
monodecarboxylated intermediate could then migrate ∼4 Å to the position observed in 
Figure 4.14 where the second decarboxylation occurs as described above. Due to the size of 
the active site cleft and positioning of the HXYXR residues, use of the two active sites 
would be mutually exclusive. Therefore the migration mechanism would appear to follow a 
single active site mechanism when studied kinetically. 
 
 
Figure 4.15. A proposed reaction mechanism for sirohaem decarboxylase AhbA/B. This 
mechanism is based on the flipping model. 
 
From this structure it is unclear where the haem molecule would bind in the complexes from 
M. barkeri and D. vulgaris. As mentioned previously the proteins are active with the haem 
bound and given the size of the binding cleft it cannot be located in the active site with the 
substrate/product. Therefore further work must be undertaken to locate the haem binding site 
of these proteins. 
 




Crystallisation of the AhbA/B complexes from D. vulgaris, M. barkeri and D. desulfuricans 
was attempted, with only D. desulfuricans yielding diffraction quality crystals. Native 
crystals diffracted to 2.2 Å and the structure was solved using three wavelength 
selenomethionine MAD data. The structure of the product bound complex was also solved 
using native crystals soaked with sirohaem to a resolution of 1.97 Å. These represent the first 
crystal structures of members of the alternative haem biosynthesis pathway, as well as the 
first structure of a sirohaem decarboxylase. 
 
The crystal structure of the AhbA/B complex confirms the presence of a heterodimeric 
protein, with the individual subunits having a nearly identical sub-structure. Both monomers 
contain a HtH domain and a RAM-like domain joined by a linker region. The arrangement of 
the two monomers forms a cleft in between the two RAM-like domains. The different 
alignment of AhbA and the flexible linker of AhbB open up the side of the protein complex 
allowing access to this active site. 
 
The AhbA and AhbB proteins display a striking structural similarity to members of the 
Lrp/AsnC family of transcriptional regulators which are similarly formed of an HtH and 
RAM domain joined by a linking region. AhbB has a higher degree of structural similarity to 
E. coli AsnC than AhbA as the HtH domain of AhbA is in a different orientation. It is yet to 
be demonstrated if the AhbA/B proteins are able to bind DNA; however, it appears likely 
that a significant conformational change of the HtH domain of AhbA must occur for the 
correct positioning of the two HtH domains. The movement of the HtH domain of AhbA 
may restrict access to the active site, thereby reducing activity when in the DNA binding 
conformation. 
 
The product bound structure revealed that didecarboxysirohaem interacts with several amino 
acids that are found in a conserved HXYXR motif in AhbA and AhbB proteins. Other 
members of this conserved motif appear to be within range of one of the sites of 
decarboxylation, further suggesting their involvement in facilitating the binding and catalysis 
of the reaction. A reaction mechanism has been proposed with Arg102B having a key role in 
facilitating the decarboxylation of the acetic acid side chains. The role of this arginine is 
similar to that of Arg37 in human uroporphyrinogen decarboxylase (HemE), an enzyme that 
performs analogous decarboxylation reactions on uro’gen III. It is interesting to note that 
despite the similar reactions these two proteins have drastically different three dimensional 
structures. Further work must be performed to ascertain the role of the conserved amino 
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acids in binding and catalysis. The structure also reveals no obvious region that may be 
involved in haem binding demonstrated by homologues of these proteins.  
 
The solution of the crystal structure of AhbA/B raises many questions about the evolution 
and functionality of these enzymes, especially in relation to the similarities with DNA 
binding proteins. For instance, if the AhbA/B complex does not bind DNA, what significant 
evolutionary pressures could cause the repurposing of a transcriptional regulator to give 
catalytic function? Alternatively, if the AhbA/B complex does bind DNA, how is this 
regulated in order to maintain haem synthesis in these organisms and what genes do they 
regulate? Many of the organisms containing the alternative haem biosynthesis pathway also 
require sirohydrochlorin for synthesis of cobalamin and coenzyme F430 and sirohaem as a 
cofactor for sulphite and nitrite reductases. Were the AhbA/B complex to regulate the 
transcription of genes related to the latter half of the pathway (i.e. ahbC and ahbD) it would 
represent a very efficient method for controlling the use of sirohaem within the organism. 
 
It should be noted that during the course of this work the structure of another sirohaem 
decarboxylase, NirDL from Hydrogenobacter thermophilus, was published in apo-form and 
with a substrate analog bound (Haufschildt et al., 2014). As mentioned previously, NirDL is 
the product of a gene fusion of nirD and nirL, which, along with nirG and nirH, are required 
for the decarboxylation of sirohaem during the synthesis of haem d1 [Fig. 3.1 (Bali et al., 
2014)]. However, H. thermophilus does not contain nirG and nirH and therefore NirDL is 
responsible for complete decarboxylation of sirohaem to didecarboxysirohaem in this 
organism. The crystal structure of NirDL displays a high degree of similarity to that of 
AhbA/B with an identical domain layout, however, the RAM-like domain equivalent to 
AhbB is contains a shorter β-sheet region and has a slightly different orientation to that of 
AhbB. The tetrapyrrole bound structure of NirDL shows an alternate binding site to that of 
AhbA/B. In the NirDL structure the tetrapyrrole is located at the top of the RAM domain just 
above the cleft, unlike the deeper positioning of didecarboxysirohaem in the AhbA/B 
complex. The tetrapyrrole is coordinated by His261, which is the equivalent residue to His98 
from AhbB. As with AhbA/B, NirDL contains two HXYXR motifs and His261 belongs to 
the second of the two. The altered binding position may be caused by the difference in the 
orientation of the RAM-like domain which elevates the position of His261 (NirDL) in 
comparison to His98 (AhbB). Alternatively, location may be due to the fact the tetrapyrrole 
is an inactive substrate analog which may have one of two effects: the analogue may bind in 
a different region to the true substrate, or this structure may represent the initial binding site 
of the substrate which may be different to that of the product if NirDL uses a migration 
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One of the difficulties in analysing tetrapyrrole biosynthesis pathways is that many of the 
compounds and their intermediates are unstable in laboratory conditions due to temperature, 
light and oxygen sensitivity. Therefore attempts to overproduce or isolate intermediates 
using recombinant systems are often unsuccessful. Host organisms have developed various 
means to overcome these issues, one of which is direct metabolite channelling between 
enzymes. Direct metabolite channelling refers to the release of an enzyme product when the 
subsequent enzyme of the pathway is in close proximity (Miles et al., 1999). Not only does 
this protect the product from oxidation and degradation but it also prevents exposure to other 
enzymes in the pathway which may cause out of order modifications leading to dead end 
products. Protection of these compounds is essential as they represent a huge energetic 
investment by the cell. It has recently been demonstrated that some enzymes from the 
aerobic cobalamin biosynthesis pathway tightly bind their products, providing a systematic 
approach for the stabilisation and isolation of pathway intermediates (Deery et al., 2012). 
Given the oxygen-sensitive nature of sirohaem and didecarboxysirohaem, it was investigated 
whether the AhbA/B enzymes are also able to bind their products tightly.  
 
Following on from the trapping experiments, site directed mutagenesis was employed to 
analyse the effect of conserved residues on product binding as well as enzyme activity. The 
sequence alignments (Fig. 4.12) combined with the crystal structure of D. desulfuricans 
AhbA/B (Chapter 4) allowed the informed selection of potentially important amino acids, 
especially those found in a conserved HXYXR motif. In the product bound structure 
His115A clearly coordinates the iron in the macrocycle (Fig. 4.14). Arg102B is positioned 
such that it would be in range of the acetate leaving group at carbon C12 prior to 
decarboxylation, and therefore has been proposed to be the catalytic residue for this reaction. 
Given the pseudo-symmetry of the active site, His98B and Arg119A may perform similar 
roles as His115A and Arg102B if the migration reaction mechanism is correct. Alternatively 
Arg119A may be involved in substrate binding as observed in the enzyme/product structure. 
His98B, Tyr100B and Tyr117A may be involved in the initiation of catalysis by facilitating 
double bond rearrangement. Site directed mutagenesis was used to examine the roles of these 
conserved residues and their effect on activity and product binding using AhbA/B from D. 
desulfuricans. Arg73A, Arg74A, Arg55B and Arg56B were also selected as they are highly 
conserved residues and are in proximity to the top of the active site cleft in the β-strand 
dimerisation region. Finally, His63B and His118B were selected as they are also conserved 
in AhbB proteins.  
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One of the striking things about the sirohaem decarboxylases studied in Chapter 3 was the 
variation in properties between species. The variety was especially surprising given the high 
degree of sequence identity for both proteins between the three organisms (summarised in 
Table 5.1). This led to the question of whether combinations of AhbA and AhbB proteins 
from different organisms can be used to make novel active chimeric complexes, and 
subsequently, whether properties such as haem binding or tetramerisation are conferred by a 
single subunit. 
 
Table 5.1. Sequence identity of AhbA and AhbB proteins from different sources. 
Sequences were analysed using LALIGN (ExPASy). 




D. desulfuricans D. vulgaris 72 67 
D. vulgaris M. barkeri 41 37 
D. desulfuricans M. barkeri 40 35 
 
The results described in this chapter aim to further elucidate the properties of the AhbA/B 
proteins. Enzyme trapping experiments were carried out with AhbA/B complexes from all 
three species to determine if they tightly bind their products. Site directed mutagenesis was 
used to assess the roles of conserved amino acids in D. desulfuricans AhbA and AhbB 
proteins with regard to product binding and catalysis. Finally, constructs were made allowing 
for the overproduction of AhbA and AhbB proteins from two different organisms in a single 
system and resultant chimeric complexes were biochemically characterised. 
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5.2.1 An enzyme-trap approach for isolation of didecarboxysirohaem 
In order to determine whether the AhbA/B complexes tightly bind their product cysG, which 
encodes the sirohaem synthase from E. coli (Warren et al., 1990), was included in all of the 
constructs containing ahbA/B (Table 2.2). Although the expression strain already contains 
cysG, the gene was included in the construct to prevent sirohaem production becoming a 
limiting factor within the cell. All necessary constructs were made using the Link and Lock 
technique with only AhbB containing a His6-tag. E. coli BL21 (DE3) were transformed with 
the appropriate plasmid (pDP019, pDP032 and pDP038; Table 2.2) and cultures were grown 
in 2YT media at 28 ºC for 24 hours with constant shaking at ~160 rpm. All trapping strain 
cultures were supplemented with 20 mg L
-1
 ALA 6 hours prior to harvest in an attempt to 
increase the production of sirohaem within the cells.  
 
To prevent degradation/oxidation of tetrapyrroles all protein purifications were performed 
anaerobically (<2 ppm O2). The AhbA/B complexes were purified using nickel affinity 
chromatography and the pull-down technique as previously described (Section 3.2.3). The 
purified AhbA/B complexes were analysed by UV-visible spectroscopy. However, in order 
to confirm which compound was bound to the complex the tetrapyrrole had to be removed 
from the protein and analysed using HPLC-MS. A number of methods were used to extract 
the tetrapyrroles from the proteins. In general protein was removed by acidification with 
equal volumes of 0.1% (v/v) TFA and purification on a TELOS C18 column, eluting in 
100% acetonitrile. Extraction with 1% (w/v) TCA allowed removal of the protein for UV-
visible analysis; however, this caused degradation of the tetrapyrrole over time and these 
samples were not suitable for analysis by HPLC-MS.  
 
After production in a trapping strain the M. barkeri AhbA/B complex purified with a red 
colouration as observed previously (Fig. 3.5C). UV-visible and HPLC analysis revealed a 
signal for haem (data not shown) demonstrating that this complex does not bind any 
substrate or product.  
 
When overproduced in the trapping strain D. desulfuricans AhbA/B complex copurified with 
a purple colour, consistent with the binding of a substrate or product (Fig. 5.1A). The protein 
bound UV-visible spectrum showed quenching of the tetrapyrrole signal with broad peaks at 
350 nm, 384 nm and 565 nm. After extraction using 1% (w/v) TCA a UV-visible trace 
characteristic of sirohaem was observed with a large Soret at 384 nm and small α/β bands at 
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~527 nm and ~583 nm (Figure 5.1). HPLC-MS analysis confirmed the presence of 
didecarboxysirohaem, as well as a smaller quantity of both sirohaem (~17%) and 
monodecarboxysirohaem (~3%; Fig. 5.2). 
 
The D. vulgaris complex also copurified with a colour after production in the trapping strain. 
The protein complex was a much darker brown colour (Fig. 5.1B) in comparison to the 
protein produced previously (Fig. 3.5B). The difference in colour is likely due to the 
combination of bound haem and product. As with the complex from D. desulfuricans, the D. 
vulgaris complex displayed a quenched UV-visible spectrum with peaks at 384 nm and 565 
nm. It is unknown why the peak at 350 nm was absent in this complex and what the cause of 
this peak was in the D. desulfuricans complex. After release of the tetrapyrrole from the 
protein using 1% (w/v) TCA, a UV-visible spectrum was observed identical to that of the 
product released from the D. desulfuricans complex (Fig. 5.1). HPLC-MS of the released 
product revealed the majority of the bound tetrapyrrole was didecarboxysirohaem, although 
a small amount of monodecarboxysirohaem (~10%) was also detected (Fig. 5.2).  
 
Figure 5.1. UV-visible spectra of D. desulfuricans and D. vulgaris AhbA/B complexes 
from trapping strains. Didecarboxysirohaem absorbance is quenched when bound to the 
protein (solid) but a characteristic profile is observed upon release using 1% (w/v) TCA 
(dashed).  D. desulfuricans AhbA/B = red, D. vulgaris AhbA/B = blue. Inset: 
didecarboxysirohaem bound to D. desulfuricans AhbA/B (A.), and D. vulgaris AhbA/B. 
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Figure 5.2. HPLC-MS analysis of tetrapyrroles extracted from D. desulfuricans and D. 
vulgaris AhbA/B trapping strains. Extracted ion chromatogram traces for masses 
equivalent to sirohaem (SH), monodecarboxysirohaem (MDSH) and didecarboxysirohaem 
(DDSH), for samples extracted from D. desulfuricans AhbA/B (A.) and D. vulgaris AhbA/B 
(B.). 
 
5.2.2 Site directed mutagenesis of D. desulfuricans AhbA/B 
Site directed mutagenesis was performed by Dr. Susanne Schroeder (University of Kent) as 





 using the mutagenic primers listed 
in Table 2.3. Mutations were confirmed by sequencing prior to formation of pET3a-ahbA/B 
and pET3a-ahbA/B-cysG constructs using the Link and Lock technique. Constructs were 
produced with a single mutation in either AhbA or AhbB; however a construct was made 
with a single mutation in both proteins (Arg119A/Arg102B). 
 
For all activity assays proteins were purified aerobically in Tris-HCl, pH 8 containing 100 
mM NaCl using the pull-down method (Section 3.2.3). Elution fractions containing most 
protein were transferred into the glovebox before buffer exchange into anaerobic Tris buffer. 
Activity assays were performed with a 10-fold excess of sirohaem that was incubated at 37 
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ºC for 10 minutes prior to the assay. Reactions were carried out for 10 minutes and overnight 
at 37 ºC, and stopped with a 1:1 ratio of acetonitrile. Insoluble protein was removed from the 
sample by centrifugation before analysis by HPLC-MS. Normalisation of data was 
performed as in Section 3.2.6, with the sum of all peaks representing the total concentration 
of tetrapyrrole in the system and conversion of each peak into a percentage. A summary of 
activity data can be found in Table 5.2. 
 
Table 5.2. Activity and binding capabilities of D. desulfuricans AhbA and AhbB 
mutants. Activities given are overall percentage of monodecarboxysirohaem (MDSH) and 
didecarboxysirohaem (DDSH) after overnight incubations with 10-fold sirohaem. The 
trapping ratios were excluded for Arg119A and Arg56B due to low concentration. Arg102B 
and Arg119A/Arg102B were excluded due to haem binding. Wild type D. desulfuricans 
AhbA/B has been included for comparison. 
 
Protein Site of mutation Activity (%) Trapping strain 
A280:A395 x100 MDSH DDSH 
AhbA Arg73 15 23 5 
AhbA Arg74 15 31 4 
AhbA His115 1 0 3 
AhbA Tyr117 22 1 5 
AhbA Arg119 2 0 - 
AhbB Arg55 12 43 3 
AhbB Arg56 10 15 - 
AhbB His63 17 83 6 
AhbB His98 3 0 5 
AhbB Tyr100 21 42 12 
AhbB Arg102 11 0 - 
AhbB His118 39 39 5 
AhbA/B Arg119/Arg102 2 0 - 
Wild type 
AB 
- 0 96 20 
  
 
After overnight incubation mutations Arg73A and Arg74A displayed 23% and 31% 
conversion to didecarboxysirohaem, respectively, showing that they formed an active 
complex. Mutations to the conserved HXYXR motif in the active site of AhbA (His115A, 
Tyr117A and Arg119A) displayed virtually no turnover (Tyr117A ~1%) to 
didecarboxysirohaem. The Tyr117A mutant still retained the ability to perform a single 
decarboxylation with 22% monodecarboxysirohaem being present after overnight 
incubation. His115A and Arg119A showed minimal conversion of sirohaem to 
monodecarboxysirohaem (1% and 2%, respectively). 
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Homologous mutations in the β1 region of AhbB (Arg55B and Arg56B), retained activity, 
although with reduced turnover (43% and 15% conversion to didecarboxysirohaem, 
respectively). As with AhbA, mutations of His98B and Arg102B from the HXYXR resulted 
in the inhibition of didecarboxysirohaem formation. His98B displayed a small degree of 
monodecarboxysirohaem production, while Arg102B produced a higher quantity (11%). 
Unlike Tyr117A, mutation of Tyr100B did not prevent the production of 
didecarboxysirohaem with 42% conversion after overnight incubation. His63B and His118B 
also resulted in an active decarboxylase capable of both decarboxylation reacions. 
Surprisingly, the His63B mutant complex exhibited a unique property. After 10 minutes the 
His63B mutant had converted 90% of the sirohaem to monodecarboxysirohaem. Overnight 
incubation resulted in majority conversion to didecarboxysirohaem. The double arginine 
mutant, Arg119A/Arg102B, was also inactive with only 2% monodecarboxysirohaem being 
produced overnight. 
 
All mutant complexes for enzyme trapping experiments were grown as described previously 
using culture volumes of 500 mL or 1 litre (Section 5.2.1). The majority of the mutant 
proteins purified with coloured compounds, with only Arg119A appearing colourless. The 
lack of colour was likely due to extremely low protein concentration. The low protein 
concentration is believed to be caused by an experimental error during purification as this 
protein complex was overproduced previously for activity assays without issue. Due to time 
constraints repetition of the growth and purification could not be performed. 
 
A range of colours was observed for all of the mutant complexes other than Arg119A (Fig. 
5.3), with the majority being purple or blue in colour. Arg102B purified with a light brown 
colour and the double mutant Arg119A/Arg102B purified with a deep red, reminiscent of M. 
barkeri AhbA/B.  
 
 
Figure 5.3. Purified mutant D. desulfuricans AhbA/B complexes from trapping strains. 
Mutations labelled with mutated amino acid, residue number and protein subunit (i.e. AhbA 
or AhbB). Arg119A was excluded due to low protein concentration. 
 
Chapter 5 - Further characterisation of sirohaem decarboxylases: 
enzyme trapping,mutagenesis and novel chimeric proteins 
125 
 
UV-visible analysis revealed the majority of proteins had a Soret peak at 385-395 nm. Many 
of the mutants displayed more prominent Soret peaks in comparison to those observed for 
wild type D. desulfuricans AhbA/B, with some of these peaks slightly shifted in comparison 
(Fig. 5.4). The ratio of A280 to A395 provided an estimation of the trapping ability of the 
protein complex. The redox state of the metal in tetrapyrroles frequently affects their 
absorbance characteristics. This may explain the slight variations in colours and spectra 
observed for the mutant proteins. Similarly, the A280 to A395 can only be used as a guideline 
as redox state may affect these values. Unfortunately, the concentrations of the Arg119A and 
Arg56B protein complexes were too low to accurately determine an A395. Tyr100B appears 
to retain the greatest quantity of tetrapyrrole with over half that observed for wild type 
AhbA/B. The majority of the mutants appear to have reduced binding capabilities with 15-
25% binding in comparison to wild type. Interestingly the UV-visible spectra of Arg102B 
and the double mutant Arg119A/Arg102B revealed the presence of a haem-like molecule, 
rather than sirohaem (Fig. 5.5). Arg102B has a Soret band at 412 nm and a broad region 
between 525 nm and 620 nm where α/β peaks are not clearly defined. The 
Arg119A/Arg102B double mutant has a much more distinct Soret peak at 424 nm and 
clearly defined α/β peaks at 526 nm and 558 nm. The haem spectrum for the double mutant 
is closer to that of the haem-loaded D. vulgaris AhbA/B complex (peaks: 423nm, 527 nm 
and 555 nm) than the single mutant which is possibly due to the oxidation state of the haem. 
Unfortunately, due to technical problems and time constraints HPLC-MS analysis of the 
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Figure 5.4. UV-visible spectra of mutant D. desulfuricans AhbA/B complexes trapping 
sirohaem derivatives. Arg73A (orange), Arg74A (pink), His115A (grey), Tyr117A (red), 
Arg55B (black, solid), Arg56B (black, dashed), His63B (yellow), His98B (blue), Tyr100B 
(green) and His118B (purple). Arg119A was excluded due to low protein concentration. 
                   
Figure 5.5. UV-visible spectra of mutant AhbA/B D. desulfuricans complexes trapping 
haem. Mutant AhbA/B complexes that trap haem-like compounds: Arg102B (green) and 
Arg119A/Arg102B (red).  
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5.2.3 Formation of novel chimeric AhbA/B complexes 
There is a high degree of identity between AhbAs and AhbBs from different species (Table 
5.1). Therefore, the possibility of chimeric complex formation was investigated. Looking at 
the protein sequences there were no obvious regions that related to properties such as 
tetramerisation of the D. vulgaris proteins or haem binding of the D. vulgaris and M. barkeri 
complexes. The use of chimeric complexes aimed see if these properties could be attributed 
to a single subunit and if activity could be maintained using an AhbA and an AhbB from 
different organisms. Constructs were made with pairs of ahbA and ahbB genes from different 
organisms using the Link and Lock technique (Table 2.2). In every case the ahbB gene was 
fused to a N-terminal His6-tag. The proteins were overproduced in BL21 (DE3) as described 
previously (Section 2.2.7) and purified using the pull-down technique via nickel affinity 
chromatography using Tris-HCl, pH 8 containing 100 mM NaCl. 
 
D. vulgaris AhbA and D. desulfuricans AhbB could be copurified as a complex and 
exhibited a similar light brown colouration to the native D. vulgaris AhbA/B complex (Figs. 
5.6 and 3.5). The UV-visible spectrum revealed a haem-like signal with a Soret peak at 423 
nm and small α/β bands at 521 nm and 552 nm, respectively (Fig. 5.6). The UV-spectrum is 
again reminiscent of the native D. vulgaris AhbA/B complex with a slight shift in the α/β 
bands (D. vulgaris peaks: 423nm, 527 nm and 555 nm; Fig. 3.7). Gel filtration analysis of 
the D. vulgaris/D. desulfuricans AhbA/B complex revealed the presence of both dimeric and 
tetrameric complexes with peaks at 41 kDa and 97 kDa (Fig. 5.7). Full activity was observed 
during in vitro assays using the D. vulgaris/D. desulfuricans AhbA/B complex incubated 
with sirohaem overnight at 37 ºC (Fig. 5.8). 
 
D. desulfuricans AhbA was also found to copurify with D. vulgaris AhbB. Intriguingly, the 
D. desulfuricans/D. vulgaris AhbA/B complex complex was colourless (Fig. 5.6). 
Furthermore, gel filtration analysis demonstrated that the D. desulfuricans/D. vulgaris 
AhbA/B complex only exists as a dimer with an estimated mass of 41 kDa (Fig. 5.7). As 
with the other Desulfovibrio chimera, the D. desulfuricans/D. vulgaris AhbA/B complex was 
active in vitro when incubated with sirohaem overnight at 37 ºC (Fig. 5.8). Combinations of 
Desulfovibrio and M. barkeri proteins did not produce soluble complexes despite 35-40% 
identity in the sequences. 
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Figure 5.6. UV-visible spectra of the purified chimeric AhbA/B complexes. D. 
vulgaris/D .desulfuricans (dashed) and D. desulfuricans/D. vulgaris AhbA/B chimeras 
reduced using excess sodium dithionite. Inset: pictures of purified protein solutions of D. 
vulgaris/D .desulfuricans (A.) and D. desulfuricans/D. vulgaris (B.) AhbA/B chimeras. 
                 
Figure 5.7. Gel filtration UV trace, recorded at a wavelength of 280 nm, of purified 
chimeric AhbA/B complexes. D. desulfuricans AhbA with D. vulgaris AhbB (solid) 
appears as a single heterodimeric species whereas D. vulgaris AhbA with D. desulfuricans 
AhbB (dashed) is present as both a dimer and tetramer. 
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Figure 5.8. HPLC traces, recorded at a wavelength of 380 nm, of sirohaem incubated 
with purified AhbA/B chimeric complexes. A. D. vulgaris AhbA with D. desulfuricans 
AhbB, B. D.desulfuricans AhbA and D. vulgaris AhbB. Arrows indicate peaks for sirohaem 
(SH; ~16 min), monodecarboxysirohaem (MDSH; ~19 min) and didecarboxysirohaem 
(DDSH; ~24 min). 
 
5.3 Discussion  
The work presented in this chapter has furthered the understanding of the AhbA/B 
complexes from D. desulfuricans, D. vulgaris and M. barkeri, through enzyme trapping and 
site-directed mutagenesis experiments as well as production of novel chimeric AhbA/B 
complexes. 
 
The AhbA/B complexes from D. desulfuricans and D. vulgaris copurify with 
didecarboxysirohaem when overproduced with excess CysG. Product binding by the 
AhbA/B complexes from Desulfovibrio species may be related to the need to protect the 
unstable product from the intracellular environment, especially as sulphate reducers are 
known to grow in oxygen exposed environments (Risatti et al., 1994). Didecarboxysirohaem 
may be handed on to the next enzyme in the pathway, AhbC, by substrate channelling to 
prevent substrate oxidation/degradation. It was shown that, unlike the sulphate reducers, the 
AhbA/B complex from M. barkeri does not bind its product. The lack of product binding in 
M. bakeri could be because this organisms thrives in more anaerobic conditions (Thauer, 
1998), and the cellular environment  is suitable for didecarboxysirohaem to be in solution 
without risk of oxidation or degradation. 
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Site directed mutagenesis has been performed on the AhbA/B enzymes from D. 
desulfuricans. Mutations of the arginines in the dimerisation region (73A, 74A, 55B and 
56B) caused reduced activity. However, they do not appear essential and this reduction is 
likely due to a general perturbation of the system. Similarly, His63B and His118B displayed 
reduction in activity, most likely for the same reasons. Interestingly, His63B caused a build-
up of monodecarboxysirohaem after 10 minutes, indicating a reduction in the rate of the 
second decarboxylation reaction. His63B is located in the disordered loop region at the top 
of the active site cleft and is too far away from the sites of decarboxylation (carbons C12 and 
C18) to be catalytic. Therefore His63B may be involved in facilitating the migration, 
flipping or positioning of the tetrapyrrole between decarboxylation reactions. The removal of 
this residue may therefore reduce the efficiency of this step causing a significantly reduced 
rate of reaction for the second decarboxylation. 
 
Mutations of residues in the HXYXR motif in AhbA (His115A, Tyr117A and Arg119A) 
prevented the production of didecarboxysirohaem. His115A and Arg119A produced minimal 
monodecarboxysirohaem (1-2%) after an overnight incubation suggesting they were 
incapable of performing both reactions. His115A and Arg119A may be involved in both 
decarboxylations; alternatively they may catalyse the initial decarboxylation which may then 
prevent the second decarboxylation from occurring. It is currently unknown if there is a 
specific order of decarboxylation. The initial decarboxylation may be required to allow the 
tetrapyrrole to flip/migrate into the position for the second decarboxylation. If the first 
decarboxylation is inhibited by mutation the flipping/migration process may be prevented. 
Therefore, what appears to be involvement in both reactions may be a secondary effect from 
inhibition of the first reaction. To confirm this hypothesis, monodecarboxysirohaem could be 
incubated with the mutants. However, both 12-monodecarboxysirohaem and 18-
monodecarboxysirohaem would have to be tested, and production of these intermediates is 
not currently possible by enzymatic means. Tyr117A appears to accrue 
monodecarboxysirohaem (22% after overnight incubation) suggesting that mutation of this 
residue may prevent the second decarboxylation from occurring, although its exact role is yet 
to be determined. 
 
Some of the mutations in the HXYXR motif of AhbB have a different effect to the 
homologous mutations in AhbA. For example, Tyr100B maintained 42% activity and 
therefore does not appear to be essential. Arg102B had greater yield of 
monodecarboxysirohaem (11%), but did not produce any didecarboxysirohaem. This would 
suggest the Arg102B protein capable of the first decarboxylation, although at a reduced 
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level, but it is not able to carry out a second decarboxylation. His98B produced a small 
quantity of monodecarboxysirohaem (3%), which close to the values observed for His115A 
and Arg119A (1% and 2%, respectively), suggesting this residue is either essential for both 
reactions or the initial decarboxylation for reasons described above. The double mutation 
Arg119A/Arg102B only produced 2% monodecarboxysirohaem after overnight incubation, 
further supporting the role of Arg119A in the initial decarboxylation reaction. 
 
In Chapter 4 two reaction mechanisms were proposed based on the structure of AhbA/B with 
didecarboxysirohaem bound. The flipping mechanism (Fig. 4.15) requires Arg102B to be the 
catalytic residue responsible for initiation of both decarboxylation reactions, with the 
tetrapyrrole leaving the active site and flipping 180º about the C5/C15 axis between 
decarboxylations. However, mutation of Arg102B produced monodecarboxysirohaem, 
suggesting involvement in only one of the two decarboxylation reactions. The migration 
mechanism uses the catalytic centres provided by both proteins with Arg119A and Arg102B 
catalysing a single decarboxylation each. The mutant activity data therefore support the 
active site migration mechanism.  
 
For the first decarboxylation reaction His98B would coordinate with the iron. His115A could 
facilitate double bond rearrangement and initial protanation/deprotonation of C19. Arg119A 
could then stabilise carboxylic acid of the acetic acid on C18, allowing decarboxylation to 
occur whilst providing a proton for the developing methyl group. The monodecarboxylated 
intermediate could then unbind/migrate to the second active site using His115A to 
coordinate the iron in the macrocycle, His98B to facilitate protonation/deprotanation of C11 
and Arg102B as the catalytic residue. Tyr117A may play a role in migration of the 
intermediate, hence why the second decarboxlation reaction is affected. 
 
As mentioned in Chapter 4, the structure of the AhbA/B homologue NirD/L from H. 
thermophilus was published during the course of this work (Haufschildt et al., 2014). Site 
directed mutagenesis was performed on a selection of amino acids within this protein, 
including equivalent residues to His115A, Tyr117A, His98B and Tyr100B. His93 (His115A 
equivalent) was shown to be essential for activity, whereas mutations of His226 (His98B 
equivalent) and the tyrosine residues affected substrate binding but not activity. Surprisingly, 
the arginine residues from the HXYXR motif in NirDL were not mutated in the study and 
therefore it is unknown whether these residues are required for the decarboxylase activity of 
NirDL. 
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Tetrapyrrole binding was examined using the mutant AhbA/B proteins and the enzyme-trap 
approach for tetrapyrrole isolation. A variety of colours were observed (Fig. 5.3), most likely 
due to the varying concentrations of protein and oxidation states of the bound tetrapyrroles. 
Of the complexes studied the majority displayed occupancies 15-30% to that of the wild type 
(based on A280:A395 ratio). The Arg102B and Arg119A/Arg102B mutants displayed haem-
like spectra. The presence of haem suggests advantageous haem uptake during 
overproduction. Addition of ALA to the cultures naturally causes an increase in haem within 
the cells, as well as the desired increase in sirohaem, increasing the availability of free haem 
for these complexes to bind. The alteration of positive arginines to small hydrophobic 
alanines would affect the overall charge of the active site cleft. The positive charge of the 
wild type active site would normally draw in the negative charges of the acetate and 
propionate side chains of sirohaem. Producing a more hydrophobic cleft appears to reduce 
the specificity of the active site. Haem lacks the acetate side chains and is therefore more 
hydrophobic, allowing it to bind more easily in the modified active site. 
 
Due to the technical problems experienced and time constraints, analysis of the bound 
tetrapyrroles could not be performed. As the UV-visible spectra of sirohaem and its 
decarboxylated derivatives are near identical the only way to determine what is bound is by 
extraction and HPLC-MS analysis. Analysis of these bound molecules would provide further 
insight into the reaction mechanisms proposed, especially if some of the mutants trap 
sirohaem or monodecarboxysirohaem. EPR analysis of histidine mutants would also provide 
information about the coordination of the iron in the tetrapyrrole/enzyme complexes. 
 
Novel chimeric complexes were produced using the AhbA and AhbB proteins from D. 
desulfuricans and D. vulgaris. In both cases the pull-down method of protein purification 
(using His6-tagged AhbB) allowed copurification of the chimeric AhbA/B complex. These 
novel chimeric complexes were equally active in comparison with the native complexes, 
demonstrating the proteins are capable of acting cooperatively to decarboxylate sirohaem. 
Whilst this may be expected given the high sequence identity (72% and 67% for AhbA and 
AhbB, respectively), these experiments allowed the tetramerisation and haem binding 
properties of the D. vulgaris complex (described in Chapter 3) to be attributed to a single 
subunit. The chimeric complex containing AhbA from D. vulgaris forms both tetrameric and 
dimeric species whereas the complex with D. desulfuricans AhbA is only present as a dimer. 
Similarly, the complex containing AhbA from D. vulgaris was able to bind haem during 
overproduction in E. coli. These data suggest that both the haem binding and tetramerisation 
domains reside in the AhbA subunit of the D. vulgaris AhbA/B complex. No chimeric 
complexes involving Ahb proteins from M. barkeri could be purified. The reason for the lack 
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of compatibility between the M. barkeri AhbA/B proteins and those from the Desulfovibrio 
species is unclear. Structural predictions using the Phyre2 server (Kelley & Sternberg, 2009) 
show a similar fold with no obvious extensions or areas or alternative secondary structure 
other than the first and final β-sheets of each protein which are predicted to be loops (Fig. 
5.9). The loops regions may be due to the protein folds being predicted independently before 
being superimposed on the known AhbA/B structure. It is likely that the poor interactions are 
a result of sequence differences in the dimerisation regions. However, due to these regions 
being poorly predicted in the model it is hard to ascertain if this is the cause.  
 
                                  
Figure 5.9. Structural prediction of the M. barkeri AhbA/B complex (red) produced 
using the Phyre2 server superimposed on D. desulfuricans AhbA/B. Structural 
predictions were performed using individual AhbA and AhbB protein sequences from M. 
barkeri and therefore are unable to predict β1 and β6 regions that likely form interactions 
between the two subunits.  
 
In summary, these data have demonstrated that the AhbA/B complexes from the 
Desulfovibrio species are able to tightly bind their product. The mutation of residues in the 
active site has supported the dual action of pseudo-symmetrical active sites resulting in the 
double decarboxylation of sirohaem with the migration of a monodecarboxylated 
intermediate between reactions. It has also been suggested that Arg119A and Arg102B not 
only play a catalytic role but also allow specificity for the negatively charged groups of the 
substrate and monodecarboxylated intermediate. Finally, production of chimeric complexes 
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revealed AhbA from D. vulgaris is responsible for formation of tetrameric complexes as well 
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6.1 Which tetrapyrrole is the most ancient cofactor? 
The results presented in this work also contribute to the discussion concerning the evolution 
of the modified tetrapyrroles. There are many arguments as to which tetrapyrrole is the most 
ancient cofactor, a question which is yet to be given a definitive answer. Cobalamin was 
once envisaged to be the oldest modified tetrapyrrole; based on the nucleotide loop and 
involvement in ribonucleotide reduction, attributes that were suggested to be relics of the 
RNA world (Benner et al., 1989, Dickman, 1977). The main roles associated with cobalamin 
are methylation reactions and radical generation for catalysis of rearrangement reactions 
(Roth et al., 1996). Both of these reactions can be carried out by radical SAM enzymes (Atta 
et al., 2010, Frey et al., 2008) and given the simplicity of SAM and the early evolution of 
iron sulphur clusters (Mendel et al., 2007), radical SAM enzymes likely predate cobalamin-
dependent processes. The earlier evolution of radical SAM enzymes suggests there was no 
evolutionary driving force for cobalamin in early life. The nickel containing coenzyme F430 
is found exclusively in methanogens and contains a highly reduced ring system (Thauer, 
1998). Whilst it has been considered to have a role in early biotic life (Benner et al., 1989) 
the enzymes involved in the pathway remain elusive restricting further understanding of the 
evolution of this pathway.  
 
Though haem and chlorophylls were once considered related to aerobic metabolism, there is 
evidence of their early (pre-oxygenic) origin. There is a strong indication that photosynthesis 
evolved three billion years ago, within half a billion years of the origin of life, suggesting 
very early evolution of chlorophylls (Tice & Lowe, 2006). Haem containing terminal 
oxidases are likely to predate oxygenic photosynthesis according to sequence and 
phylogenetic analysis (Schafer et al., 1996). The discovery of the alternative haem 
biosynthesis pathway, which operates under anaerobic conditions, further supports the 
existence of haem in ancient life (Akutsu et al., 1993, Bali et al., 2011). 
 
Sirohaem, however, is a prime candidate as the most ancient modified tetrapyrrole. With the 
shortest biosynthesis pathway of all the modified tetrapyrroles, sirohaem is the easiest to 
make biosynthetically (Warren & Scott, 1990). Some obligate anaerobes lack cytochromes 
but contain sirohaem, suggesting the use of sirohaem as a primitive alternative to haem 
(Crane & Getzoff, 1996). In this way, dissimilatory sulphite reduction coupled to electron 
transport facilitated energy generation before oxidative respiration was possible. The 
requirement of sirohaem as an intermediate of alternative haem and haem d1 synthesis (Bali 
et al., 2014) further promotes the antiquity of this cofactor. Whilst current research has still 
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not come to a conclusion on which modified tetrapyrrole represents the most ancient 
specimen, the evidence for sirohaem being one of the forerunners is undeniable. 
 
6.2 Development of the haem biosynthesis pathways 
The discovery of the alternative haem biosynthesis pathway raises questions as to how and 
why Nature derived two very different methods for the synthesis of the same molecule. 
Dissimilatory sulphate reduction represents one of the oldest energy conserving respiratory 
systems on Earth and proceeds via the highly toxic intermediate sulphite (Susanti & 
Mukhopadhyay, 2012). Organisms using this process employ a dissimilatory sulphite 
reductase in order to combat this toxicity. Sulphite reductases belong to two groups, the 
simplest of which utilises sirohaem as a cofactor. Therefore, as mentioned previously, early 
prokaryotic life probably contained sirohaem. Given the anaerobic nature of alternative haem 
biosynthesis and the group of organisms that utilise it, the alternative pathway likely 
represents a primitive pathway for haem biosynthesis. The alternative pathway was probably 
formed via the patchwork model of pathway evolution. The patchwork model describes the 
fortuitous development of new intermediates by the action of broad specificity enzymes, 
followed by duplication and specialisation of advantageous enzymes resulting in formation 
of novel pathways (Ycas, 1974, Jensen, 1976). Through the action and evolution of 
promiscuous enzymes, modifications to sirohaem could have occurred eventually leading to 
the new, more stable tetrapyrrole, haem. With its broader functionality haem has been 
adopted as the prosthetic group for a plethora of proteins across all domains of life. Prior to 
classical haem and chlorophyll biosyntheses all modified tetrapyrroles would have stemmed 
from the intermediates precorrin-2 and sirohydrochlorin. An overview of the branched 
tetrapyrrole biosynthesis pathways is shown in Figure 6.1. Most of the intermediates of the 
alternative haem pathway are oxygen sensitive. Therefore, as atmospheric oxygen increased 
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Figure 6.1. The known branch points of the tetrapyrrole biosynthesis pathways. 
Potential points of regulation between coenzyme F430, cobalamin, sirohaem, haem, and haem 
d1 are displayed as dashed lines. 
 
The cobalamin biosynthesis pathway similarly evolved both aerobic and anaerobic routes 
(Holliday et al., 2007). Cobalamin biosynthesis branches from a common precursor 
(precorrin-2) and converges again at adenosylcobyric acid before final modifications are 
made (Raux et al., 1999b). Many of the enzymes in the cobalamin pathways also share a 
high degree of sequence similarity (Roth et al., 1996, Blanche et al., 1993). In contrast, the 
haem biosynthesis pathways do not reconvene and none of the enzymes involved share 
sequence homology. However, the modifications to the ring system are carried out in a near 
identical fashion during the classical and alternative haem biosynthesis pathways. The 
similarities in side chain modifications demonstrate a chemical precedence for these 
reactions, which allowed the evolution of very different enzymes that perform similar 
reactions.  
 
The evolution of the classical pathway also resulted in a more energetically favourable 
method of haem synthesis. The alternative pathway first requires production of sirohaem 
from uro’gen III, consuming 2 SAM molecules and NAD+. Although the initial action of 
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AhbA/B does not require any cofactor (at least in sulphate reducing bacteria), completion of 
haem synthesis via AhbC and AhbD requires further use of SAM (Lobo et al., 2014, Bali et 
al., 2011). Total SAM consumption from uro’gen III to haem via the alternative pathway lies 
in the region of 4-6 molecules (quantitative studies with AhbC and AhbD are yet to be 
performed) and 1 NAD
+
. In contrast, the synthesis of haem along the classical pathway 
requires fewer cofactors. Here, HemE catalyses four decarboxylations of uro’gen III in a 
cofactor-independent manner, essentially carrying out the roles of AhbA/B and AhbC. 
Conversion of the northern propionate groups to vinyl groups is either catalysed by the 
SAM-dependent enzyme HemN or the cofactor-independent membrane associated enzyme 
HemF. Ring oxidation by HemY/G requires FAD or FMN as a cofactor (it is unknown what 
cofactor is used by HemJ). Finally, chelation of iron into the macrocycle is another cofactor-
free reaction. In total the classical pathway only requires FAD/FMN, with the addition of 2 
molecules of SAM for organisms using HemN to convert copro’gen to proto’gen. Therefore 
there is a significant energetic advantage for organisms using the classical haem synthesis 
pathway. 
 
6.3 The similarities and differences of HemE and AhbA/B 
HemE catalyses four successive decarboxylations of uro’gen III (at carbons C3, C8, C12 and 
C18) to form copro’gen III (Fig. 1.6). The decarboxylations at carbons C12 and C18 are 
analogous to those carried out on sirohaem by the AhbA/B complex. HemE functions 
without use of a cofactor as do the AhbA/B complexes from D. desulfuricans and D. 
vulgaris; whilst it is unknown if the haem associates with the M. barkeri AhbA/B complex 
functions as a cofactor or as regulatory mechanism in an indirect fashion. Despite these 
similarities, the HemE and AhbA/B proteins do not share sequence or structural similarity 
(Fig. 6.2A/C). HemE forms a homodimer; however each monomer is a catalytic unit capable 
of binding one uro’gen III molecule (Phillips et al., 2003). Whilst similar in size to the 
AhbA/B complex, the 40.8 kDa monomeric protein is comprised of a single domain with 
(β/α)8-barrel fold (Whitby et al., 1998). The active site cleft is formed by loops at the C-
terminal ends of the barrel strands. The product bound complex (PDB 1R3Y) shows that 
copro’gen III adopts a domed conformation with the active site with Asp86 (human 
numbering) coordinating a pyrrole NH group conferring stability. The substrate binding 
pocket is overall positively charged with several conserved arginine residues, some of which 
coordinate with the substrate propionate groups (Fig. 6.2B). One of these conserved 
arginines (Arg37 in humans) has been attributed to catalysis, playing a direct role in the 
decarboxylation process (Lewis & Wolfenden, 2008). 






Figure 6.2. Product bound structures of human HemE (PDB 1R3Y) and D. 
desulfuricans AhbA/B (PDB 4UN1). A. Overall view of the human HemE protein with 
bound copro’gen III (atom coloured), B. Close-up of active site of human HemE with 
conserved residues (Arg37, Arg41, Arg50 and Asp86) and copro’gen III displayed as sticks, 
C. Overall view of D. desulfuricans AhbA/B with bound didecarboxysirohaem (atom 
coloured), D. Close-up of active site of D. desulfuricans AhbA/B with conserved residues 
(His115A, Tyr117A, Arg119A, His98B, Try100B and Arg102B) and didecarboxysirohaem 
displayed as sticks.  
 
The crystal structure of D. desulfuricans AhbA/B revealed that is has an entirely different 
fold to that of HemE. The heterodimer is formed of two domains, an N-terminal head 
domain consisting of two HtH motifs and a C-terminal RAM-like domain where the active 
site cleft is located (Fig. 6.2C/D). The two proteins interact at the start of the linker regions, 
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the base of the RAM-like domains and finally at the side of the RAM-like domains, where 
the terminal β-strands form a β-sheet with the opposing proteins. Both AhbA and AhbB 
share a near identical fold with the only exception being a short helical region in AhbA, 
located in the linker region. The different linkers appear to effect the orientation of the HtH 
domains, with AhbA being angled towards that of AhbB.  
 
Previous research surveying archaeal genomes for the ahb genes revealed that all of the 
archaea that contain the alternative haem biosynthesis pathway either have both ahbA and 
ahbB or and ahbA/B fusion (Storbeck et al., 2010), demonstrating the essential requirement 
for both genes. The presence of ahbA and ahbB is likely due to a gene duplication event and 
subsequent sequence variation, producing an asymmetric dimer which provides a match of 
rigidity on one side of the dimer and an open conformation on the other, allowing access to 
the active site. The difference in the linker regions appears to be essential in forming this 
asymmetry. A homodimer of AhbA would cause clashes with the HtH domains as they adopt 
a more upright conformation with a more ordered linker region. The linker regions would 
also block access to the active site cleft on both sides of the complex. Conversely the flexible 
linkers of AhbB would likely produce more unstable homodimer as well as generating a 
much more solvent accessible active site cleft. The close association of the two Ahb proteins 
explains why the individual proteins were so unstable during purification (Section 3.2.1). 
Without their counterpart the individual proteins would have exposed hydrophobic areas 
causing aggregation of the proteins. Whilst the in vitro activity assays of individual AhbA 
and AhbB proteins demonstrated their ability to perform the decarboxylation reactions to 
varying degrees of efficiency, combinations of AhbA and AhbB displayed full activity and 
supports the essential nature of both proteins for a fully functional sirohaem decarboxylase 
(Section 3.2.2). From the structure of the active site it is likely that the activity observed with 
individual proteins was catalysed by poorly formed homodimers.  
 
As with HemE, the base of the active site cleft of AhbA/B contains a positive charge 
provided by Arg119A and Arg102B. Arg119A interacts with the propionate group of ring D 
in the product bound structure and Arg102B is within range of C12, where the propionate 
leaving group would be located prior to decarboxylation. Unlike copro’gen III, 
didecarboxysirohaem adopts a much flatter conformation in the active site with the sites of 
decarboxylation located within the cleft (Fig. 6.2D). His115A plays a similar role to Asp86 
in HemE, however instead of coordinating a pyrrole nitrogen it coordinates the iron in the 
macrocycle that is not present in copro’gen III. Sequence similarity suggested the role of a 
conserved HXYXR motif in both AhbA and AhbB. Site directed mutagenesis of the 
HXYXR motif in both proteins provided evidence of the involvement of all of these 
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conserved residues except Tyr100B. From these data Arg102B does not appear to be the sole 
catalytic residue as the mutated protein was capable of producing monodecarboxysirohaem, 
supporting the migration mechanism of decarboxylation (described in Chapter 4). What is 
remarkable about the use of Arg102B (and probably Arg119) as catalytic residue(s) is the 
fact that, despite the differences in sequence and structure between HemE and AhbA/B, 
Nature has evolved two enzymes that enhance the decarboxylations of kinetically stable 
substrates by very similar mechanisms. 
 
The work presented in this thesis has provided an insight into the active site of the AhbA/B 
complex and the residues that are involved in product binding and catalysis. However, some 
questions remain unanswered, including whether there is a specific order of decarboxylation 
and the exact reaction mechanism utilised by AhbA/B. The active site mutants generated 
provide an excellent tool to address these questions. It is unknown whether His115A, 
Tyr117A and Arg119A are essential for both decarboxylation reactions or if loss of function 
is due to the inhibition of the initial decarboxylation. To test this hypothesis 
monodecarboxysirohaem must be isolated and then assayed with these mutant AhbA/B 
complexes. If turnover is achieved then this would support the migration mechanism of 
decarboxylation and it may be possible to ascertain an order of decarboxylation. Mutagenesis 
also revealed the unexpected involvement of His63B located in the linker region of AhbB. 
Analysis of this mutation demonstrated an overproduction of monodecarboxysiorhaem after 
10 minutes, which was then converted to didecarboxysirohaem after overnight incubation. 
His63B is therefore expected to play a role in substrate migration or flipping. Use of the 
His63B mutant complex can be employed for the production of monodecarboxysirohaem 
which can be utilised in the aforementioned experiments to determine the order of 
decarboxylation. Whilst all mutations tested appear to trap sirohaem or haem derivatives, 
mass spectrometry data would be essential for the characterisation of the bound compounds. 
Again, this may represent a convenient method for the determination of the order of 
decarboxylation.  
 
6.4 Regulation of overlapping biosynthesis pathways 
Many organisms have the ability to produce multiple tetrapyrroles which all stem from the 
common precursor uro’gen III and further branch at intermediates such as precorrin-2 and 
sirohydrochlorin (Fig. 6.1). Therefore, tight regulation of each tetrapyrrole biosynthesis 
pathway is required to allow flux along the correct pathway according to the organisms 
needs. Pathway regulation is particularly relevant for the sulphate reducing bacteria and 
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methanogenic archaea which require cobalamin, sirohaem, haem and coenzyme F430 
(methanogens only). These organisms require regulation at each branch point including 
precorrin-2, sirohydrochlorin and sirohaem. Furthermore, it has been shown that D. 
desulfuricans uses iron coproporphyrin III as a unique cofactor in bacterioferritin (Romao et 
al., 2000), again requiring a further point of regulation in the alternative haem pathway in 
this organism. Whilst regulation of anaerobic cobalamin and sirohaem syntheses likely 
occurs via modulation of chelatase activity (Stroupe et al., 2003), further regulation is 
required for the conservation of sirohaem within the cell, modulating its use as both an 
enzyme cofactor and a pathway intermediate. 
 
The redox controlled activity observed with the haem bound M. barkeri AhbA/B complex 
might represent a regulatory mechanism for sirohaem conservation utilised by the Archaea. 
Purification of other archaeal AhbA/B proteins will help determine if this is a conserved 
mechanism within the Archaea. D. vulgaris AhbA/B was found to bind haem at a much 
lower occupancy, and aerobically purified protein demonstrated full activity in vitro 
suggesting the haem does not affect activity of this complex. Similar haem-redox regulation 
would also appear to be absent from the D. desulfuricans complex as it did not copurify with 
haem. Therefore it is suspected that the sulphate reducers have an alternative method of 
regulation in comparison to the Archaea.  
 
From the product bound AhbA/B structure it is clear that only a single tetrapyrrole could fit 
in the active site cleft at one time, therefore the haem bound to the D. vulgaris and M. 
barkeri complexes must be located at an alternative site. Given that D. vulgaris and M. 
barkeri do not contain any conserved histidines that are not also present in D. desulfuricans 
and both haem binding proteins display slightly different characteristics (e.g. haemochrome 
peak differences and tight binding by D. vulgaris) it is possible they have different haem 
binding sites.  
 
The chimeric complexes produced from the proteins of the sulphate reducing bacteria reveal 
that both the haem binding and tetramerisation capacity of the D. vulgaris complex can be 
attributed to the AhbA subunit, although it is unknown if these are in any way linked. The N-
terminal region of D. vulgaris AhbA contains 4 histidine residues that are not conserved in 
the other proteins, which may be a candidate for haem binding. M. barkeri AhbA contains a 
histidine (His171) that is not present in the other AhbA proteins tested. The equivalent 
residue is from D. desulfuricans is Lys159A which is located on sheet β6, the final strand 
that interacts with the RAM-like domain of the other subunit. Lys159A is exposed to the 
solvent within range of α4 which may provide a surface suitable for further interactions with 
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the haem molecule. However, His171 is not conserved among the archaeal proteins. 
Therefore, if haem binding is an archaeal trait His171 is unlikely to be the coordinating 
residue.  
 
Site directed mutagenesis or crystallisation of a haem bound AhbA/B complex could be 
employed to further study these potential binding sites. Similarly, a comparative analysis of 
the binding/dissociation constants of the two haem binding proteins would be useful to 
further understand the association of these complexes and the prosthetic group. Whilst D. 
vulgaris has a lower occupancy it appears to have a great binding affinity as the haem is 
extremely hard to remove. However, these experiments would be difficult to perform as the 
proteins advantageously bind haem within the cell and therefore purify in the haem bound 
state. This would affect any binding measurements as there would already be a level of haem 
occupancy. Unfolding the protein and then removal of the haem by HPLC separation or 
dialysis followed by reconstitution of the complex may be a means to obtain apo-protein. 
Haem-free M. barkeri AhbA/B would also be extremely interesting for analysis of in vitro 
activity of the apo-protein complex. 
 
Another appealing theory for the regulation of the alternative haem biosynthesis pathway 
stems from the crystal structure of D. desulfuricans AhbA/B. Solution of the structure 
revealed a striking resemblance to the Lrp/AsnC family of transcriptional regulators. While 
sequence similarity predicted the HtH motif to be present, the conservation of the lower 
RAM-like domain was unexpected. The similarity of these proteins furthers the question as 
to whether AhbA/B carries out both a catalytic and a regulatory role at the level of DNA. 
AhbB is more structurally similar to E. coli AsnC (PDB 2CG4; overall RMSD of 2.6 Å for 
138 Cα atoms) than AhbA (overall RMSD of 3.8 Å for 123 Cα atoms). However, the lower 
structural similarity is clearly caused by the angling of the HtH domain of AhbA towards 
that of AhbB (Fig. 4.10), causing the opening of the side of the dimer and allowing access to 
the cleft formed between the RAM-like domains (Fig. 6.2C). Movement of the AhbA HtH 
domain into a position similar to AhbB would allow both domains to be in the correct 
orientation for DNA binding, but would likely block or reduce access to the active site cleft. 
If the AhbA/B complex is also a DNA binding protein, this domain movement would 
represent an extremely elegant method of both enzyme and DNA regulation. One can 
envisage that when haem synthesis is required AhbA/B is in the catalytic form, unable to 
bind DNA but allowing access to the active site cleft. In the event of haem synthesis no 
longer being required, an HtH domain movement would allow AhbA/B to switch to the 
catalytically inactive DNA binding form. The domain movement may occur after the binding 
of an effector molecule. Binding of amino acids (including leucine, asparagine, alanine, 
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valine, lysine and proline) by members of the Lrp/AsnC family regulates multimerisation 
and DNA binding properties of these proteins (Brinkman et al., 2003). Therefore, these 
amino acids represent prime candidates as effector molecules for the AhbA/B complex. An 
obvious target for repression would be the ahbC and/or ahbD genes. This hypothesis is 
strengthened by the fact that the AhbA/B homologue NirL from H. fasciatum has been 
shown to bind DNA, specifically the putative promoter of nirJ2, a gene homologous to ahbC 
and ahbD (Xiong et al., 2007). Experimental evidence is required to confirm the DNA 
binding properties of the AhbA/B complex.  
 
The structural similarities of the AhbA/B complex and the Lrp/AsnC family raises many 
questions about the evolution of this decarboxylase. If the AhbA/B complex does bind DNA, 
was AhbA/B a transcriptional regulator which gained the catalytic function, or a fusion of 
two proteins to form a bifunctional enzyme? Alternatively, if the complex does not bind 
DNA, does this represent a loss of function and a repurposing of the protein? Genome-wide 
searches may aid the understanding of the origin of these proteins. However, misannotations 
of many of the AhbA/B proteins as Lrp/AsnC proteins hinders this process. Confirmation of 
the function of the HXYXR motif in AhbA/B proteins may provide a means for discovering 
true AhbA/B proteins and allow annotation of many of these family members. 
 
Unlike the complexes from D. desulfuricans and M. barkeri the D. vulgaris complex forms 
both dimeric and tetrameric structures. The tetrameric complex may have a functional 
application with regards to regulation of activity or haem/DNA binding. Dimeric and 
tetrameric fractions were not separated prior to in vitro assays, therefore it is unknown if one 
form is active and the other is not. It is also unknown if these complexes are dynamic, 
reaching an equilibrium between the two forms in solution, or if an effector molecule is 
required for their formation. Members of the Lrp/AsnC family have been shown to form a 
variety of oligomers, some of which are regulated by amino acid binding (Brinkman et al., 
2003). Lrp/AsnC proteins form homodimeric subunits which are then arranged into higher 
order structures by dimer-dimer associations between their C-terminal RAM domains (Ren 
et al., 2007). Therefore it is likely that the tetrameric form of D. vulgaris AhbA/B is 
produced by similar dimer-dimer interactions. Site directed mutagenesis of potential 
tetramerisation regions or cross-linking experiments may be useful methods for analysis of 
the dimeric and tetrameric species. 
 




The alternative haem biosynthesis pathway likely represents a primitive route for haem 
synthesis. Although the metabolic pathway has been elucidated much remains unknown 
about the enzymes involved. The work presented within this thesis has provided major 
insights into the enzymes that catalyse the decarboxylation of sirohaem, the initial step of the 
alternative haem biosynthesis pathway. Sirohaem decarboxylase was revealed to be a 
heteromeric complex formed by AhbA and AhbB. Although only three AhbA/B protein 
complexes were examined, a surprisingly high degree of cross-species variation was 
observed raising many questions regarding enzyme regulation, haem/product binding and 
oligomerisation state of AhbA/B proteins. The structure of the AhbA/B complex from D. 
desulfuricans presented in this work represents the first enzyme from the alternative haem 
biosynthesis pathway to have its structure solved, and the first structure of a sirohaem 
decarboxylase. The structure of the AhbA/B complex revealed that whilst AhbA/B and its 
counterpart HemE have distinctly different sequences and structures, they have both evolved 
a similar mechanism for catalysis of decarboxylation reactions. Furthermore, a striking 
similarity with the Lrp/AsnC family of transcriptional regulators was revealed, leading to the 
question as to whether these proteins have both a catalytic and regulatory function. Whilst 
many properties of sirohaem decarboxylases have been discovered during this work, the 
cross-species variations have given rise to many unanswered questions, demonstrating there 
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Appendix I – Thermal Shift Assay Buffers 
Screen 1 
All buffers were pH adjusted using glacial acetic acid or sodium hydroxide prior to use. All 
conditions were used at a final concentration of 100 mM containing 100 mM NaCl. 
 
Buffer pH Melting temperature (°C) 
Tri-sodium citrate 4.2 25.2 
Tri-sodium citrate 4.6 34.8 
Tri-sodium citrate 5 50.0 
Tri-sodium citrate 5.4 54.6 
Tri-sodium citrate 5.8 50.8 
Tri-sodium citrate 6.2 55.8 
MES 5.7 47.4 
MES 5.9 48.4 
MES 6.4 53.0 
MES 6.8 53.2 
Sodium cacodylate 6.5 54.6 
HEPES 6.8 52.2 
HEPES 7.2 56 
HEPES 7.6 57 
HEPES 8.0 56.8 
Tris  7.2 57.2 
Tris  7.6 54.6 
Tris  8.0 55.6 
Tris  8.4 54.6 
Tris  8.8 54.8 
Tris  9.0 54.4 
Glycine 9.4 54.8 












Screen 2 was performed using 100 mM HEPES, pH 8.0 (adjusted using glacial acetic acid), 
with the following additives: 
Additive(s) Concentration (mM) Melting temperature (°C) 
NaCl 10 58.2 
NaCl 100 58.6 
NaCl 250 58.8 
NaCl 500 42.8 
NaCl / β-mercaptoethanol 100 / 2.5 58 
NaCl / β-mercaptoethanol 100 / 5 58.6 
NaCl / dithiothreitol 100 / 2.5 57.6 
NaCl / dithiothreitol 100 / 5 58.4 
NaCl / glycerol 100 / 5% (v/v) 58 
NaCl / glycerol 100 / 10% (v/v) 58.6 
KCl 100 58 
 
Appendix II – Crystallisation Screens 
Structure screen 1™ 
Condition Salt Precipitant(s) Buffer 
1 0.02 M Calcium 
chloride dihydrate 
30% (v/v) 2-methyl-2,4 
pentanediol 
0.1 M Na Acetate 
trihydrate pH 4.6 
2 0.2 M Ammonium 
acetate 
30% (w/v) PEG 4000 0.1 M Na Acetate 
trihydrate pH 4.6 
3 0.2 M Ammonium 
sulphate  
25% (w/v) PEG 4000 0.1 M Na acetate 
trihydrate pH 4.6 
4  2.0 M Sodium formate 0.1 M Na acetate 
trihydrate pH 4.6  
5  2.0 M Ammonium sulphate 0.1 M Na acetate 
trihydrate pH 4.6 
6  8% (w/v) PEG 4000  0.1 M Na acetate 
trihydrate pH 4.6 
7 0.2 M Ammonium 
acetate 
30% (w/v) PEG 4000 0.1 M tri-sodium citrate 
dihydrate pH 5.6 




0.1 M tri-sodium citrate 
dihydrate pH 5.6 
9   20% (w/v) 2-propanol, 20% 
(w/v) PEG 4000 
0.1 M tri-Sodium citrate 
dihydrate pH 5.6 
10   1.0M Ammonium 
dihydrogen phosphate 
0.1 M Na Citrate pH 5.6 
11 0.2 M Calcium 
chloride dihydrate 
20% (v/v) 2-propanol 0.1 M Na acetate 
trihydrate pH 4.6 
12  1.4 M Na acetate trihydrate 0.1 M Na Cacodylate pH 
6.5 
13 0.2 M tri-sodium 
citrate dihydrate 
30% (v/v) 2-propanol 0.1 M Na Cacodylate pH 
6.5 




sulphate  6.5 
15 0.2 M Magnesium 
acetate tetrahydrate 
20% PEG 8000 0.1 M Na Cacodylate pH 
6.5 
16 0.2 M Magnesium 
acetate tetrahydrate  
30% (v/v) 2-methyl-2,4-
pentanediol 
0.1 M Na Cacodylate pH 
6.5 
17  1.0 M Sodium acetate 
trihydrate 
0.1 M Imidazole pH 6.5 
18 0.2 M Sodium 
acetate trihydrate 
30% (w/v) PEG 8000 0.1 M Na Cacodylate pH 
6.5 
19 0.2 M Zinc acetate 
dihydrate  
18% (w/v) PEG 8000 0.1 M Na Cacodylate pH 
6.5 
20 0.2 M Calcium 
acetate hydrate 
18% (w/v) PEG 8000 0.1 M Na Cacodylate pH 
6.5  




0.1 M Na HEPES pH 7.5 
22 0.2 M Magnesium 
chloride hexahydrate 
30% (v/v) 2-propanol 0.1 M Na HEPES pH 7.5 
23 0.2 M Calcium 
chloride dihydrate 
28% (v/v) PEG 400 0.1 M Na HEPES pH 7.5  
24 0.2 M Magnesium 
chloride hexahydrate  
30% (v/v) PEG 400 0.1 M Na HEPES pH 7.5 
25 0.2 M tri-sodium 
citrate dihydrate  
20% (v/v) 2-propanol 0.1 M Na HEPES pH 7.5 
26   0.8 M K, Na tartrate 
tetrahydrate 
0.1 M Na HEPES pH 7.5 
27  1.5 M Lithium sulphate 
monohydrate 
0.1 M Na HEPES pH 7.5 
28  0.8 M Na dihydrogen 
phosphate 
0.1 M Na HEPES pH 7.5 
      0.8 M K dihydrogen 
phosphate monohydrate 
29   1.4 M tri-Sodium citrate 
dihydrate 
0.1 M Na HEPES pH 7.5  
30   2% (v/v) PEG 400, 2.0M 
Ammonium sulphate 
0.1 M Na HEPES pH 7.5  
31   10% (v/v) 2-propanol, 20% 
(w/v) PEG 4000 
0.1 M Na HEPES pH 7.5 
32  2.0 M Ammonium sulphate 0.1 M Tris HCl pH 8.5 
33 0.2 M Magnesium 
chloride hexahydrate 
30% (w/v) PEG 4000 0.1 M Tris HCl pH 8.5 
34 0.2 M tri-sodum 
citrate dihydrate 
30% (v/v) PEG 400 0.1 M Tris HCl pH 8.5 
35 0.2 M Lithium 
sulphate 
monohydrate 
30% (w/v) PEG 4000 0.1 M Tris HCl pH 8.5 
36 0.2 M Ammonium 
acetate 
30% (v/v) 2-propanol 0.1 M Tris HCl pH 8.5 
37 0.2 M Sodium 
acetate trihydrate  
30% (w/v) PEG 4000 0.1 M Tris HCl pH 8.5 
38   8% (w/v) PEG 8000 0.1 M Tris HCl pH 8.5 
39   2.0 M Ammonium 
dihydrogen phosphate 
0.1 M Tris HCl pH 8.5 






41   0.4 M Ammonium 
dihydrogen phosphate 
 
42 0.2 M Ammonium 
sulphate 
30% (w/v) PEG 8000   
43 0.2 M Ammonium 
sulphate  
30% (w/v) PEG 4000   
44   2.0 M Ammonium sulphate   
45   4.0M Sodium formate   
46 0.05 M Potassium 
dihydrogen 
phosphate 
20% (w/v) PEG 8000  
47   30% (w/v) PEG 1500  
48   0.2M Magnesium formate   
49 1.0 M Lithium 
sulphate 
monohydrate 
2% (w/v) PEG 8000  
50 0.5 M Lithium 
sulphate 
monohydrate 
15% (w/v) PEG 8000  
 
 
Structure screen 2™ 
Condition Salt/Additive Precipitant(s) Buffer 
1 0.1 M Sodium chloride 30% (w/v) PEG 
monomethylether 550 
0.1 M Bicine pH 9.0 
2   2.0 M Magnesium 
chloride hexahydrate 
0.1 M Bicine pH 9.0 
3 2% (w/v) Dioxane 10% (w/v) PEG 
20,000  
0.1 M Bicine pH 9.0 
4 0.2 M Magnesium chloride 
hexahydrate 
3.4 M 1,6 Hexanediol 0.1 M Tris pH 8.5 
5  25% (v/v) tert-butanol 0.1 M Tris pH 8.5 
6 0.01 M Nickel chloride 
hexahydrate 
1.0 M Lithium 
sulphate 
0.1 M Tris pH 8.5 
7 1.5 M Ammonium sulphate 12% (v/v) Glycerol 0.1 M Tris pH 8.5 
8 0.2 M Ammonium phosphate 
monobasic 
50% (v/v) MPD 0.1 M Tris pH 8.5 
9   20% (v/v) Ethanol 0.1 M Tris pH 8.5 
10 0.01 M Nickel chloride 
hexahydrate 
20% (w/v) PEG 
monomethylether 2000 
0.1 M Tris pH 8.5 
11 0.5 M Ammonium sulphate 30% (v/v) MPD 0.1 M HEPES pH 
7.5 
12   10% (w/v) PEG 6000, 
5% (v/v) MPD 
0.1 M HEPES pH 
7.5 
13   20% (v/v) Jeffamine 
M-600 
0.1 M HEPES pH 
7.5 
14 0.1 M Sodium chloride 1.6 M Ammonium 
sulphate 
0.1 M HEPES pH 
7.5 
15  2.0 M Ammonium 
formate 





16 0.05 M Cadmium sulphate 
octahydrate 
1.0 M Sodium acetate 0.1 M HEPES pH 
7.5 
17  70% (v/v) MPD 0.1 M HEPES pH 
7.5 
18  4.3 M Sodium chloride 0.1 M HEPES pH 
7.5 
19  10% (w/v) PEG 8000, 
8% (v/v) Ethylene 
glycol 
0.1 M HEPES pH 
7.5 
20  1.6 M Magnesium 
sulphate heptahydrate 
0.1 M MES pH 6.5 
21 0.1 M Na phosphate 
monobasic 
2.0 M Sodium 
Chloride 
0.1 M MES pH 6.5 
  0.1 M K phosphate monobasic      
22  12% (w/v) PEG 
20,000 
0.1 M MES pH 6.5 
23 1.6 M Ammonium sulphate 10% (v/v) Dioxane 0.1 M MES pH 6.5 
24 0.05 M Cesium chloride 30% (v/v) Jeffamine® 
M-600 
0.1 M MES pH 6.5 
25 0.01 M Cobalt chloride 
hexahydrate 
1.8 M Ammonium 
sulphate 
0.1 M MES pH 6.5 
26 0.2 M Ammonium sulphate 30% (w/v) PEG 
monomethylether 5000 
0.1 M MES pH 6.5 
27 0.01 M Zinc sulphate 
heptahydrate 
25% (v/v) PEG 
monomethylether 550 
0.1 M MES pH 6.5 
28  20% (w/v) PEG 
10,000 
0.1 M HEPES pH 
7.5 
29 0.2 M K/Na Tartrate 2.0 M Ammonium 
sulphate 
0.1 M Sodium 
citrate pH 5.6 
30 0.5 M Ammonium sulphate 1.0 M Lithium 
sulphate 
0.1 M Sodium 
citrate pH 5.6 
31 0.5 M Sodium chloride 4% (v/v) 
polyethyleneimine 
0.1 M Sodium 
citrate pH 5.6 
32  35% (v/v) tert-butanol 0.1 M Sodium 
citrate pH 5.6 
33 0.01 M Ferric chloride 
hexahydrate 
10% (v/v) Jeffamine® 
M-600 
0.1 M Sodium 
citrate pH 5.6 
34 0.01 M Manganese chloride 
tetrahydrate 
2.5 M 1,6 Hexanediol 0.1 M Sodium 
citrate pH 5.6 
35   2.0 M Sodium chloride 0.1 M Sodium 
acetate pH 4.6 
36 0.2 M Sodium Chloride 30% (v/v) MPD 0.1 M Sodium 
acetate pH 4.6 
37 0.01 M Cobalt Chloride 
hexahydrate 
1.0M 1,6 Hexanediol 0.1 M Sodium 
acetate pH 4.6 
38 0.1 M Cadmium chloride 30% (v/v) PEG 400 0.1 M Sodium 
acetate pH 4.6 
39 0.2 M Ammonium sulphate 30% (w/v) PEG 
monomethylether 2000 
0.1 M Sodium 
acetate pH 4.6 
40 2.0 M Sodium chloride 10% (w/v) PEG 6000  
41 0.01 M Cetyl trimethyl 
ammoniumbromide 
0.5 M Sodium chloride 
0.1 M Magnesium 
chloride hexahydrate 
 





43   35% (v/v) Dioxane  
44 2.0 M Ammonium sulphate 5% (v/v) Isopropanol  
45   1.0 M Imidazole pH 
7.0 
  
46  10% (w/v) PEG 1000, 
10% (w/v) PEG 8000 
 
47 1.5 M Sodium chloride 10% (v/v) Ethanol  
48  1.6 M Sodium citrate 
pH 6.5 
 
49 15% (w/v) 
polyvinylpyrolidone 
    
50 2.0 M Urea   
 
Clear Strategy Screen I™ 
Clear Strategy Screen I™ is formulated such that a range of buffers (see below) can be added 
to each salt/precipitant solution to expand the range of conditions screened. Typically, 0.1 





1 0.3 M sodium acetate 25% (w/v) PEG 2000 MME 
2 0.2 M lithium sulphate 25% (w/v) PEG 2000 MME 
3 0.2 M magnesium chloride 25% (w/v) PEG 2000 MME 
4 0.2 M potassium bromide 25% (w/v) PEG 2000 MME 
5 0.2 M potassium 
thiocyanate 
25% (w/v) PEG 2000 MME 
6 0.8 M sodium formate 25% (w/v) PEG 2000 MME 
7 0.3 M sodium acetate 15% (w/v) PEG 4000 
8 0.2 M lithium sulphate 15% (w/v) PEG 4000 
9 0.2 M magnesium chloride 15% (w/v) PEG 4000 
10 0.2 M potassium bromide 15% (w/v) PEG 4000 
11 0.2 M potassium 
thiocyanate 
15% (w/v) PEG 4000 
12 0.8 M sodium formate 15% (w/v) PEG 4000 
13 0.3 M sodium acetate 10% (w/v) PEG 8000 + 10% (w/v) PEG 1000 
14 0.2 M lithium sulphate 10% (w/v) PEG 8000 + 10% (w/v) PEG 1000 
15 0.2 M magnesium chloride 10% (w/v) PEG 8000 + 10% (w/v) PEG 1000 
16 0.2 M potassium bromide 10% (w/v) PEG 8000 + 10% (w/v) PEG 1000 
17 0.2 M potassium 
thiocyanate 
10% (w/v) PEG 8000 + 10% (w/v) PEG 1000 
18 0.8 M sodium formate 10% (w/v) PEG 8000 + 10% (w/v) PEG 1000 
19 0.3 M sodium acetate 8% (w/v) PEG 20000 + 8% (w/v) PEG 550 
MME 
20 0.2 M lithium sulphate 8% (w/v) PEG 20000 + 8% (w/v) PEG 550 
MME 
21 0.2 M magnesium chloride 8% (w/v) PEG 20000 + 8% (w/v) PEG 550 
MME 





23 0.2 M potassium 
thiocyanate 
8% (w/v) PEG 20000 + 8% (w/v) PEG 550 
MME 




Sodium acetate, pH 4.5 
Sodium acetate, pH 5.5 
Sodium cacodylate, pH 6.5 
Tris, pH 7.5 
Tris, pH 8.5 
All buffers are titrated to the specified pH using glacial acetic acid. 
 
Clear Strategy Screen II™ 
Clear Strategy Screen II™ is formulated in an identical manner to Clear Strategy Screen I™ 
using the same buffers and volumes as above. 
Condition Salt Preciptant(s) 
1 1.5 M ammonium sulphate  
2 0.8 M lithium sulphate  
3 2 M sodium formate  
4 0.5 M potassium dihydrogen 
phosphate 
 
5 0.2 M calcium acetate 25% (w/v) PEG 2000 MME 
6 0.2 M calcium acetate 15% (w/v) PEG 4000 
7 2.7 M ammonium sulphate  
8 1.8 M lithium sulphate  
9 4 M sodium formate  
10 1 M potassium dihydrogen 
phosphate 
 
11 0.2 M calcium acetate 10% (w/v) PEG 8000 + 10% (w/v) PEG 
1000 
12 0.2 M calcium acetate 8% (w/v) PEG 20000 + 8% (v/v) PEG 550 
MME 
13  40% (v/v) MPD 
14  40% (v/v) 1,4-Butanediol 
15 0.005 M cadmium chloride 20% (w/v) PEG 4000 
16 0.15 M potassium thiocyanate 20% (v/v) PEG 550 MME 
17 0.15 M potassium thiocyanate 20% (v/v) PEG 600 
18 0.15 M potassium thiocyanate 20% (w/v) PEG 1500 
19  35% (v/v) 2-Propanol 
20  30% (v/v) Jeffamine® M-600 




22 0.15 M potassium thiocyanate 18% (w/v) PEG 3350 
23 0.15 M potassium thiocyanate 18% (w/v) PEG 5000 MME 




Condition Salt/Additive Precipitant(s) Buffer 
1  50% (v/v) polypropylene glycol 400 + 5% 




2  12% (w/v) polyvinylpyrrolidone 0.1 M MES 
pH 5.5 





4  14% (v/v) poly(acrylic acid-co-maelic acid) 
solution 
 




12.5% (w/v) poly(acrylic acid sodium salt) 
2100 
 
6  19% (v/v) poly(acrylic acid-co-maelic acid) 
solution 
0.1 M Tris 
pH 8.5 
7  10% (v/v) polypropylene glycol 400  
8  5% (w/v) poly(acrylic acid sodium salt) 2100  
9  25% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) 
0.1 M MES 
pH 6.0 
10 0.1 M sodium 
sulphate 
24% (w/v) polyvinylpyrrolidone  
11 0.2 M calcium 
chloride 
dihydrate 





12  35% (v/v) polypropylene glycol 400 0.1 M K/Na 
phosphate 
pH 7.0 
13 0.2 M sodium 
chloride 
20% (v/v) Jeffamine® D-2000 + 10% (v/v) 
Jeffamine® M-2005 
0.1 M MES 
pH 5.5 
14 0.2 M sodium 
thiocyanate 





15 0.2 M 
potassium 
acetate 





16 0.2 M sodium 
chloride 
45% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) 
0.1 M MES 
pH 6.0 





18 0.1 M lithium 
sulphate 






19  40% (v/v) polypropylene glycol 400 0.2 M 
Imidazole pH 
7.0 
20 0.06 M 
lithium 
sulphate 
8% (v/v) poly(acrylic acid-co-maelic acid) 





21 0.1 M sodium 
chloride 
35% (v/v) Jeffamine® SD-2001 0.1 M Tris 
pH 8.0 
22  30% (v/v) Jeffamine® M-600 + 10% (v/v) 
dimethyl sulphoxide 
 
23  20% (v/v) polypropylene glycol 400 + 10% 
(v/v) 1-propanol 
 





25  15% (v/v) Jeffamine® ED-2003 + 10% (v/v) 
ethanol 
 
26 0.2 M sodium 
chloride 
30% (v/v) Jeffamine® ED-2003 0.1 M MES 
pH 6.0 




25% (v/v) Jeffamine® SD-2001 0.1 M MES 
pH 5.5 
28 0.2 M sodium 
chloride 
15% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) 
0.1 M MES 
pH 6.0 




35% (v/v) pentaerythritol ethoxylate (3/4 
EO/OH) 
 
30  40% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) + 15% (v/v) ethanol 
 
31  50% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) 
0.1 M Tris 
pH 8.0 
32 0.2 M sodium 
chloride 
12.5% (w/v) polyvinylpyrrolidone + 10% 
(w/v) PEG 4000 
0.1 M Tris 
pH 8.0 
33 0.1 M sodium 
chloride 
25% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) + 10% (v/v) dimethyl sulphoxide 
 
34 0.2 M 
ammonium 
sulphate 









30% (v/v) pentaerythritol ethoxylate (15/4 
EO/OH) 
0.1 M Tris 
pH 8.5 
36 0.2 M 
potassium 
acetate 
24% (v/v) poly(acrylic acid-co-maleic acid) 
solution 
 
37  60% (v/v) polypropylene glycol 400 0.1 M Tris 
pH 8.0 
38  30% (v/v) pentaerythritol ethoxylate (15/4 







39  45% (v/v) polypropylene glycol 400 + 10% 
(v/v) ethanol 
 
40  10% (v/v) pentaerythritol ethoxylate (3/4 
EO/OH) +  10% (v/v) 1-butanol 
 
41  12.5% (w/v) poly(acrylic acid sodium salt) 




42  6% (w/v) polyvinylpyrrolidone 0.1 M 
HEPES pH 
6.5 
43  20% (v/v) Jeffamine® ED-2003 0.1 M 
HEPES pH 
6.5 
44  20% (v/v) glycerol ethoxylate + 10% (v/v) 
tetrahydrofuran 
0.1 M Tris 
pH 8.0 
45  25% (v/v) Jeffamine® D-2000 0.2 M 
Imidazole pH 
7.0 
46 0.2 M 
potassium 
chloride 
30% (v/v) Jeffamine® SD-2001 0.1 M 
HEPES pH 
6.5 
47 0.1 M sodium 
chloride 
30% (v/v) polypropylene glycol 400  
48  20% (v/v) Jeffamine® SD-2001 + 15% (v/v) 
1-propanol 
 
49 0.2 M lithium 
sulphate 
25% (v/v) Jeffamine® T-403 0.1 M Tris 
pH 8.0 
50 0.2 M 
potassium 
acetate 
35% (v/v) pentaerythritol propoxylate (5/4 
PO/OH) 
 
51 0.2 M 
potassium 
chloride 





52 0.2 M sodium 
thiocyanate 





53 0.2 M 
potassium 
chloride 





54 0.2 M 
potassium 
acetate 
15% (v/v) pentaerythritol ethoxylate (15/4 
EO/OH) + 3% (v/v) Jeffamine® T-403 
0.1 M MES 
pH 6.0 









56  10% (v/v) Jeffamine® D-2000 + 10% (v/v) 
Jeffamine® M-2005 + 10% (v/v) ethanol 
 
57 0.1 M lithium 
sulphate 
25% (v/v) Jeffamine® ED-2003 0.1 M Tris 
pH 8.0  
58  10% (v/v) Jeffamine® T-403 
10% (v/v) 
Jeffamine® ED-2003 
0.1 M Tris 
pH 8.0 




sulphate 2100 HEPES pH 
6.5 









61  40% (v/v) Jeffamine® D-2000 0.1 M 
HEPES pH 
6.5 
62 0.5 M sodium 
chloride 
10% (w/v) poly(acrylic acid sodium salt) 
2100 
0.1 M Tris 
pH 8.0 
63  14% (v/v) Jeffamine® ED-900 + 11% (v/v) 
Jeffamine® SD-2001 
0.1 M K/Na 
phosphate 
pH 7.0 
64 0.2 M sodium 
chloride 









20% (v/v) Jeffamine® D-2000 0.1 M MES 
pH 5.5 
66 0.2 M 
potassium 
chloride 
30% (v/v) Jeffamine® M-2070 0.1 M Tris 
pH 8.0 
67  20% (v/v) Jeffamine® M-2070 + 20% (v/v) 
dimethyl sulphoxide 
 




40% (v/v) pentaerythritol propoxylate (17/8 
PO/OH) 
0.1 M MES 
pH 5.5 
69  20% (w/v) poly(acrylic acid sodium salt) 
5100 
0.1 M Tris 
pH 8.0 
70  28% (v/v) polyethyleneimine 0.1 M 
HEPES pH 
7.0 
71 0.1 M 
ammonium 
formate 
20% (v/v) SOKALAN® CP 7 0.1 M 
HEPES pH 
7.0 
72 0.2 M sodium 
sulphate 
20% (w/v) SOKALAN® HP 56 0.1 M Tris 
pH 8.0 
73 0.1 M 
potassium 
chloride 
25% (v/v) SOKALAN® CP 7 0.1 M 
HEPES pH 
7.0 
74 0.3 M 
ammonium 
formate 
20% (v/v) SOKALAN® CP 5 0.1 M 
HEPES pH 
7.0 
75  40% (v/v) glycerol ethoxylate  
76  30% (v/v) glycerol ethoxylate 0.1 M Tris 
pH 8.5 
77  55% (v/v) polypropylene glycol 400  
78 0.2 M lithium 
citrate tribasic 
tetrahydrate 




79 0.2 M 
ammonium 
acetate 
30% (v/v) glycerol ethoxylate 0.1 M MES 
pH 6.5 
80  20% (w/v) SOKALAN® CP 42 + 5% (v/v) 
methanol 
0.1 M Tris 
pH 8.0 
81  25% (w/v) SOKALAN® CP 42 + 10% (v/v) 
tetrahydrofuran 
0.1 M Tris 
pH 7.0 
82 0.1 M lithium 
acetate 
dihydrate 
20% (w/v) SOKALAN® CP 42 0.1 M Bis-
Tris pH 6.0 
83  10% (v/v) Jeffamine® M-2005 0.2 M 
HEPES pH 
6.5 
84  15% (v/v) SOKALAN® CP 5 0.1 M Bis-
Tris pH 6.0 
85  25% (w/v) SOKALAN® CP 42 0.1 M Bis-
Tris pH 6.0 
86  35% (v/v) Jeffamine® D-2000  
87  20% (v/v) glycerol ethoxylate + 3% (v/v) 
polyethyleneimine 
0.1 M Tris 
pH 8.5 
88 0.2 M 
ammonium 
chloride 
25% (v/v) glycerol ethoxylate 0.1 M 
HEPES pH 
7.5 
89  10% (w/v) SOKALAN® CP 42 0.1 M Tris 
pH 8.5 
90  30% (w/v) poly(acrylic acid sodium salt) 
5100 + 10% (v/v) ethanol 
0.1 M MES 
pH 6.0 




15% (w/v) SOKALAN® CP 42  
92  30% (w/v) SOKALAN® CP 42 0.1 M Tris 
pH 8.5 
93 0.2 M 
ammonium 
acetate 
25% (w/v) SOKALAN® HP 56 0.1 M 
HEPES pH 
7.0 
94  25% (v/v) SOKALAN® CP 5 0.1 M Tris 
pH 8.5 
95 0.2 M 
ammonium 
formate 
10% (w/v) polyvinylpyrrolidone + 20% (w/v) 
PEG 4000 
 
96  15% (w/v) polyvinylpyrrolidone + 25% (w/v) 
PEG 5000 MME 
0.1 M Tris 
pH 8.0 
 
Hampton Additive Screen 
Standard screens were performed with 0.2 µL additive combined with 1 µL protein and 0.8 
µL well condition, with the exception of ethanol, isopropanol and methanol. Ethanol, 
isopropanol and methanol were added to the well solution (200 µL additive : 800 µL well 
solution) prior to drop mixing. However, after initial hits with BaCl2, conditions were mixed 





BaCl2 100 mM 
CdCl2 100 mM 
CaCl2 100 mM 
CuCl2 100 mM 
MgCl2 100 mM 
MnCl2 100 mM 
SrCl2 100 mM 
YCl3 100 mM 
ZnCl2 100 mM 
Ethylene glycol 30% (v/v) 
Glycerol (anhydrous) 30% (v/v) 
1,6-hexanediol 30% (v/v) 
MPD 30% (v/v) 
PEG 400 50% (v/v) 
Trimethylamine HCl 100 mM 
Guanidine HCl 1 M 
Urea 100 mM 
1,2,3-heptanetriol 15% (v/v) 
Benzamidine HCl 20% (v/v) 
Dioxane 30% (v/v) 
Ethanol 30% (v/v) 
Isopropanol 30% (v/v) 
Methanol 30% (v/v) 
 
Appendix III – Heavy Atom Soak Solutions 
Crystals were soaked in 1.8 µL stabilising solution [30% (v/v) PEG 4000, 0.2 M ammonium 
acetate, 0.01 M BaCl2, 0.1 M sodium acetate, pH 5.0] containing 0.2 µL heavy atom solution 
for 10-120 min.  
Heavy Atom Compound Stock Concentration (mM) 
Gold (III) chloride 100 
Mercury (II) acetate 100 
Methylmercury (II) chloride 100 
 
